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ABSTRACT 
 
The anterior refractive segment comprises the tear film (TF), cornea and lens.  This 
composite of structures primarily contributes to the refractive power and the quality of 
vision (QOV). Postoperative small incision lenticule extraction had significantly better 
and expedient corneal surface physiology recovery than femtosecond laser-assisted 
laser in situ keratomileusis patients; thereby enhancing their QOV scores. 
Postoperative tear lipid measurements correlated with postoperative glare and 
fluctuating vision. Further research is needed to explore other preoperative TF 
parameters. 
 
 
Functional vision is a binocular function; however, clinical assessment of vision is 
routinely monocular. This dichotomy to some degree confounds the subjective 
questionnaire assessments.  Pupil size (PS) has a direct influence upon light and 
aberration entering the eye. Moreover, diffraction of light can be induced iatrogenically 
by refractive surgeries, intra- and extraocular implants and ageing.  The major factor 
found to impact the QOV in an asymmetric multifocal intraocular lens (IOL) was 
preoperative PS and visual axis eccentricity (angle kappa). Since PS generally 
decreases with age, a larger preoperative pupil ensures that postoperatively there is 
adequate exposure of the IOL.  
 
 
Corneal cross-linking (CXL) is a well-accepted treatment for keratoconus. 
Transepithelial phototherapeutic keratectomy (trans-PTK) can remove the epithelium 
and smoothen the anterior cornea. Nine-month follow-up of trans-PTK and CXL 
procedures showed benefits of improved visual acuity and stabilisation of KC at nine-
months follow-up. 
 
Since the 1980’s vision-related quality of life (VR-QOL) questionnaires have been 
explored to capture and measure this concept. The results demonstrate that VR-QOL 
questionnaire performs better than VF-14 questionnaire with less variability in the 
mean range scores. This suggests that the customisable items of VR-QOL 
questionnaire is better at assessing the individuals VR-QOL.  
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This body of work demonstrates the impact of these pathologies and anatomical 
variations upon VA, QOV and VR-QOL. These findings should help guide clinicians 
preoperatively stratify and postoperatively manage patients. 
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CHAPTER 1: INTRODUCTION 
 
Refractive surgery traditionally has been designed with the aim to enable patients to 
see clearly in both the distance and near. In pre-presbyopic patients, that is achieved 
by trying to correct any distance refractive error. If this is successfully achieved, the 
natural focusing mechanisms within the eye enable intermediate and distance vision 
(Miranda and Krueger, 2004). However, presbyopic patients, poses more significant 
problems as correction of distance vision in both eyes does not naturally enable near 
or intermediate vision; especially when the focusing mechanisms have been 
compromised through the ageing process (Salvi, 2006). Currently there is no 
interventional system that can perfectly simulate and substitute the natural focusing 
mechanism within the eye. However, various imperfect solutions that use either laser 
or lens-based techniques have been developed to overcome this intrinsic problem 
(Alió et al., 2009; Reinstein, Archer and Gobbe, 2011; Alió and Pikkel, 2014; McNeely 
et al., 2017). Traditional surgical approaches used by ophthalmologists for the 
treatment of presbyopia (both laser and lens-based) has been through the use of 
monovision techniques (Miranda and Krueger, 2004; Finkelman, Ng and Barrett, 
2009). This consists of making one eye clear for distance and the fellow eye for near 
vision. In the early ‘90s, multifocal IOLs were developed which enabled the 
simultaneous viewing of both distance and near vision through the use of one IOL.  
These multifocal IOLs used more than one focal point within the IOL (Duffey, Zabel 
and Lindstrom, 1990; Kohnen, 2008). 
 
Meanwhile, laser refractive surgery was developed at a similar period and the first 
human eye treated in 1989 by Marguerite B. MacDonald MD (McDonald et al., 1989). 
This advancement enabled surgeons to treat ametropia by changing the shape of the 
cornea. It was achieved by either flattening or steepening the cornea to treat myopia 
or hyperopia respectively. The early stages of laser development produced 
remarkable success in correcting myopia through flattening of the central cornea. 
Myopic laser treatments were initially planned through the use of the Munnerlyn 
formula to define the amount of corneal flattening required (Chang et al., 2003). This 
represented a very successful commencement to laser refractive surgery. However, it 
was noted that some patients suffered from significant dysphotopic symptoms of glare 
and haloes postoperatively (O’Brart et al., 1994; Pop and Payette, 2004). The lesson 
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learnt from this problem was that the peripheral corneal shape also needed to be 
modified along with the flattening of central cornea. This understanding prevented the 
induction of large amounts of spherical aberrations which occurred due to a change in 
corneal shape (from a prolate to an oblate shape) (Chang et al., 2003). The 
advancements in assessment tools in vivo corneal and whole eye allowed the 
measurement of aberrations induced by laser surgery. This allowed iterative 
modification of laser profiles to enhance the corneal shape and measure 
improvements achieved using berrometers (Oshika et al., 1999). These aberrometers 
and topographers allowed clinicians and researchers to study topographic alterations 
and induction of higher-order aberrations in keratoconic eyes. These tools have 
demonstrated that corneal cross-linking (CXL) treatment not only stops the 
progression of disease but also improves visual acuity (VA), spherical equivalent (SE), 
astigmatism and keratometric parameters of the diseased cornea. These findings 
have prompted researchers to investigate outcomes by combining CXL with other 
refractive procedures in- order to improve visual and topographic outcomes. These 
findings have prompted researchers to investigate outcomes by combining CXL with 
other refractive procedures in order to improve visual and topographic outcomes.  
 
In addition to the development of these further objective measurements of optical 
quality within the cornea and eye, the importance of assessing patients’ subjective 
perception of their vision through the use of questionnaires was also recognised by 
clinicians and researchers. Various questionnaires have since been developed and 
validated in an attempt to objectively document the subjective quality of vision (QOV) 
(Wolffsohn and Cochrane, 2000; McAlinden, Pesudovs and Moore, 2010). 
Psychometric methods were also used to document these subjective aspects of vision. 
This was done so that questionnaires could be deemed valid, reproducible and 
objective as possible in recording subjective symptoms. The importance of subjective 
symptom documentation gained importance while trying to document subjective 
issues regarding multifocal IOLs. Additionally,  various researchers and clinicians have 
come to the conclusion that VA alone cannot capture the entire aspects of vision 
function (Massof and Rubin, 2001; Stelmack, 2001).  
 
As surgical techniques have advanced, so have patients’ expectations. This has 
prompted constant research in an attempt to enhance patients visual and quality of 
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life (QOL) outcomes. This thesis attempts to investigate the impact of various anterior 
segment and ocular surface factors upon the quality of outcomes.   
The median age of the UK population according to statistical data has increased 
steadily from 38.7 years in 2005 to 40.0 years in 2015. Increased prevalence of 
presbyopia among the population is due to the increase in the middle-age population. 
As the middle-aged and elderly population continues to increase in UK and Europe, it 
is estimated that visual impairment and cataract will increasingly become the leading 
causes of disability (Holden et al., 2015). Therefore, this will potentially have a 
negative impact on QOL and productivity in these patients (Desai et al., 1996; Alan L. 
Robin,Thulasiraj Ravilla, Rengaraj Venkatesh, 2016). Dry eye (DE) is one of the most 
common ocular complaints among patients visiting eye clinics (Hyman et al., 2009) 
and the prevalence of DE increases with age (Schaumberg, 2009). 
 
Laser refractive surgery has now become one of the most common elective ophthalmic 
surgical procedures. This is due its excellent postoperative uncorrected VA, and 
minimal and accelerated corneal wound healing. This is a result of improved technique, 
laser technology and ablation nomograms (Denoyer, 2015). Change in lifestyle of 
patients has also prompted current multifocal IOL design to accommodate extended 
spectacle-free use of computers and mobile devices. As there is a growing trend of 
patients who desire to be spectacle-free following cataract surgery, these also include 
patients who previously had laser refractive surgery for myopia (Khor and Afshari, 
2013; Chang et al., 2017). The ever-increasing number of post-refractive surgery 
patients and contact lens wearers who consequently develop DE is an issue that 
needs to be addressed imperatively by clinicians. 
 
A better understanding of pre-- and postoperative factors and their influence upon the 
postoperative QOV and VR-QOL can help guide treatments as per individual needs. 
The purpose of this body of work is to build upon the knowledge of screening, 
monitoring and management of these ophthalmic anomalies and their effects upon 
QOV and VR-QOL. 
 
This introductory chapter presents details of the ophthalmic anomalies and a review 
of the current literature. 
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1.1 The tear film  
 
The tear film (TF) envelops the anterior surface of the eye. The TF represents a 
dynamic conglomerate of lipids, proteins, and mucins in an aqueous saline solution  
suspended over the hydrophobic surface of the epithelium (Foulks, 2007). The TF has 
been classically described as a three-layer system, each with a specific composition 
and function (Rolando and Zierhut, 2001).  Apart from providing a moist physical shield 
to the corneal epithelium, the TF also has a surface power of 43.08 diopters (D) which 
contributes to the retinal image quality and visual function (Montés-Micó, 2007). There 
are various methodologies for measuring the TF thickness. Optical coherence 
tomography (OCT) is one such tool that is a non-invasive, in vivo imaging modality 
that generates images of biological tissues with high axial and transverse resolutions. 
Non-invasive measurement of tear film thickness has yielded values of approximately 
3.4 ± 2.6 μm. These measurements have been found to be reliable with an intra-class 
correlation coefficient of 0.97. (Prydal et al., 1992; Kaya et al., 2015). 
 
The TF is found to vary in volume, composition and stability in various ocular surface 
pathologies. Of these, tear film evaporation leading to DE is the most researched and 
published topic (Nichols et al., 2011).  In a healthy ocular surface, meibomian glands 
secrete the outer lipid layer which acts to prevent rapid evaporation of the aqueous 
and mucin layer (McCulley and Shine, 1997). The blinking action of the eyelids 
reassembles the tri-layered structure of the TF, which is immediately exposed to the 
environment and subject to evaporation and disorganisation. This process of tear film 
layer disorganisation, termed as tear break up time (TBUT). Lower TBUT is indicative 
of underlying ocular pathology such as meibomian gland dysfunction (MGD) or 
another systemic physiological irregularity. It has been documented that alterations to 
the TF brought about by DE unveils underlying corneal irregularities leading to poor 
QOV due to glare and decrease in contrast sensitivity (Huang et al., 2002; Miljanović 
et al., 2007). 
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1.2 Definition of dry eye  
 
The Dry Eye Workshop (DEWS) defines DE as ‘a multifactorial disease of the tears 
and ocular surface that results in symptoms of discomfort, visual disturbance and TF 
instability, with potential damage to the ocular surface. It is accompanied by increased 
tear osmolarity and inflammation of the ocular surface’ (Lemp, Baudouin and Baum, 
2007a). Evidence by research conducted on tissue culture, animal models and DE 
patients demonstrates that hyperosmolarity is the core mechanism and plays a major 
role in the pathogenesis of DE. This initiates a vicious cascade of inflammatory 
processes that leads to mucin deficiency, dryness of the corneal surface and damage 
to the overlying corneal epithelium (Lemp, Baudouin and Baum, 2007a). DE can be 
categorised into either aqueous deficient or evaporative type. Additionally, these two 
conditions are not mutually exclusive and can occur concurrently as mixed type. It is 
reported that MGD-dependent evaporative DE is the most common form of DE overall 
(Pult, Riede-Pult and Nichols, 2012) This is primarily due to decreased or obstructed 
secretion of meibum to the lid margin or negative alterations to the composition of 
meibum which leads to inflammation (Millar and Schuett, 2015).   
 
 
1.3 Risk factors for dry eye 
 
Cohort studies such as the Beaver Dam Eye Study have explored the relationship 
between various risk factors for DE. They have revealed that demographics and 
clinical factors such as age, gender, and androgen levels have been found to 
predispose towards the development and progression of DE (Moss and Klein, 2000; 
Paulsen et al., 2014). Additionally, lifestyle and environmental factors such as 
computer use and seasonal allergies are also associated with abnormal tear function 
and DE symptoms (Tsubota and Nakamori, 1993; Nakamura et al., 2010; Paulsen et 
al., 2014). Surveys have also reported that more than 50% of contact lens wearers 
experience ocular dryness and decreased corneal sensitivity (Pritchard, Fonn and 
Brazeau, 1999; Stahl et al., 2009). Various systemic diseases can also have 
manifestations of DE symptoms, particularly those of autoimmune or immune-
mediated nature. Several studies have examined transient and chronic DE  after laser 
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refractive surgery as DE has been documented to be frequently observed in patients 
immediately after surgery (De Paiva et al., 2006; Denoyer, Landman, Trinh, J.-F. 
Faure, et al., 2015). The incidence of DE in the nasal and superior hinge group in 
LASIK procedure was found to be different, 47.06% and 52.94% respectively at week 
1, with consequent improvement over the following weeks and months (Savini, 
Barboni and Zanini, 2006). In comparison, the incidence of DE after cataract surgery 
is documented to be significantly less, in the region of 10% (Kasetsuwan et al., 2013) 
This is due to the fact that corneal nerve damage is much more severe with laser 
ablation in comparison to that produced by a corneal incision in cataract surgery. 
 
 
1.4 Clinical evaluation of dry eye  
 
Currently there are a wide array of tests that have been developed to screen, test and 
diagnose the onset and progression of DE (Bron et al., 2014; McGinnigle, Eperjesi 
and Naroo, 2014). However, due to the lack of a gold standard diagnostic test, 
complex aetiology and pathophysiology diagnosis of DE is difficult (Benjamin D 
Sullivan et al., 2014). Clinical tests for DE include Schirmer test, TBUT, fluorescein 
staining of the cornea and conjunctiva, meibomian gland assessment, interferometry 
examination of the TF and meibomian gland assessment (Bron et al., 2014). These 
DE tests to a large extent can diagnose moderate to severe forms of DE. However, 
mild forms of DE, usually remain an undiagnosed disorder (Agarwal et al., 2016). 
 
 
1.4.1 Subjective assessment of dry eye  
 
Invariably the examination and assessment of DE starts with history talking and 
symptoms of the patient by the clinician. The most frequent symptom among DE 
patient includes the sensation of burning ocular discomfort and dryness (Begley, 
Chalmers and Abetz, 2003; Williamson et al., 2014). Although, symptom assessment 
in DE patients has been considered one of the components of DE assessment, 
literature reports that symptom questionnaires and ocular signs in DE don’t typically 
correlate with each other (Johnson, 2009; Benjamin D. Sullivan et al., 2014; Bartlett, 
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Keith and Sudharshan, 2015). The poor association between signs and symptoms 
could also be explained by the fact that symptom measures may assess properties of 
the disease (e.g. grittiness or fatigue) but may not be related to measurable signs. 
Several researchers also have suggested that sensory changes on the ocular surface 
may be an important factor. One theory postulates that in early/mild DE, corneal 
hyperalgesia may cause ocular discomfort before any clinical signs are evident and 
tear osmolarity is potentially the best approach as they both demonstrated close 
agreement (Schiffman, 2000; Suzuki et al., 2010). However, other studies have shown 
increasing variability in DE subjects (Sullivan et al., 2014). Ocular dryness followed by 
discomfort and tired eyes are the most reported symptom in DE patients (Begley, 
Chalmers and Abetz, 2003). Validated DE questionnaires are still the most effective 
screening tool to assess individuals in research or clinic settings (Oden et al., 1998).  
DE symptomology and QOL questionnaires consists of a series of questions that have 
numeric values attributed to their corresponding answers, thereby allowing the 
symptoms to be scored and the severity numerically quantified and compared. The 
most widely used DE questionnaires are Ocular Surface Disease Index (OSDI), the 
Impact of Dry Eye on Everyday Life questionnaire (IDEEL) and McMonnies Dry Eye 
Index (Grubbs et al., 2014; Bartlett, Keith and Sudharshan, 2015). Other researches 
such as Chalmers have tried to streamline the subjective assessment by asking only 
five questions to distinguish between patients with and without DE (Nichols, Nichols 
and Mitchell, 2004; Chalmers, Begley and Caffery, 2010). 
 
 
1.4.2 Objective evaluation of dry eye  
 
A consensus among DE researchers has ranked the following diagnostics tests as 
follows, per their use: TBUT (93%), corneal staining (85%), TF assessment (76%), 
conjunctival staining (74%), and the Schirmer test (54%) (Lin and Yiu, 2014). These 
are widely administered diagnostic tests for initial assessment of DE (Serin et al., 
2007). An ideal diagnostic method should preferably be non-invasive in assessment, 
objective, specific, reproducible, cost effective and non-time consuming. Currently 
none of the DE diagnostic tools meet these standards.  Aside from the standard clinical 
tests, recently accepted clinical tests such as tear hyperosmolarity and TF 
interferometry will also be reviewed.  
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Tear breakup time  
 
Measuring the TF  stability can provide valuable information about the DE condition of 
the patient (Sweeney, Millar and Raju, 2013). There are a variety of methodologies 
that ascertain different aspects of the TF and provide insights into the stability of the 
TF. TBUT was first introduced by Norn in 1969 and to date is the most frequently used 
diagnostic test used to assess TF stability (Norm, 1969). TBUT can be observed with 
and without instilling fluorescein dye. Cho, et al., found that the instillation of 
fluorescein did not cause any significant change in the non-invasive TBUT in a Hong 
Kong, Chinese sample population (Cho et al., 2004). Conversely, Mengher et al.,  
using non-invasive methodology (using grid lines projected onto the corneal surface 
and distortion or discontinuity of the image was regarded as tear break-up), found that 
instillation of fluorescein significantly decreases the stability of the tear (Mengher et 
al., 1985). Non-invasive TBUT can be assessed using aberrometry, confocal 
microscopy, corneal topography and interferometry and the first discontinuity or break 
of the anterior tear surface is recorded in seconds from the last blink as the TBUT. 
 
 
Topographical analysis systems 
 
In comparison to eyes with normal TF, DE patients have TF irregularities on the 
corneal surface. The corneal topography can be used to monitor optical changes 
associated with irregular TF surface and generate indices such as, surface regularity 
index (SRI), surface asymmetry index (SAI) and topographic pattern. These findings 
can be used to assess the corneal surface regularity and TF stability. These indices 
enable the objective quantification of the quality of the TF, its breakdown and its 
consequent effects upon the QOV (Montés-Micó, Cáliz and Alió, 2004).  
 
 
Interferometry 
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Interference between light reflected from the surface of the lipid layer and the interface 
between the lipid layer and aqueous layer of the TF generates observable patterns. 
These interference patterns can be observed using the interferometry and captured 
using photograph or video and can be used to infer the thickness and stability of the 
TF (Lin and Yiu, 2014). Since interference patterns have been correlated with the 
thickness of tear lipid layer,  quantitative values from interference patterns of lipid layer 
thickness can be derived (Yokoi, Takehisa and Kinoshita, 1996). Tear lipid thickness 
has been used in research to assess changes in MGD (Lin and Yiu, 2014). 
 
 
Optical coherence tomography 
 
Apart from measuring the anterior segment of the cornea, OCT can also measure the 
TF thickness (Wang et al., 2003), tear meniscus (Shen et al., 2009), grading lid parallel 
conjunctival folds (LIPCOF) (Bandlitz et al., 2016), corneal epithelial thickness 
(Bayhan, Aslan Bayhan and Can, 2014) and meibomian gland structures (Liang et al., 
2015). The advantages of using optical coherence tomography is that it achieves in 
producing non-invasiveness scans of high resolution, good accuracy, and repeatability. 
Studies by Nguyen et al. suggests that lower tear meniscus measurement by the OCT 
correlates well with symptoms of DE and Schirmer test (Nguyen et al., 2012). 
 
 
Confocal microscopy 
 
Corneal in vivo confocal microscopy is a non-invasive, high-resolution tool that allows 
imaging of the cornea at the cellular level and produces images comparable to 
histochemical methods. These images enable the microscopic visualisation of corneal 
epithelium, corneal stroma and keratocytes, endothelial cells, corneal nerves, corneal 
immune and inflammatory cells, conjunctiva and meibomian glands in various ocular 
and systemic pathologies. It can also be used for diagnostic purposes and measure 
therapeutic efficacy in patients with DE. In vivo confocal microscopy in DE patients 
can capture conjunctival epithelial cyst formation, decreased density of conjunctival 
epithelial cells, goblet cells and increased inflammatory cell density. As therapeutic 
trauma caused by laser can trigger a cascade of responses and potentially affect the 
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optical properties of corneal tissue (Spadea, Giammaria and Trabucco, 2016). In vivo 
confocal microscopy has provided researchers with a better understanding of the 
conjunctival wound healing process, and corneal changes induced by medications and 
their preservatives (Villani et al., 2014). 
 
 
Corneal and conjunctival staining 
 
This a minimally invasive procedure as it requires the instillation of dye such as sodium 
fluorescein, rose bengal, or lissamine green and examining the cornea and 
conjunctiva staining under a slit lamp biomicroscope. The evaluation and scoring of 
the staining is subjective, however the Oxford, Van Bijsterveld, and CLEK grading 
schemes can facilitate consistent recording of staining severity (Bron, Evans and 
Smith, 2003). The repeatability of staining tests in some studies has been found to be 
poor and lacks the ability to discriminate between mild and moderate cases of DE 
(Sullivan et al., 2010). The SS International Registry modified the Oxford grading 
scheme to allow simultaneous grading of the cornea and bulbar conjunctiva using a 
combination of 0.5% fluorescein (1 drop) for corneal staining and 1% lissamine green 
(1 drop) for conjunctival staining. Grades between 0 and 3 are assigned for staining 
the cornea, the nasal and the temporal conjunctiva. The maximum possible total score 
is 9 points. Three additional points are then allotted for fluorescein only if there is 
confluent staining (t1), staining in the pupillary area (t1), or if one or more filaments 
are present (t1), granting a maximum possible score of 12 (Whitcher et al., 2010). 
 
 
Conjunctival impression cytology or brush cytology 
 
Impression cytology requires harvesting conjunctival epithelial, goblet, and 
inflammatory cells from the bulbar mucosa (Reddy, Reddy and Reddy, 1991). It is a 
rapid and minimally invasive, and relatively painless. Studies have demonstrated that 
cytokines IL-1a, mature IL-1b, and IL-1Ra are found in a significantly greater 
percentage of conjunctival cytology specimens from eyes with DE due to Sjögren’s 
syndrome (Solomon et al., 2001; Barabino et al., 2010). Along with flow cytometry, the 
DE group was found to have a significant difference in the CD4/CD8 ratio, CD14 
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positive cells (monocytes/macrophages), HLA-DR expression in CK19 positive 
conjunctival epithelial cells and elevated matrix metalloproteinases levels (Solomon et 
al. 2001). These studies exhibit the role and nature of immune cells on the superficial 
layer of the conjunctiva in DE pathology. 
 
Conjunctival brush cytology is another variation in which a soft brush is used to harvest 
superficial cells (as in impression cytology) and basal cells. These sample are then 
examined for squamous metaplasia, inflammatory cells, and the expression of surface 
markers on the ocular surface epithelium (Tsubota et al., 1990; Wakamatsu et al., 
2009). In combination with flow cytology, it is highly sensitive and specific analysis of 
epithelial cell markers, goblet cells and inflammatory cells (Wakamatsu et al. 2009) 
 
 
1.4.3 Treatment for dry eye  
 
Three steps towards treating DE were identified in a European Ocular Surface 
Workshop held in Italy in 2009 (Rolando et al., 2010): 
1. ‘Patient education, monitoring the eyelid environment, use of artificial tear substitute 
and eyelid therapy’. 
2. ‘Addition of temporary anti-inflammatory agents, temporary punctual occlusion, 
secretagogue administration’. 
3. ‘Autologous serum and amniotic membrane.’ 
 
There are a variety of treatments available for DE and these are used according to the 
severity of the problem (Lemp et al. 2007). Combinations of artificial tears, oral omega-
3 essential fatty acid supplements, mucin secretagogues, short-term steroids, and 
daily cyclosporine A (CsA) are a few methods used to alleviate underlying 
inflammation.  These treatments can help revive normal TF and ocular function in 
patients suffering with mild-to-moderate forms of DE.  The next level of treatment for 
more severe forms of DE consists of autologous serum, oral tetracyclines, and 
prosthetic lens. The use of systemic immune-suppressants is restricted to patients 
with higher levels of DE severity (Behrens et al., 2006). DE due to systemic origin such 
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as Sjogren's syndrome, Stevens–Johnson syndrome are treated surgically by 
tarsorrhaphy and amniotic membrane transplant. 
 
Since the primary aim of DE treatment is symptomatic relief, the use of tear substitutes 
can provide transient symptomatic relief. Ideally, the tear substitute should be 
analogous in composition to natural tears. Eye drops containing glucans, such as 
sodium hyaluronate (0.1–0.4 %) and carboxymethylcellulose (0.5 %) compounds have 
been tested in various clinical trials and concluded to be effective and better in 
comparison to saline solution eye drops (Aragona, 2002; Brignole et al., 2005; 
Rolando et al., 2009; Lee et al., 2011).  These drops are usually recommended to be 
administered at least four times a day. Although gel formulations have a longer lasting 
effect, they are usually recommended for night-time use, but frequency can be 
increased with severity of DE symptoms. Topical steroids such as fluorometholone, 
clobetasone, loteprednolol, and methylprednisolone have also proven to be beneficial 
in terms of initial therapy and symptomatic relief of DE. However, these formulations 
cannot be used continuously as they pose they increase the risk of developing 
subcapsular cataracts (Aragona, 2002; Lee et al., 2014). Since fatty acids such as 
omega-3 have be attributed anti-inflammatory action, studies have shown that dietary 
supplementation of fatty acids has proven beneficial to symptomatic relief in DE 
patients. Additionally, improved ocular tests, decreased ocular discomfort, and 
decreased tear osmolarity are some of the documented benefits(Bhargavaa et al., 
2015; Deinema et al., 2017). 
 
 
1.5 The cornea  
 
The average horizontal diameter of an adult human cornea is between 11.5 to 12.0 
mm, and about 1.0 mm larger than the vertical diameter. It is also approximately 0.5 
mm thick in the centre and the thickness increases towards the periphery (Rüfer, 
Schröder and Erb, 2005). Common pathologies associated with the structural changes 
to the cornea are Keratoconus (KC) (collagen disorders) and Fuchs’ endothelial 
dystrophy (endothelial-based corneal dystrophies), which alter the corneal central 
thicknesses beyond the normal variance (Ehlers and Hjortdal, 2004). The dome shape 
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of the cornea which is flatter at the periphery and steeper centrally constructs an 
aspheric optical structure. The cornea consists of 6 recognised layers: 
 
• 3 cellular layers: epithelium, stroma and endothelium  
• 2 interface layers: Bowman membrane and Descemet membrane 
• Dua’s layer (pre-Descemet’s layer) has also been accepted since its discovery 
in 2013 (Dua et al., 2013). 
 
The epithelium covering the cornea surface constitutes the initial cellular barrier to the 
external environment. It is an essential component of the TF cornea interface that is 
significant to the refractive power of the eye. It comprises of stratified, non-keratinizing 
squamous layer characterized by extreme uniformity which is 4 to 6 cell layers thick 
(50 to 52μm). The TF covering the epithelium smoothens out micro-irregularities of the 
anterior epithelial surface. This air–TF interface, along with the underlying cornea, 
accounts for two thirds of the total refractive power of the eye. The TF also provides a 
protective barrier to the corneal surface from microorganisms, toxins and small foreign 
particles. It also provides immunological and growth factors that nurture epithelial 
growth and repair (Derek W. DelMonte, 2011). The mucinous layer of the TF is in 
direct contact with the corneal epithelium, which is produced by the conjunctival goblet 
cells.  This allows the hydrophilic spread of the TF over the corneal epithelial cell 
glycocalyx. The superficial epithelia also utilises mechanisms of scaffolding with the 
help of microvilli and microplicae to bind to mucin (Nichols, Dawson and Togni, 1983).  
A compromised glycocalyx due to injury or disease can results in loss of TF stability 
and subsequent breakdown of the ocular surface homeostasis. The epithelial 
basement membrane is approximately 0.05μm thick and comprises of type IV collagen 
and laminin secreted by basal cells. During injury, fibronectin levels rises and the 
healing process can last for up to 6 weeks. Throughout this process, the epithelium 
bonds to the underlying, newly laid basement membrane tend to be unstable and weak 
(Dua, Gomes and Singh, 1994). The Bowman layer lies between the epithelial 
basement membrane and anterior stroma.  It is not a true membrane but rather the 
acellular condensate of the most anterior part of the stroma which is approximately 
15μm thick and aids the cornea uphold its shape. When injured, it does not have the 
regenerative capacity and can form a scar.  
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Light and electron microscope scans have shown that in KC, the basement layer 
undergoes disintegration that results in irregular thinning, fragmentation and 
consequent breaks (Chi, Katzin and Teng, 1956; McPherson and Kiffney, 1968; 
Sawaguchi and Fukuchi, 1995; Sawaguchi et al., 1998; Sykakis et al., 2012). These 
structural changes are observed when the stroma is minimally affected, suggesting 
that basement membrane assessment can serve as a diagnostic method to possibly 
predict KC progression (Tuori et al., 1997). Ophthalmic pathologists have long used 
these signs for in vitro diagnosis of KC using light microscopy. However, 
advancements and the use of high-speed ultra-high resolution spectral domain optical 
coherence tomography has enable clinicians to visualise this layer in vivo (Xu et al., 
2015).  
 
The corneal stroma constitutes approximately 80% to 85% of the total thickness of the 
cornea. The stroma differs from other collagenous structures in its transparency, due 
to its precise organization of the stromal fibres and extracellular matrix (Wilson, 1970; 
Boote et al., 2003).   
 
Keratocytes are the major cell type of the stroma and maintain the extracellular 
environment by synthesising the collagen molecules, glycoaminoglycans and matrix 
metalloproteases important in maintaining stromal homeostasis. Most keratocytes 
reside in the anterior stroma and contain 25% to 30% corneal crystallins; a soluble 
protein in the cells which is responsible maintaining corneal transparency and 
reducing backscatter of light from the keratocytes (Jester et al., 1999).  
 
The endothelial layer of the cornea preserves corneal clarity by ensuring it remains in 
a relatively dehydrated state. Endothelial cell density and topography continue to 
change throughout life, declining from 4000 to 3000 cells/mm2 from the second decade 
of life to about 2600 cells/mm2 at the eighth decade with a total reduction of 60% to 
75% in hexagonal cells (Yee et al., 1985). It has been observed endothelial cell counts 
below 500 cells/mm2 can be a risk factor for the development of corneal oedema. The 
density of endothelial cells varies with location, being approximately 10% higher in the 
periphery of cornea (Amann et al., 2003). Studies have observed that the peripheral 
endothelial cells are resilient and can remodel and  radiate to cover damaged sections 
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(Edelhauser, 2000). Since the human cornea is avascular in nature it therefore must 
rely on components of the blood supplied by the end branches of the facial and 
ophthalmic arteries via the aqueous humour and TF (Langham et al., 2009).  
 
The cornea is considered as one of the most densely innervated tissue and therefore 
is one of the most sensitive tissue of the body. Corneal nerves are derived from the 
nasociliary branch of the first (ophthalmic) division of the trigeminal nerve. In the 
superficial cornea, the nerves enter the stroma radially in thick trunks forming plexiform 
arrangements. These nerves eventually perforate Bowman membrane to provide a 
rich plexus beneath the basal epithelial layer while the internal cornea can also receive 
innervations from the maxillary branch (Müller et al., 1997). 
 
 
1.5.1 The cornea and surgery 
 
Injury can occur to the cornea after intraocular and corneal refractive surgery. The 
injury or detachment of the Descemet’s membrane is rare but considered to be one of 
the most serious complications in an anterior segment surgery. This can lead to 
significant loss and decompensation of endothelial cells (Al-Mezaine, 2010). 
Inappropriate surgical technique, substandard equipment (Yi and Dana, 2002) and 
phacoemulsification of a dense nuclear cataract (Luo et al., 2014) can all lead to injury 
or detachment of the Descemet’s membrane. Since the deposition of a new basement 
membrane requires endothelium cell migration, the use of an air bubble tamponade to 
hold in place the loose membrane tags against the posterior cornea has been found 
to facilitate the healing process (Ti et al., 2013). Direct mechanical injury, high 
ultrasound energy and effects of irrigation solution can also lead corneal oedema 
(Polack and Sugar, 1977). Endothelial cell health can be maintained by carefully 
managing the temperature, pH, osmolarity, irrigation solution preservation method and 
ocular medication (Edelhauser et al., 1976; Edelhauser, 2000). Corneal wound healing 
after laser refractive surgery procedures is an important factor that can determine the 
success of the treatment. Therapeutic trauma caused by laser can trigger a cascade 
of physiological responses and potentially affect the optical properties of corneal tissue 
(Spadea, Giammaria and Trabucco, 2016). Overcorrection, undercorrection, 
regression, haze and refractive instability is to a large extent related to corneal wound 
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healing response (Netto et al., 2005). Since laser ablation of the cornea has the ability 
to stimulate a fibrotic response that leads to opacity, contraction and alteration to the 
corneal curvature, controlling fibroblast activation is key for optimal recovery (Fini and 
Stramer, 2005). The healing response of the cornea varies from surface area and 
depth of stromal ablation procedures. In surface ablation procedures, the fibrotic 
response is more aggressive, the possible reason for which may be disruption of the 
basement membrane (Fini and Stramer, 2005; Nishida, 2012). Conversely, non-
disruption of the basement membrane leads to cellular repair without fibrosis (Netto et 
al., 2005). It has also been documented, in LASIK surgery, that protecting the integrity 
of the central corneal epithelium leads to less keratocyte apoptosis and necrosis due 
to reduced epithelial stromal cell interaction (Wilson, Mohan and Ambrosio, 2003). 
Less haze and regression has also been found to correlated with less keratocyte 
proliferation and myofibroblastic differentiation (Siganos, Katsanevaki and Pallikaris, 
1999).  Regression after LASIK has been mostly attributed to epithelial hyperplasia 
and stromal remodelling (Lohmann and Guell, 1998; Reinstein et al., 1999) whereas 
in SMILE, the observed epithelial changes do not appear to affect the refractive 
outcome (Sekundo et al., 2014). Haze occurrence can be in the stromal tissue at the 
flap junction where there is direct contact between the normal and activated 
keratocytes (Vesaluoma et al., 2000) or a diffuse lamellar keratitis which can lead to 
central haze (Linebarger, Hardten and Lindstrom, 2000). Doughnut shaped flaps and 
retention of epithelial debris in the interface can also occur (Wilson, 1998). Hyperopic 
SMILE has less postoperative corneal wound healing response and stromal interface 
reaction than hyperopic LASIK treatment. However, compared to myopic SMILE, 
hyperopic SMILE treatment results in greater central derangement of collagen fibrils  
(Liu et al., 2016). Laser subepithelial keratectomy (LASEK), which uses ethanol to 
create an epithelial flap, has reduced pain, promotes faster visual recovery and less 
haze as the flap serves as a mechanical barrier to protect the stroma from the TF that 
contains growth factors (Lee et al., 2002; Vinciguerra, Camesasca and Randazzo, 
2003). However, these conclusions have been contested on the viability of the 
removed epithelial cell layer in relation to re-adhesion when the basement membrane 
is not present on the stroma (Litwak et al., 2002; Espana et al., 2003). 
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1.6 Cataract classification 
 
There are several clinical classifications systems that can be used to evaluate cataract, 
such as the Age-Related Eye Disease Study (AREDS, 2001) system of classification, 
Laser slit-lamp evaluation (Hall et al., 1999) and LOCS III (Chylack et al., 1993) which 
is the most establish method of assessment. However, LOCS III and other clinical 
measurements methods employ a subjective assessment of grading the cataract, 
therefore the assessment is dependent on the examiner (Brown, Bron and Sparrow, 
1988) and their level of training and experience (Kashima et al., 1993).  The possible 
drawback to this method is that it could lead to inconsistencies when results are 
compared between different assessors. To minimise this discrepancy studies have 
resorted to Scheimpflug imaging of cataracts (Kim, Chung and Joo, 2009; Nixon, 
2010).  Scheimpflug images can present sections of the lens which are evenly focused 
from the anterior to posterior capsule. These images are continuous measurements 
as compared with the LOCS III, which has stepwise grading system. This allows the 
Scheimpflug imaging to detect minimal cataract progression (Grewal, 2009). However, 
the limitations of using Scheimpflug imaging for assessing cataracts is that the internal 
crystalline lens is observed through the anterior refractive surfaces, which is the 
cornea and the anterior lens surface, and the refraction at these two surfaces has the 
tendency to distort the internal structure image of the crystalline lens. Another 
drawback is that inadequate dilatation of the pupil can interfere with the Scheimpflug 
camera’s image acquisition. Similarly, eyes with abnormalities such as 
pseudoexfoliation, intraoperative floppy iris syndrome, or white cataracts cannot be 
assessed accurately using a Scheimpflug camera (Grewal, Brar and Grewal, 2009). 
 
 
1.6.1 Cataract surgery  
 
The goal of cataract surgery is to rehabilitate the blind or visually impaired patients by 
restoring normal or close to normal sight as possible. This goal can generally be 
achieved by extracapsular cataract extraction (ECCE) that utilises phacoemulsification 
or nuclear expression and the lens capsule is reserved for the implantation of an 
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intraocular lens. However, during an intracapsular cataract extraction (ICCE), the 
entire capsule holding the lens and the lens are removed. 
 
ECCE extraction by phacoemulsification involves the opening and removal of the 
central section of the anterior capsule following the emulsification of the nucleus with 
an ultrasonic probe. The emulsified nucleus is then removed by a suction device. The 
posterior lens capsule is left intact to facilitate the placement of a posterior chamber 
IOL in the capsular bag (Minassian et al., 2001). This extraction and implantation of 
the IOL is performed through incisions less than 2mm which allows fast healing and 
recovery of the cornea and improved visual outcomes (Minassian et al., 2001).  
 
 
1.7 Modern multifocal intraocular lens design  
 
There has been considerable evolution and improvement in the field of cataract 
surgery techniques over the last few decades. Cataract surgery by 
phacoemulsification of the crystalline lens and replacing it with an artificial IOL is now 
considered a safe, effective and predictable treatment for cataract (Powe et al., 1994). 
It is also considered to be the most common surgery performed globally (WHO, 2002; 
Richard Lindstrom, 2015). Modern techniques such as the micro-incisional cataract 
surgery has minimal impact upon postoperative astigmatism (Kohnen and Kasper, 
2005). Advancements in IOL designs and materials have also significantly reduced 
the risk of complications such as posterior capsule opacification (Kohnen et al., 2008). 
Monofocal IOL can provide good visual acuity at a fixed focal length. They are usually 
targeted for distance viewing and therefore for near and intermediate vision, spectacle 
correction is required. Spherical IOLs were found to induce spherical aberrations and 
thereby compounding the positive spherical aberrations of the cornea. This led to the 
development of aspheric IOLs, which improved contrast sensitivity and VA. However 
since aspheric IOLs are pupil dependent and therefore perform less optimally on small 
pupil size than spherical IOLs (Kohnen, Klaproth and Bühren, 2009). 
 
Independence from glasses is an important concern in presbyopia patients and was 
highlighted by Luo et al. (2008), who found 10% of presbyopic patients would trade 5% 
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of their life expectancy for good all round unaided vision. This is one of the reasons 
that has led to the development of multifocal IOLs. Multifocal IOLs can provide high 
levels of spectacle independence, independent of ciliary body function. Even though 
monofocal IOLs can also provide near vision with the addition of monovision or 
blended vision methods. This technique compromises on binocularity and 
effectiveness within a difference of 1.50 dioptres. There are a variety of multifocal IOLs 
with varying optical properties. Refractive multifocal IOLs are either concentric or 
sectorial and diffractive lenses are partially of entirely diffractive. Presbyopia is 
considered one of the most challenging and final frontiers in cataract and refractive 
surgery. Surgical removal and replacement of the crystalline lens with either 
monofocal or multifocal IOL has advantages and disadvantages and no available 
treatment option has so far proven to be problem free. 
 
 
1.7.1 Zonal multifocal intraocular lenses  
 
Zonal multifocal IOLs consists of multiple concentric refractive zones. These zones 
have different curvature thereby creates two or more refractive powers. The first 
multifocal IOL that was approved in the USA was AMO array (Abbot Medical Optics 
Inc. CA, USA) which had a spherical posterior surface optic with a central zone for 
distance surrounded by four alternating zones for distance and near (Steinert et al., 
1999). A prospective, fellow eye, non-randomised study on this IOL revealed that the 
mean uncorrected and corrected VA for distance and near at one-year after 
implantation improved by two lines on the VA LogMAR chart. However, the side-
effects were glare, haloes and reduced contrast sensitivity (Steinert et al., 1999). This 
design was further refined in the Rezoom (Abbot Medical Optics Inc. CA, USA) IOL 
which incorporated aspherical surface. MFlex (Rayner Intraocular Lens Ltd, Hove, UK), 
further added the option of two additions of either four or five refractive zones relative 
to the power of the IOL. The addition of multiple refractive zones was to reduce the 
IOLs dependency to pupil size and IOL decentration. However, the downside of 
combining  small pupil and concentric ring multifocal IOL was that the majority of the 
light energy was being directed towards the distance zone (Lane et al., 2006). It has 
been documented that in ReZoom (Advanced Medical Optics, Santa Clara, California, 
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USA) refractive multifocal IOL with its five concentric refractive zones, that the 
distribution of light is dependent on the pupil size. In a 2 mm pupil, approximately 83% 
of the light entering the pupil is projected towards the distance zone an 17% towards 
the intermediate zone, while in a 5 mm pupil, approximately 60%, 10% and 30% of 
light is directed towards distance, intermediate and near zones of the IOL respectively 
(Lan et al., 2017).  
 
 
1.7.2 Sectorial multifocal intraocular lenses  
 
Refractive asymmetric IOL with sectorial design has been in clinical use for over 5 
years and is currently been widely accepted by surgeons globally. The sectorial design 
brought a new concept to multifocal IOL technology. Although the physical IOL design 
resembles a bifocal spectacle lens. However, it provides simultaneous vision similar 
to other multifocal IOLs. The difference in its design is that sectorial multifocal IOLs 
have two sectors: a larger sector for distance vision and a smaller sector for near 
vision. Theoretically, it has been argued that fewer transition zones from one power to 
the next results in less dispersion of light, hence improved contrast sensitivity (Venter 
et al., 2014). McAlinden & Moore (2011) found that Lentis MPlus (Oculentis GmbH, 
Berlin, Germany) resulted in good VA with high-level contrast sensitivity thereby 
resulting in significant improvement in QOL.  
 
Venter et al. (2014) while assessing the assess efficacy, safety, predictability, and 
patient satisfaction on SBL-3 (Lenstec, Inc., Christ Church, Barbados) concluded that 
SBL-3 multifocal IOL implantation resulted in good range of vision for near, 
intermediate, and distance. However, these IOLs are also dependent on pupil size and 
pupil centroid shift as documented by Pazo et al. (2016). 
 
 
1.7.3 Diffractive multifocal intraocular lenses  
 
Diffractive multifocal IOLs creates two or more focal points by using the principle of 
diffraction. The concentric ring boundary creates an interference of light and the 
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separation between the edges of the rings determines the power. However, the major 
drawback to this design is that the light energy is lost to higher order and results in 
aberrations (Hütz et al., 2006).  
 
Total diffractive multifocal IOLs such as the Tecnis ZM900 (Abbott Medical Optics Inc., 
Santa Ana, CA, USA) are  pupil independent as it can split light between distance and 
near (Hwang, Kim and Kim, 2014). Clinical studies carried out by Kretz et al. (2015) 
that Tecnis ZKB00 IOL with a lower near addition (+2.75 D.) increased intermediate 
VA and had satisfactory near vision. These IOLs are found to have less photopic 
phenomena in comparison to Rezoom (Abbot Medical Optics Inc., Santa Ana, CA, 
USA) (Cillino et al., 2008).  
 
Partially diffractive multifocal IOLs have a combination of diffractive and refection 
surfaces. ReSTOR (Alcon, Fort Worth, Texas, US), has a single refractive surface 
dedicated for distance and is surrounding the diffractive section. The anterior of this 
IOL is apodized and therefore there is a step height of the concentric rings. To counter 
the positive corneal spherical aberration.  The posterior side of the IOL is convex 
aspheric. Since this IOL is pupil dependent, larger pupils tend to allow more light to 
the distance section. Vingolo et al. (2007) found that 10% of the patients implanted 
with ReSTOR (Alcon, Fort Worth, Texas, US) had severe haloes, glare and the 
intermediate vision was also not satisfactory (De Vries et al., 2010). By increasing the 
near power to +4 dioptres Rasp et al. (2012) found that good reading performance 
was achievable which was significantly better than that obtained with a refractive 
multifocal or monofocal IOL. 
 
 
1.8 Management of patients with multifocal intraocular lenses 
 
Various studies have evaluated the aetiology of patient dissatisfaction after multifocal 
IOL implantation. The primary factors that lead to dissatisfaction are reduced distance, 
intermediate and near vision, along with reduced contrast sensitivity and photopic 
phenomena. Kamiya et al. (2014) conducted a retrospective study and evaluated 50 
eyes of 37 patients who underwent multifocal IOL explantation. The most common 
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complaints for IOL explantation were waxy vision, glare and halos, blurred vision at 
distance viewing, dysphotopsia, blurred vision at near, and blurred vision at 
intermediate respectively. The most common reasons for undergoing IOL explantation 
were decreased contrast sensitivity, followed by photic phenomenon, unknown origin, 
failure to neuroadapt, error in IOL power calculation, excessive preoperative 
expectation, IOL dislocation/decentration, and anisometropia.  Similar findings from 
other studies highlights these key issues with multifocal IOL implantation (Woodward, 
Randleman and Stulting, 2009).  Therefore, appropriate patient selection and 
preoperative stratification of patients can improve postoperative patient satisfaction. 
The initial step is the proper education of patients about the procedure and clearly 
communicating the cost and benefits of the multifocal IOL implantation treatment to 
the potential patient (Pepose, 2008; Lichtinger and Rootman, 2012; De Vries and 
Nuijts, 2013). Since multifocal IOL are sensitive to factors such as pupil size and minor 
ocular aberrations (De Vries and Nuijts, 2013), it is therefore imperative that careful 
screening and selection is mandatory for postoperative patient satisfaction. 
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CHAPTER 2: THE IMPACT OF PUPIL SIZE AND VISUAL AXES UPON QUALITY 
OF VISION FOLLOWING CATARACT SURGERY 
 
 
2.1 Introduction 
 
The experimental chapters of this thesis aim to investigate what pre or postoperative 
factors may influence or impact upon the QOV after laser or lens based refractive 
surgery. A comprehensive series of both objective and subjective tests incorporating 
a variety of diagnostic instruments and techniques were used within this study. Visual 
acuity (VA) assessment has been traditionally the primary method of quantifying visual 
outcomes in both clinical setting and clinical studies. However, it is well recognised 
that VA measurements alone cannot not adequately define the complex concept of 
vision (de Boer et al., 2004). Patients with the same objectively measured VA may 
have totally different subjective perspective as to how good or bad they feel that their 
QOV and therefore VA may not capture all important aspects of visual function from 
the patient's perspective (Massof and Rubin, 2001; Stelmack, 2001). 
 
Refractive surgery traditionally has been designed with the aim to enable patients to 
see clearly for distance and near. In the prepresbyopic patient, VA can be improved 
by correcting distance refractive error. If this is successfully achieved the natural 
focusing mechanisms within the eye enables intermediate and distance vision 
(Miranda and Krueger, 2004). However, presbyopic patients pose more significant 
problems as correction of distance vision in both eyes does not naturally enable near 
or intermediate vision. Since the focusing mechanisms is compromised by the ageing 
process (Salvi, 2006). Currently there is no interventional system which perfectly 
simulates the natural focusing mechanism within the eye. Although various imperfect 
solutions utilising either laser or lens-based techniques have been developed to 
overcome this intrinsic problem (Reinstein, Archer and Gobbe, 2011; McNeely et al., 
2017).  In the early 90s multifocal IOLs were developed which enabled the 
simultaneous viewing of both distance and near vision through the one IOL.  This 
technology used more than one focal point within the one IOL (McNeely et al., 2017).   
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Recent studies on multifocal IOLs report good VA for both near and distance vision in 
terms of spectacle independence (McNeely et al., 2017). 
 
Laser refractive surgery was developed to enable the surgeon to treat either myopia 
or hyperopia by changing the shape in the cornea. The cornea is flattened in myopia 
eyes and steepen for hyperopia eyes. The early stages of laser development produced 
remarkable success in correcting myopia through flattening of the central cornea. 
Good VA was achieved by using the Munnerlyn formula to predict the amount of 
corneal flattening required for myopic treatments. It was later made apparent that  
patients often suffered postoperative glare and haloes (Chang et al., 2003). The lesson 
learnt early laser treatment for myopes was that the peripheral corneal shape also 
needed to be modified during the flattening of the central cornea.  This prevented the 
induction of large amounts of spherical aberrations which occurred due to a change in 
corneal shape from a prolate to an oblate shape. As advancements were made in 
measurement tools that measured corneal and whole eye aberrations.  It made 
possible for clinicians and researchers to measure the induced aberrations that 
occurred through laser surgery. This allowed iteratively modification of laser profiles 
to enhance corneal shape and measure the improvements achieved via these 
modifications (Cervio et al., 2007).  In addition to the development of aberrometers 
and topographers that measures the objective optical quality, the importance of 
recording patient’s subjective appreciation of the vision was also was recognized 
(Aaronson, 1988). In an attempt to objectively document the subjective appreciation 
of vision, various questionnaires were developed to record visual symptoms and its 
impact upon the QOL. Psychometric methods were also used to validate 
questionnaires so that it could be deemed as valid, reproducible and objective as 
possible in recording subjective symptoms (de Boer et al., 2004). The importance of 
subjective documentation was recognized to be very useful when studying subjective 
issues which occurred secondary to multifocal IOL implantation.  This allowed for an 
objective assessment of dysphotopic side effects of various multifocal IOLs (McNeely 
et al., 2017).  
 
It has been long understood that though the eye is often graphically depicted as a 
sphere. It is in fact not spherical but rather asymmetric with the light sensitive macula 
temporally displaced. Angle kappa, is defined as the difference between the primary 
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line of sight and the pupillary axis (Hage and Grand, 1980).  Measuring the distance 
between the pupillary axis and the visual axis is directly related to angle kappa. The 
pupillary axis is the line from the centre of the entrance pupil and the visual axis is the 
line that connects the fixation point and the fovea in the retina (Figure 2.1). In shorter 
eyes with larger angle kappa the displacement of the corneal reflex is usually inter 
related and therefore larger (Artal, Benito and Tabernero, 2006).  
 
The importance of the intrinsic angle kappa in an individual eye to subsequent surgical 
outcomes from either laser or IOLs is being increasingly investigated (Reinstein, 
Gobbe and Archer, 2013; Karhanová et al., 2015). Reinstein et al. documented that in 
high hyperopic corneal ablations eyes with large angle kappa lead to poor visual 
outcomes when compared to patients with eyes with negligible angle kappa (Reinstein 
et al., 2013).  
 
Prakash et al. found that on Rezoom multifocal IOLs there was a low correlation 
between visual acuity and angle kappa (Prakash et al., 2011), it may possibly allude 
that large angle kappa (negative or positive) might be responsible for night time 
photopic phenomenon and visual symptoms such as glare and hales due to 
misalignment of light passing through the IOL and projecting abnormally upon the 
retina (Moshirfar, Hoggan and Muthappan, 2013). Recent advancement in multifocal 
IOL technology provides an increasing variety of IOL choices to the ophthalmic 
surgeon. It is well recognised that patients can experience different subjective 
responses to these IOLs with a small number of patients being dissatisfied with the 
QOV postoperatively (Dick et al., 1999; Häring et al., 2001; Pepose, 2008; Woodward, 
Randleman and Stulting, 2009). There is therefore a need to investigate and ascertain 
what pre or postoperative factors can impact the postoperative QOV. This will enable 
the surgeon to stratify patients’ preoperatively with regards to those who would be less 
likely to obtain substandard QOV postoperatively. This would allow either greater 
levels of preoperative counselling to specific patient groups less likely to be totally 
satisfied and enable the surgeon to advise against the actual use of a multifocal IOL. 
Patients undergoing refractive-cataract procedures have high expectations and failing 
to stratify has been shown to result in less satisfied patients obtaining less than optimal 
visual performance (Cochener et al., 2011).  
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The general concept of the asymmetric multifocal IOLs is relatively recent and 
asymmetrical IOLs are now available in commercial practice. The design of 
asymmetrical multifocal IOL means that potential IOL deviation from the centre of the 
pupil. Particularly, in the presence of a small pupil could result in reduced exposure of 
either the near or distance component of the IOL.  As the near component usually 
utilizes a reduced surface area in Lentis MF20, 40% of IOL surface area compared to 
60% for distance refractive component (McAlinden and Moore, 2011; de Wit et al., 
2015).  Therefore, it can potentially be affected by deviation of IOL from the pupil 
centre.  
 
 
2.2 Objective measurement of angle kappa 
 
In a ray diagram, angle kappa represents a misalignment of light passing through the 
cornea and entering the pupil Figure 2.1. The assessment of large angle kappa is 
relevant because failing to intraoperatively align the multifocal IOL with respect to the 
angle kappa may lead to misalignment and decentration.  
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Figure 2.1. Schematic ray diagram showing the critical angle kappa with the optical 
model of the pseudophakic eye with an optical axial length (AL) and an effective 
position (ELP) of a thin multifocal IOL with the centre (C) of the multifocal IOL on the 
eye optical axis. ‘R’ marks the border of the central part of the IOL of the diameter ‘d’. 
The points N and N' represent the first and second nodal points of the pseudophakic 
optical system, F' is the second focal point of this system  
 
 
 
 
The standard method of measuring angle kappa is by using a non-invasive 
topography-aberrometry system which utilises two different techniques to calculate 
the result: a Placido-disk system, assesses anterior corneal topographical 
representation map, while horizontal moving scanning camera acquires slit-lamp 
images. The angle kappa calculated automatically with the internal software that 
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calculates the distance between the pupil centration and the centre of the Placido ring 
reflection on the cornea. This analysis of the angle kappa has a resolution of 0.01 mm.  
 
Various clinical studies and clinical ophthalmic practice have used topography-
aberrometry system for the assessment of angle kappa. The distribution of angle 
kappa using more than once measuring device has been studies (Basmak, Sahin, 
Yildirim, Saricicek, et al., 2007; Hashemi et al., 2010) and the prevalence of high angle 
kappa has been confirmed in conditions such as albinism and strabismus (Brodsky 
and Fray, 2004; Merrill et al., 2004; Basmak, Sahin, Yildirim, Saricicek, et al., 2007).  
While others have explored the implication in laser refractive study (Reinstein, Gobbe 
and Archer, 2013).  
 
 
2.3 Evaluation of angle kappa assessment using NIDEK OPD-Scan II 
 
The NIDEK OPD Scan II aberrometer/corneal topographer workstation which is has a 
touchscreen user interface which provides autorefractor, keratometry, angle kappa 
and pupillometry assessments. It plots sixteen different maps which displays 
information about the patients’ corneal shape, wavefront, internal aberrations and 
visual quality. The software in the workstation can also assist in the management of 
KC, cataract surgery and refractive laser surgery. The measurement range of the 
NIDEK OPD Scan II is -20.00 to +22.00 dioptres, 0 to ± 22.00D cylinder and 0 to 180° 
axis, and a minimum measurable pupil size of 2.6 mm.  These assessments can be 
obtained in one particular session, therefore all of the data gathered can be referenced 
to each other. It uses the principle of dynamic skiascopy wavefront sensor. As a serial, 
double-pass aberrometer, an infrared light slit and photodetectors are locate on a 
revolving wheel that rotates along a fixed axis across the pupil (MacRae and Fujieda, 
2000). As the incident beam moves along a specific pupillary perimeter which results 
in a reflected beam that travels in the same or reverse direction. When the wheel 
revolves the instrument assesses the time delay for light to peak at each photodiode 
after passing a beam splitter (Jonathan D Solomon, 2010). The device then calculates 
the optical pathway difference and derives the wavefront error by comparing the 
results with the theoretical reference time and creates a refractive map, wavefront 
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profile and angle kappa coordinates (Buscemi, 2002; Jonathan D Solomon, 2010; 
Jonathan D. Solomon, 2010).  
 
 
2.4 Angle kappa measurements in the general population 
 
The general prevalence of a minor positive angle kappa in the non-hyperopic 
demographic was first reported by Srivannaboon et al. where 97% of the eyes that 
underwent myopic refractive surgery had a positive angle kappa of 0.5 mm or less 
(Srivannaboon and Chotikavanich, 2005).  
Various other studies have also confirmed that in a general population the mean angle 
kappa value is positive. The results of these studies stating this finding is summarised 
in Table 2.1. 
 
 
Table 2.1: Summary of studies report angle kappa values  
Author  Study type Sample 
size 
Method of 
assessment 
Angle kappa 
values  
Findings  
Basmak 
et al. 
(2007) 
Prospectiv
e group 
compariso
n  
108 
strabismi
c 
subjects 
and 102 
healthy 
controls  
Synoptophor
e 
Topographer 
(Clement 
Clarke, 
London, UK)  
Esotropic: OD 
2.35° ±0.41° 
OS 2.55° 
±0.42°.  
Exotropic: OD 
3.83° ±0.36° 
OS 4.38° 
±0.28°  
Exotropes 
have 
significantly 
higher values 
of angle 
kappa than 
esoptropes 
or controls. 
Angle kappa 
was found to 
be larger in 
left eye than 
in right eye. 
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Positive 
correlation 
between 
angle kappa 
and positive 
refractive 
errors.  
Basmak 
et al. 
(2007)  
Prospectiv
e group 
compariso
n  
150 men 
and 150 
women  
Synoptophor
e 
Topographer 
and Orbscan 
II (Bausch 
and Lomb, 
USA)  
Synoptophore
: Myopic: OD 
1.74° ±0.13° 
OS 1.91° 
±0.14 
Hyperopic: 
OD 3.44° 
±0.14° OS 
3.84° ±0.17°  
Orbscan II: 
Mypoic : OD 
4.51° ±0.11° 
OS 4.73° 
±0.11°     
Hyperopic: 
OD 5.65° 
±0.10° OS 
5.73° ±0.10° 
Orbscan II 
values were 
on an 
average of 
1.55 mm 
larger than 
Synoptophor
e values  
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Hashemi 
et al. 
(2010) 
Cross 
sectional 
survey  
442 
subjects, 
800 eyes.  
Orbscan 
Topographer 
(Bausch and 
Lomb, USA)  
Myopic: 5.13° 
±1.50° 
Emmertropic 
Group: 5.72° 
±1.10° 
Hyperopic: 
5.52° ±1.19°    
Mild 
Hyperopic: 
5.53° ±1.24° 
Moderate 
Hyperopic: 
5.45° ±1.26° 
Angle kappa 
is larger in 
hyperopes 
than myopes. 
Angle kappa 
slightly 
decreases 
with age. 
Angle Kappa 
did not 
correlated to 
gender  
Zarei-
Ghanavat
i et al. 
(2014)  
Prospectiv
e 
controlled 
study  
48 
myopic 
subjects, 
96 eyes 
Orbscan 
Topographer 
(Bausch and 
Lomb, USA)  
Severe 
Hyperopic: 
5.59° ±2.61°. 
Preoperative 
mean angle 
kappa values: 
4.97° ±1.24°. 
Postoperative 
mean angle 
kappa values: 
4.99° ±1.10°  
No significant 
change were 
found in 
angle kappa 
pre and post 
PRK  
 
 
According to the current body of research the mean angle kappa value in a normal 
demographic of emmetropes lies between 2.78 ± 0.12° in right eyes and 3.32 ± 0.13° 
in left eyes. However, these values have only been assessed by a single instrument, 
Syntophore corneal topography system (Clement Clarke International Ltd, London, 
UK) (Basmak, Sahin, Yildirim, Papakostas, et al., 2007). However, studies using the 
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Orbscan II corneal topographer (Bausch and Lomb, USA) have found the values to be 
4.97 ± 1.24°(Zarei-Ghanavati et al., 2014).   
 
Variation in angle kappa values with regards to different machines used for 
assessment or significant of eye dominance have yet to be completely understood, 
however, it has been noted gender goes not correlated with angle kappa (Hashemi et 
al., 2010) and has a tendency show a non-significant decrease with age (Berrio, 
Tabernero and Artal, 2010).  
 
 
2.5 Multifocal intraocular lenses and angle kappa  
 
Asymmetric and symmetric multifocal IOLs are designed to provide functional vision 
for distance, intermediate and far. These multifocal IOLs have specifically designed 
optical surfaces that allows them to provide optimal vision, therefore decentration or 
misalignment of the lens can adversely affect VA and the QOV (Hayashi et al., 2001; 
Pazo et al., 2016). Although the effects of decentration and angle kappa on various 
designs of IOLs have not been completely assessed. However, photopic phenomenon 
as a result of multifocal IOL decentration has been documented to be one of the main 
reasons for multifocal exchange (Woodward, Randleman and Stulting, 2009). It has 
been postulated that an increase in angle kappa values could contribute to functional 
misalignment on the multifocal optical zones to the pupillary or visual axis and thereby 
lead to photopic side-effects. 
 
Prakash et al. (2011) reported that larger preoperative angle kappa values in 
symmetrical multifocal intraocular lens (Rezoom IOL, Abbott Medical Optics) 
correlated with photopic phenomenon such as glare (R2= 0.26, P= 0.033). Severity of 
haloes in this study also correlated to angle kappa and postoperative uncorrected 
distance visual acuity (UCVA) (R2 = 0.26, P = 0.029) (Prakash et al., 2011). Although 
there was a correlation between angle kappa and photopic phenomenon but patient 
dissatisfaction can have multiple aetiologies’ (de Vries et al., 2011). Rosales et al. 
(2010) research used anatomical, Purkinje, and Sheimpflug data to simulate 
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aberration models of 21 eyes to demonstrate that aspheric intraocular lenses (Tecnis, 
AMO, and AcrySof IQ, Alcon Research labs) tilt and decentration (mean tilt of 1.54 
degrees and mean decentration of 0.21mm) had a small effect on higher order 
aberrations. However, Hayashi et al. (2001) states that in zonal-progressive multifocal 
lens decentration greater than 0.7mm has the consequence of substantial VA 
impairment. The premise of large angle kappa negatively affecting the QOV lies in the 
fact the human eye is not geometrically symmetrical, the fovea and the optical axis do 
not lie on the same point therefore optical region of a multifocal IOL which fails to 
accommodate the large angle kappa can miss centration leading to less optimal vision. 
 
 
2.5.1 Study aim 
 
Since the human eye is not geometrically symmetrical, the fovea and the optical axis 
do not lie on the same point (Prakash et al., 2011). Therefore, the angular distance 
between the visual axis and the pupillary axis measured by the Nidek OPD Scan  is 
calculated as angle kappa (Basmak, et al. 2007; Okamoto et al. 2011). The aim of the 
study assesses the impact of preoperative angle kappa upon QOV of patients 
implanted with asymmetrical multifocal IOL. Since high angle kappa could potentially 
impair/reduce light transmission through either the distance or near component of 
these IOLs without actual physiological IOL decentration within the pupil.  
 
 
2.5.2 Sample size  
 
The power calculation was conducted using G*Power 3.1 (Faul et al., 2007)  (ANOVA 
repeated measures within factor) to show a medium effect size with 90% power and 
an alpha level of 0.05. Two hundred eyes of 100 cataract patients (41 men, 59 women; 
mean age: 64.3 years ± 4.9) who had undergone phacoemulsification and implantation 
of an asymmetrical IOL (Lentis-Mplus MF20) were assessed. The maximum number 
of subjects required was 100 and therefore 100 subjects were retrospectively 
assessed to ensure adequate statistical power. Sample size was determined using 
power calculation (90% power at the 5% level of statistical significance, α=0.05) to 
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detect a change of 1 unit change in QOV Score with 90% power (β=0.2) at the 5% 
level of statistical significance (α=0.05), 100 subjects were required based upon 
published data (standard deviation in patients =± 1.08) (McNeely et al., 2017) 
 
 
2.5.3 Subjects  
 
This retrospective, case series is from a population of patients seeking IOL 
implantation surgery due to cataracts at Cathedral Eye Clinic, Belfast, Norther-Ireland, 
UK. Because this was a retrospective study, only informed consent and permission to 
use their data for analysis and publication was obtained from each patient as part of 
our routine preoperative protocol. The nature of the study was explained verbally and 
on paper to the participants by trained clinicians before obtaining a written informed 
consent (ref: Appendix D). A complete ocular examination was performed to screen 
for ocular abnormalities and determine patient candidacy for surgery. Exclusion 
criteria were previous ocular surgery, ocular disease such as corneal opacity, corneal 
irregularity, DE, and any degree of amblyopia, glaucoma or retinal disease, and 
complications during surgery.  
 
 
2.5.3 Experimental procedure 
 
Preoperatively, all patients had a full ophthalmic examination including unaided 
distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) (4m 
logMAR, Early Treatment of Diabetic Retinopathy Study Chart 1 [ETDRS]), unaided 
near visual acuity (UNVA) and corrected near visual acuity (CNVA) at 40cm with 
Radner reading charts under a standard mesopic lighting condition, (Radner charts 
allow direct conversion i.e. 0.2 logMAR distance acuity is comparable to 0.2 logRAD 
reading acuity with high correlation at 40 cm to a logMAR equivalent for size of letters) 
and unaided intermediate visual acuity (UIVA) and corrected intermediate visual acuity 
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(CIVA) at 70cm. Further examinations included keratometry, topography and auto 
refraction (OPD-Scan aberrometer (NIDEK Co. Ltd., Gamagori, Japan), subjective 
refraction, uncorrected and corrected distance visual acuity (UDVA+CDVA), 
uncorrected near visual acuity (UNVA), contrast sensitivity (Pelli-Robson Contrast 
Sensitivity Chart), slit-lamp examination, Goldmann tonometry, dilated funduscopy 
and biometry (IOL Master, version 4.3, Carl Zeiss Meditec AG). and angle kappa (mm) 
with Nidek OPD Scan II (NIDEK Co. Ltd. Gamagori, Japan). 
 
The IOL Master was used to measure corneal curvature, anterior chamber depth, axial 
length and subsequent IOL calculation using the Hoffer Q formula for eyes with AL 
<22 mm and SKR/T formula for AL 22-25 mm and Haigis for AL >25 mm (A- constant 
of 118.2 for SRKT and a0 constant of 0.83, a1, a2 for Haigis). Emmetropia was the 
target in all cases. QOV scores were obtained using a validated QOV questionnaire 
(McAlinden, Pesudovs and Moore, 2010) assessing the outcome measures of 
symptom frequency, severity, and bothersome nature. The safety and efficacy of 
Lentis-Mplus MF20 IOL implantation were calculated by the mean change in 
preoperative CDVA at six months and mean change in preoperative UDVA at six 
months respectively. Postoperatively, patients were evaluated at one month, three 
months and six months and further in addition to the above-mentioned examinations, 
unaided vision, CDVA and near vision were assessed looking for evidence of 
differences in their mean or in their level of variation through assessment of outlier 
differences. Posterior capsule opacification was graded as follows: 1=none, 2=mild 
(early development of PCO), 3 = moderate (increased PCO with early visual acuity 
changes not requiring secondary capsulotomy) and 4 = severe (PCO affecting vision 
and requiring neodymium: YAG laser capsulotomy). 
 
 
2.5.4 Surgical technique  
 
One experienced surgeon (JEM) performed all surgeries. The steep axis was marked 
in all patients preoperatively at the slit-lamp. Subtenons or topical anaesthesia was 
carried out on all patients. A standard sutureless on-steep axis corneal phaco surgery 
(2.75mm incision) was performed through a 5.0 mm anterior capsulorrhexis in all 
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patients without complication. After irrigation/aspiration of cortex the MIOL mentioned 
above were implanted in all cases with recommended injector cartridge. All residual 
viscoelastic was removed prior to intracameral antibiotic injection (cefuroxime). Where 
on-axis surgery was not possible, a 2.75mm supero-temporal corneal position was 
used to minimise induced astigmatism. Postoperative topical therapy included 1 drop 
of ofloxacin 0.3% (Exocin) four times daily for two weeks, one drop of ketorolac 
trometamol 0.5% (Acular) four times daily for one month and one drop of 
dexamethasone 0.1% (Maxidex) four times daily for three weeks.  
 
 
2.5.5 Questionnaire 
 
For this study a validated QOV Questionnaire (McAlinden, Pesudovs and Moore, 2010) 
was used (ref: Appendix A). The questionnaire was administered preoperatively and 
postoperatively at one month, three months and six months follow-up to assess for 
possible neural adaption. The patients were asked to rate their overall QOV separately 
for day and night from (0) very poor, to (10) excellent. Photopic phenomenon was 
scored from of (0) normal, (1) mild, (2) moderate and (3) severe. 
 
 
2.5.6 Statistical analysis 
 
Subjective and objective results were entered into Microsoft Excel spreadsheet. 
Descriptive statistics were created using SPSS (Statistical Package for the Social 
Sciences, Version 11.5, Chicago, Illinois, USA) and Excel (Microsoft; Redmond, 
Washington, USA). The Kolmogorov-Smirnov test was used to assess normality. The 
Student t test for paired parametric data was applied to assess the significance of 
differences between preoperative and postoperative data; the Wilcoxon rank-sum test 
was used when non-parametric data prevailed. Linear regression analysis was 
conducted to evaluate predictors and response. Ordinal median data was assessed 
using the non-parametric test; Mann Whitney U. P values less than 0.05 were 
considered statistically significant. 
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2.6 Results  
 
Due to the retrospective nature of this study all 100 patients in this study reported no 
intraoperative complications during the six months postoperative follow-up. The mean 
preoperative angle kappa was 5.69 ± 0.97 and postoperative at one month and six 
months was 5.64 ± 0.92 and 5.67 ± 0.94 respectively. There was no significant 
difference between pre and postoperative angle kappa measurements.  
 
 
Quality of Vision  
 
A regression analysis was performed between the preoperative angle kappa and the 
postoperative QOV following cataract surgery to assess for evidence of correlation. 
The results show that one-month postoperative QOV at day and night correlated with 
the preoperative angle kappa with a coefficient of determination: (r2 = 0. 677; p<0.05 
and r2 = 0. 726; p<0.05 respectively) (Figure 2.1 and 2.2). However, the correlation 
between angle kappa and QOV day and night diminished at three months after 
operation assessment (r2 = 0.281; p<0.05 and r2 = 0.319; p<0.05 respectively) (Figure 
2.3 and 2.4).  At six months QOV at day and night correlated with the preoperative 
angle kappa with a coefficient of determination: (r2 = 0. 255; p<0.05 and r2 = 0. 268; 
p<0.05 respectively) (Figure 2.5 and 2.6). 
 
Analysis of the relationship between pupil diameter and QOV during day at one month 
and three months after operation revealed that it was statistically significant r2 =0.652 ; 
p<0.05 and r2 = 0.461; p<0.05 (Table 2.2).  The correlation of QOV and pupil diameter 
at night was also significant (r2 = 0.622; p<0.05 and r2 = 0.527; p<0.05). (Table 2.2). The 
mean combined QOV day and night score preoperative saw a significant improvement 
postoperatively (Table 2.3).  
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Figure 2.1. Scatterplot of the association between the angle kappa vs. QOV day at 
one-month after operation.  
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Figure 2.2. Scatterplot of the association between the angle kappa vs. QOV night at 
one-month after operation. 
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Figure 2.3. Scatterplot of the association between the angle kappa vs. QOV day at 
three months after operation. 
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Figure 2.4. Scatterplot of the association between the angle kappa vs. QOV night at 
three months after operation.  
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Figure 2.5. Scatterplot of the association between the angle kappa vs. QOV day at 
six months after operation. 
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Figure 2.6. Scatterplot of the association between the angle kappa vs. QOV night at 
six months after operation.  
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Table 2.2. Analysis of the relationship between pupil diameter and QOV.  
  
1-month 
postop 
P-
value  
3-months 
postop 
P-
value  
6-months 
postop 
P-value  
Correlation of 
QOV and pupil 
diameter 
            
Day  r2 =0.652 0.016 * r2 = 0.622 0.029* r2 = 0.540  0.021* 
Night  r2 = 0.461 0.022 * r2 = 0.527 0.034* r2 = 0.472  0.037* 
*statistically significant 
 
 
Table 2.3. Comparison of preop, 1-month and 3-months and 6-month subjective data 
after asymmetric multifocal IOL implantation. 
 
Parameter Preop 
1-month 
postop 
3-month 
postop 
6-month 
postop P-value 
QOV Day 5.27 ± 1.95 7.83 ± 1.03 8.95 ±1.70 9.01 ±0.10 0.030* 
QOV Night 4.95 ± 2.10 7.10 ± 1.10 7.86 ± 1.05 8.10 ± 0.22 0.023* 
Glare 0.84 ± 0.72 0.45 ± 0.45  0.27 ± 0.20  0.18 ± 0.15 0.041* 
Haloes 0.86 ± 0.65 0.40 ± 0.20 0.19 ± 0.22 0.15 ± 0.10 0.019* 
*: P-value <0.05 
QOV scale: 0 (bad) to 10 (Good).                                                                                                                 
Glare and haloes grading scale: 0 = not at all; 1 =a little; 2 = quite; 3 = very 
 
 
Visual Acuity  
 
Figure 2.7, 2.8 and 2.9 shows the 6-month postoperative cumulative monocular UDVA, 
UIVA, and UNVA visual outcomes respectively. The safety plots in Figure 2.10 and 
Figure 2.11 show the accuracy of the attempted spherical equivalent (SE). At six 
months after operation, 0% of eyes lost two or more lines of CDVA vision compared 
to preoperative vision.  
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Figure 2.7. Cumulative monocular UDVA at 6 months postoperative assessment.  
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Figure 2.8. Cumulative monocular UIVA at 6 months postoperative assessment.  
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Figure 2.9. Cumulative monocular UNVA at 6 months postoperative assessment.  
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Figure 2.10. Monocular CDVA at 6 months postoperative assessment. 
 
 
CDVA: corrected distance visual acuity.  
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Figure 2.11. Accuracy to the intended SE refraction at 6 months postoperative 
assessment. 
 
 
SE: spherical equivalent.  
 
 
Efficacy 
 
The mean preoperative CDVA was −0.06 ± 0.10 logMAR, at one month it was 
−0.08 ± 0.06 logMAR and at six months it was −0.08 ± 0.09 logMAR. The mean UDVA 
also saw improvements, postoperatively at one month and six months it was stable at 
−0.02 ± 0.17 logMAR and −0.01 ± 0.25 logMAR respectively. The mean UIVA at one 
month postoperatively was 0.35 ± 0.15 logMAR and 0.32 ± 21 logMAR after six months. 
The mean UNVA improved from 0.14 ± 0.12 logMAR at one month and 0.15 ± 0.12 
logMAR at six months after operation (Table 2.4).  
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Refractive Error 
 
The postoperative sphere at one month and six months was 0.13 ± 0.35 D and 0.21 ± 
0.37 D respectively and mean cylinder was −0.25 ± 0.30 D and −0.32 ± 0.25 D at one 
and six months postoperatively (Table 2.4).  
 
 
Table 2.4. One month and three months objective postoperative data after bilateral 
asymmetric multifocal IOL implantation. D: dioptres; CDVA: corrected distance visual 
acuity; logMAR: logarithm of minimum angle of resolution; UDVA: uncorrected 
distance visual acuity; UIVA: uncorrected intermediate visual acuity; UNVA: 
uncorrected near visual acuity 
 
Parameters  Preoperative  
Postop 1-
month 
Postop 3-
month 
Postop 6-
month 
Sphere (D) 1.23 ± 2.85  0.13 ± 0.35 0.20 ± 0.40 0.21 ± 0.37 
Cylinder (D) −0.53 ± 0.50 −0.25 ± 0.30 −0.35 ± 0.35 −0.32 ± 0.25 
CDVA 
(LogMAR) −0.06 ± 0.10 −0.08 ± 0.06  −0.09 ± 0.04  −0.08 ± 0.09 
UDVA 
(LogMAR) -- −0.02 ± 0.17 −0.01 ± 0.15  −0.01 ± 0.25  
UIVA (LogMAR) -- 0.35 ± 0.15  0.30 ± 20   0.32 ± 21  
UNVA 
(LogMAR) -- 0.14 ± 0.12 0.13 ± 0.10 0.15 ± 0.12 
 
 
Complications  
 
No serious complications (posterior capsule rupture, endophthalmitis, macular edema 
or persistent raised intra-ocular pressure) occurred during the study. None of the eyes 
lost any lines of BCVA at the latest follow-up (six months). 
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2.7 Discussion 
 
There was an overall high level of patient satisfaction (Figure 4 and 5) despite obvious 
improvements and good objective overall VA, glare and haloes were perceived by 
some patients (3.3%) with a range of severity (Table 2.3) resulting in an overall 
reduced QOV in a small percentage at one-month review period.  Dysphotoptic 
symptoms are well-recognised problems perceived from various types of multifocal 
IOLs (Cochener et al., 2011; Gil et al., 2012; Schmickler et al., 2013).  However, in 
this study there was a rapid diminution in their severity resulted in increased QOV by 
the three month and six-month review. This improvement in QOV night scores can be 
attributed to postoperative neuroadaptation (Voskresenskaya et al., 2010; Prakash et 
al., 2011) which is congruent with the findings of other studies (Voskresenskaya et al., 
2010) where postoperative improvement in the QOV of patients was reported between 
six to twelve months. Therefore, in our study we also found that the initial severity of 
photic phenomenon in asymmetrical multifocal improved within three and six months. 
A comparative study with other lens design to evaluate parameters that affect neural 
adaptation will be a further extension of this study.  
 
In order to better define potential causes for variation in postoperative QOV, this study 
sought to analyse a comprehensive set of preoperative factors. The factors assessed 
included: angle kappa, pupil diameter, UNVA, CNVA, UNVA, CNVA, spherical error, 
cylindrical power, age and gender. Among these, regression analysis demonstrated 
substantial association between the postoperative visual experience and angle kappa 
and pupil diameter. 
 
When comparing the scatter plot of QOV one-month scores and angle kappa, the 
findings were: QOV night scores (r2 = 0.726; p<0.5) were more correlative to angle 
kappa as compared to QOV day scores (r2 = 0.677; p<0.05). This suggests that 
alignment error due to larger angle kappa is a possible cause of dysphotopsia, hence 
poor QOV during night. However, this influence of angle kappa over the QOV at three 
months during night gradually diminished. A higher angle kappa leads to a fovea-
centric ray passing closer to the edge of the IOL and not through the pupillary area 
exactly concentric with the centre of the IOL.  This raises the question as to whether it 
is possible to modify the IOL centration with the prior knowledge of a large angle kappa. 
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IOL currently centre themselves based upon their haptics pushing against the edge of 
the capsular bag. A capsular tension ring may prevent capsular contraction to some 
degree but if the actual capsule is not centred either on the pupil or the visual axis 
there is a potential to result in less than optimal visual outcome (Mester et al., 2007). 
A different option available to the asymmetric IOL is the ability to rotate the smaller 
near segment to different regions of the pupil such as in the opposite vectoral position 
to angle kappa, thus maximising the exposure of the near segment surface area within 
the pupil. 
 
Multiple variable factors are involved in the position of the multifocal IOL, capsular 
contraction, memory of the haptics and IOL rotation. Surgeons have performed 
pupilloplasty to centre the pupil to realigning the visual axis in cases of significant angle 
kappa to improve the QOV.  
 
It is well recognised from various studies on symmetrical multifocal IOLs that pupil size 
can affect the performance. The effect of the pupil size upon QOV in this study was 
analysed (Table 2.3) and it is evident that larger pupil size providing better QOV during 
the day and night. Asymmetric multifocal IOLs differ from symmetric IOLs since in the 
prior the near or distance segment can be affected by loss of surface area of IOL 
exposed during pupil meiosis. This effect would potentially be more heightened by 
pupil meiosis due to bright lights and reading close-up. An increase in pupil diameter 
results in greater proportion of light being directed to the distance section and near 
section of the asymmetrical multifocal IOL, thereby resulting in good QOV for distance 
and near. The reduction of light available due to a smaller pupil diameter is likely to 
cause a significantly poorer visual acuity in photopic compared to mesopic conditions 
due to the loss of IOL surface area exposure to either distance or near section. We 
found that pupils with greater diameter appear to help in maintaining good night vision 
and could possibly even be compensating for high angle kappa in some patients (Pazo 
et al, 2018). However, an assessment of a larger sample of significant angle kappa 
and small pupil size is warranted to make definitive claims on this phenomenon. As 
for now, it is safe to speculate that potentially the combined effects of ‘small pupils and 
large angle kappa (visual angle offset)’ can lead to poor QOV in asymmetric multifocal 
IOL patients.  
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The validated QOV questionnaire (McAlinden, Pesudovs and Moore, 2010) 
demonstrated improvement in QOV between one, three and six months. The overall 
increase in satisfaction can be attributed to the decrease in photopic phenomena as 
patients in this study experienced less dysphotopsia as time progressed (Table 2.3). 
Glare demonstrated a statistically significant improvement while halo remained stable 
and did not worsen. It can be argued that VA plays a more significant role in patient 
satisfaction rather than dysphotopsia as the sheer time spent in harsh lighting 
conditions is less.  In our VA analysis we found that VA from one month to six months 
postoperatively did not have significantly improvement. Hence the reduction in 
dysphotopic phenomenon can be safely accredited for the improvement in QOV 
scores and over-all visual satisfaction. Therefore, it is vital for lens manufactures to 
focus on negating dysphotopsia in order improve patient satisfaction. Similarly, it 
would be of value to study whether a lens could be customized to match the angle 
kappa and pupil diameter measurements of individual patients’. The overall photic 
components like glare, haloes and starburst were reported greater in high angle kappa 
patients but as the percentage of cases with a high angle kappa was only 8.6% of the 
total study population, these findings are statistically less reliable. A larger sample size 
of ‘large angle kappa’ patient group could be used in the future to segregate specific 
components of dysphotopsia that are potentially affected by angle kappa and other 
visual axes.  
 
 
2.8 Conclusion  
 
In summary, the QOV of cataract patients in this study improved within two to three 
months. However, a small subgroup of patients with significant angle kappa and small 
pupil diameter had unsatisfactory visual performance outcomes during the first month 
due to photic phenomena but neural adaption during postoperative at two and three 
months resulted in improved QOV. This study proves that preoperative angle kappa 
and pupil diameter have an influence on the postoperative QOV in asymmetrical 
multifocal IOL patients. Further studies will be conducted to demonstrate if these 
findings are similar in other forms of asymmetric multifocal IOLs. The influence of 
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angle kappa on QOV coincides with studies such as Prakash et al. (2011) study on 
symmetric multifocal IOLs. Although angle kappa had a strong correlation with QOV 
especially during night, it cannot be used as an isolated parameter because 
approximately 20% of the patients in this study that experienced poor QOV have 
normal to small angle kappa and therefore this solidifies the fact that postoperative 
QOV experience is an interplay between various factors and angle kappa alone is not 
sufficient to predict the final visual performance. However, one of the limitations to this 
study is that the groups were not gender and age matched. Additionally, it can be used 
along with pupil diameter to counsel and help patient better understand the potential 
initial postoperative outcomes and the implication of neural adaptation when opting for 
asymmetric multifocal IOL. 
 
 
2.8 Summary  
Visual axes and pupil diameter are some of the parameters that affect QOV in patients 
with bilateral implantation of asymmetrical IOL. The combined effects of these two 
parameters, improves a surgeon’s ability to predict potential problem cases. Chapter 
3 will investigate the effects of pupil size on visual performance in asymmetric 
multifocal IOLs. 
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CHAPTER 3: PUPIL INFLUENCE ON THE QUALITY OF VISION IN 
ROTATIONALLY ASYMMETRICAL MULTIFOCAL IOLS WITH SURFACE-
EMBEDDED NEAR SEGMENT 
 
 
3.1 Introduction  
 
The previous chapter demonstrated a relationship between the magnitude of angle 
kappa and the postoperative QOV after asymmetric multifocal IOL implantation. It also 
demonstrated the value of the Nidek OPD-Scan II to accurately and efficiently 
measure angle kappa. The role of the aberrometer/corneal topographer extends 
beyond this basic assessment of angle kappa. Pupil size measurements and 
wavefront sensing over a wide range of photopic and mesopic pupil performance 
within an eye can also be analysed. The assessment of preoperative pupil diameter 
and pupil centroid shift has been recognized as an important preoperative screening 
criteria in both laser refractive and IOL implantation surgeries. Studies have shown 
that larger scotopic pupil size in refractive surgery can lead symptoms such as glare, 
halos and monocular diplopia postoperatively (Martnez et al., 1998; Haw and Manche, 
2001) 
 
 
3.2 Analysis of pupil size 
 
There are various methodologies that can employed to evaluate pupil size. Colvard 
Colvard hand-held infrared pupillometer (Oasis Medical, Glendora, Calif) has been 
considered the standard for pupil measurement in refractive surgery. Additionally, 
Procyon pupilometer (Procyon, London, United Kingdom) is considered an accurate 
pupilometer (Schmitz et al., 2003). OPD Scan (NIDEK Co Ltd, Gamagori, Japan), is 
designed to perform pupillometry. A comparison study by McDonnell et al. (2006) 
found that the OPD Scan measurements of the pupils produce similar results to 
Procyon pupillometer and Colvard pupilometer readings. Mantry and colleagues also 
confirmed that the mean pupil diameter with the Colvard pupillometer (4.8 ±1.0 mm) 
and OPD Scan (4.8 ± 0.9 mm) were comparable in low mesopic light conditions. The 
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mean photopic pupil diameter with Colvard pupillometer and OPD Scan was 3.3 ± 0.8 
mm with the and 3.9 ± 0.8 mm respectively (Mantry et al., 2005). 
 
Table 3.1 shows the studies that have related to pupil assessment using various 
devices.  Since there is plenty of variations among studies, it is important to precisely 
assess each individual eye before IOL implantation surgery. 
 
 
Table 3.1. Pupil diameter assessment with different devices.  
Device 
Illumination 
(lux) 
Eyes 
Pupil diameter 
(mm) 
Colvard IR pupilometer 
(Colvard, 1998) 
15, 3 200 6.2 (3.2–9.0) SC 
Colvard IR pupilometer 
(Kohnen et al., 2003) 
0.28 100 5.78 SC 
Procyon IR pupilometer  
(Kohnen et al., 2003)   
0.07, 0.88, 
6.61 
100 5.90 SC 
Procyon IR pupilometer 
(Rosen et al., 2002) 
0.02, 0.15, 
10.6 
116 6.61 SC 
Colvard IR pupilometer 
(Schnitzler, Baumeister 
and Kohnen, 2000) 
0.5–0.6 66 6.08 LM 
Colvard IR pupilometer 
(Mantry et al., 2005) 
0.1 46 5.6 LM 
Nidek OPD IR auto-
refractor (Mantry et al., 
2005) 
0.1 46  4.9 LM 
IR, infrared; SC, scotopic; LM, low mesopic. 
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3.3 Pupil size and multifocal intraocular lens  
 
The aim of multifocal IOL use is to restore distance, intermediate and near visual 
function after cataract or clear lens extraction surgery (de Wit et al., 2015; Gil-Cazorla 
et al., 2016).  Various methods have been implemented to achieve some degree of 
pseudo-accommodation, such as: aiming for myopic astigmatism (Huber, 1981) 
targeting one eye for myopia (monovision) (Boerner and Thrasher, 1984) or multifocal 
IOL implantation (De Vries and Nuijts, 2013). The impact of pupil size in multifocal IOL 
implantation plays varying roles in the visual performance and optical quality with 
respect to design of the IOL. Therefore,  individual assessment of each multifocal IOL 
design across various pupil sizes is necessary (García-Domene et al., 2015; Wang et 
al., 2016).  The new generation of refractive rotationally asymmetrical multifocal IOLs 
aims to alleviate the occurrence of optical side effects (Venter et al., 2014).   
Asymmetrical multifocal IOLs such as the SBL-3 (Lenstec. Inc., Christ Church, 
Barbados) in general provide both far and near vision by splitting light to two or more 
focal points (Venter et al., 2014). The SBL-3 IOL has a +3.0 dioptre near portion with 
a seamless transition zone between the distance and near section (Figure 3.1). It is 
crucial that ophthalmologists help retain the ability of elderly patients to see a range of 
distances enabling multiple daily life scenarios, including driving (Hessemer et al., 
1994). Anecdotal evidence from patients and a case report by Pazo et al. (2016) on 
bilateral implantation of asymmetrical multifocal IOL suggests that due to the 
asymmetrical design of the IOL,  patients can experience a reduced QOV while driving 
and in bright supermarket lighting conditions (Javitt and Steinert, 2000).  The centre 
of the pupil has a tendency to move slightly nasally when constricting (Yang Y, 
Thompson K, 2002).  Therefore, a small photopic pupil can alter the amount of incident 
light directed to either the distance or near section. Therefore, the visual performance 
and subjective experience of asymmetric multifocal IOLs is dependent upon pupil size 
(Montés-Micó et al., 2004; Kawamorita and Uozato, 2005a; Alfonso et al., 2007). A 
case report by Pazo et al. (2016) and the findings of Montés-Micó et al. (2004) 
highlights the point that variation of pupil size affects the relative exposure of sections 
of IOLs. However, to our knowledge, there is no report of the influence of pupil 
diameter on VA and subjective QOV in patients with the SBL-3 IOL. Kawamorita & 
Uozato's (2005) investigation with zonal progressive multifocal IOLs found that a pupil 
diameter of 3.4 mm or larger was desirable to enhance near vision. Table 3.2 shows 
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the studies that have assessed the impact of pupil size in various multifocal IOLs.  
Since there are variations among studies due to the multifocal IOL designs, it is 
therefore important to precisely assess each multifocal IOL for their individual optical 
visual outcome.  
 
 
Figure 3.1. SBL-3 asymmetrical multifocal intraocular lens (Lenstec Barbados, Inc., 
Christ Church, Barbados) with a superior distance sector and inferior near addition.  
 
 
 
Table 3.2. Chronological order of studies that have assessed the impact of pupil size 
with various multifocal IOL designs.  
Study IOL Type Findings  
Effect of pupil size 
and astigmatism 
on contrast acuity 
with monofocal 
and bifocal 
intraocular lenses 
True Vista™ bifocal 
IOL; monofocal IOL 
BCCA decreased slightly 
with increasing pupil size in 
each group, and differences 
between 2.0 mm and 6.0 mm 
pupils were significant at 
each contrast level. In all 
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(Knorz et al., 
1994).  
bifocal groups, BCCA 
decreased significantly with 
increasing pupil size and 
decreased with increasing 
corneal astigmatism; 
differences were significant 
at most pupil sizes and 
contrasts tested. 
Correlation 
between Pupillary 
Size and 
Intraocular Lens 
Decentration and 
Visual Acuity of a 
Zonal-progressive 
Multifocal Lens 
and a Monofocal 
Lens (Hayashi et 
al., 2001).  
 
Array multifocal IOL 
(PA154N; Allergan)                       
Monofocal IOL 
(MA60BM; Alcon 
Surgical, Fort Worth, 
TX). 
Smaller pupil size correlated 
significantly with worse near 
VA.  Pupil 
diameter of less than 4.5 mm 
could not provide useful near 
VA, and decentration of 0.9 
mm is the maximum 
allowable limit for adequate 
distance VA.                                    
Pupil size and IOL 
decentration did not 
influence VA in eyes 
with monofocal IOLs. 
Visual 
performance with 
multifocal 
intraocular lenses: 
Mesopic contrast 
sensitivity under 
distance and near 
conditions 
(Montés-Micó et 
al., 2004).  
Zonal-progressive 
multifocal IOL 
implantation (Allergan 
Medical Optics Array 
SA-40N); Monofocal 
IOL implantation 
(Allergan Medical 
Optics SI-40NB). 
Zonal-progressive multifocal 
IOL distance CS was within 
normal limits under bright 
photopic conditions. Deficits 
at higher spatial frequencies 
(more than approximately 12 
cpd) under dim mesopic 
conditions. Near CS 
obtained with the multifocal 
IOL is below that which can 
be achieved by monofocal 
near correction, for all spatial 
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frequencies and illumination 
conditions. 
Modulation 
transfer function 
and pupil size 
in multifocal and 
monofocal 
intraocular 
lenses in vitro 
(Kawamorita & 
Uozato 2005).  
Refractive multifocal 
IOL Array SA-40N 
(Allergan); Monofocal 
IOL PhacoFlex SI-
40NB (AMO) 
Zonal progressive multifocal 
IOL, the pupil size was a 
trade-off between 
the far and near MTFs: The 
near MTF increased at the 
expense of the far MTF at 
large pupil sizes (effective 
pupil diameter >3.4 mm). For 
near vision with a multifocal 
IOL, the desirable effective 
pupil diameter should be 3.4 
mm or larger. 
Correlation of pupil 
size with visual 
acuity and contrast 
sensitivity after 
implantation of an 
apodized 
diffractive 
intraocular lens 
(Alfonso et al., 
2007).  
AcrySof ReSTOR IOL 
(SN60D3, Alcon).  
A larger pupil was correlated 
significantly with better 
distance visual acuity and 
with worse near visual acuity. 
For all pupil diameters, 
intermediate visual acuity 
worsened significantly as the 
distance of the test 
increased. Distance contrast 
sensitivity was better with 
larger pupils at all spatial 
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frequencies in bright-light 
and dim-light conditions. 
Functional 
outcomes after 
implantation of 
Tecnis ZM900 and 
Array SA40 
multifocal 
intraocular lenses  
(Mester et al., 
2007).  
Tecnis ZM900 and the 
Array SA40 multifocal 
IOLs  
Diffractive Tecnis multifocal 
IOL is independent of the 
pupil size, a 3.0 mm pupil 
should not theoretically have 
an impact on visual 
performance. 
Optical 
performance of 
two new trifocal 
intraocular lenses: 
through-focus 
modulation 
transfer function 
and influence of 
pupil size (Ruiz-
Alcocer et al., 
2014).  
AT LISA tri 839MP 
with a trifocal 
diffractive design; 
FineVision apodized 
bifocal diffractive IOL.  
For larger pupil sizes, the 
FineVision provided better 
results at far Vision while the 
AT LISA tri 839MP provides 
better vision at intermediate 
and near distance and is less 
pupil size-dependent. 
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Pupil influence on 
the quality of vision 
in rotationally 
asymmetrical 
multifocal IOLs 
with surface-
embedded near 
segment. (Pazo et 
al, 2017 Under 
Press) 
SBL-3 (Lenstec. Inc., 
Christ Church, 
Barbados) 
asymmetrical 
multifocal IOL.  
The preoperative photopic 
pupil is an important 
parameter for consideration 
in this type of IOL as smaller 
pupil sizes demonstrate a 
significant negative 
subjective impact upon the 
QoV. 
 
 
3.3.1 Study aim 
 
The objective of our study was to assess whether varying pupil sizes has an impact 
upon the QOV in eyes implanted with asymmetrical multifocal IOLs. 
 
 
3.3.2 Sample size  
 
The maximum sample size was calculated using G*Power 3.1 (Faul et al., 2007)  using 
two way paired t-test to show a medium effect size with 85% power and an alpha level 
of 0.05.  The maximum number of subjects required was 180 eyes of 90 subjects and 
therefore 90 subjects were recruited to ensure adequate statistical power. Sample size 
was determined using power calculation (85% power at the 5% level of statistical 
significance, α=0.05) to detect a change of 1 unit change in QOV Score 90 subjects 
were required based upon published data (standard deviation in patients =± 1.08) 
(McNeely et al., 2017). 
 
 
3.3.3 Subjects  
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This retrospective, case series is from a population of patients seeking IOL 
implantation surgery at Cathedral Eye Clinic, Belfast, Norther-Ireland, UK. Because 
this was a retrospective study, only informed consent and permission to use their data 
for analysis and publication was obtained from each patient as part of our routine 
preoperative protocol. The nature of the study was explained verbally and on paper to 
the participants by trained clinicians before obtaining a written informed consent (ref: 
Appendix D). A complete ocular examination was performed to screen for ocular 
abnormalities and determine patient candidacy for surgery. Exclusion criteria were 
previous ocular surgery, ocular disease such as corneal opacity, corneal irregularity, 
DE, and any degree of amblyopia, glaucoma or retinal disease, and complications 
during surgery. 
 
 
3.3.4 Experimental procedure 
 
The preoperative characteristics of patients are shown in Table 3.3.  This retrospective 
study included cataract patients that had undergone bilateral phacoemulsification 
followed by SBL-3 Lenstec, IOL implantation. The near section of the SBL-3 IOL was 
placed in an inferonasal position within a dilated pupil. In all patients, photopic pupil 
diameters were assessed using NIDEK OPD-Scan (NIDEK Co Ltd, Gamagori, Japan). 
To determine the effect of pupil size on the QOV during the day, patients were divided 
into groups based on photopic pupil diameter: 2.50 to 2.99 mm (group A), 3.00 to 
3.50mm (group B), 3.51 to 4.00 mm (group C), and 4.00 to 4.50 mm (group D). All 
patients received thorough informed consent detailing individual benefits, risks and 
alternatives to surgery. In addition, each signed a consent form indicating their 
permission to publish their anonymized results. The study adhered to the tenants of 
the Helsinki Declaration and was approved by the local ethics committee. Exclusion 
criteria were previous ocular surgery, ocular disease such as corneal opacity, corneal 
irregularity, DE, and any degree of amblyopia, glaucoma or retinal disease, and 
complications during surgery.  
 
 
Table 3.3. Patient demographics 
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  Group A Group B Group C Group D P-value 
Age (years) 59.80±8.30 60.12±7.42 59.63±7.90 61.37±7.65 0.004 
Sex M/F 
(patients) 
8/14 10/12 11/10 10/15 -- 
Follow-up time 
(months) 
19.33±5.24 19.25±5.62 19.80±5.83 20.12±6.21 0.281 
Mean 
Astigmatism (D) 
0.79±0.10 0.76±0.24 0.77±0.45 0.82±0.10 0.342 
Mean CDVA 
LogMAR 
0.2±0.12 0.18±0.17 0.2±0.15 0.19±0.13 0.097 
Mean QOV Score 
(0-10) 
6.5±1.2 6.7±1.1 6.5±1.5 6.7±1.4 0.265 
M: Male; F: Female; D: Dioptres; CDVA: Corrected Distance Visual Acuity; QOV: 
Quality of Vision 
 
 
3.3.5 Preoperative and Postoperative Examinations 
 
Preoperatively, all patients had a full ophthalmic examination including uncorrected 
distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) (4m 
logMAR, Early Treatment of Diabetic Retinopathy Study Chart 1 [ETDRS]), 
uncorrected near visual acuity (UNVA) and corrected near visual acuity (CNVA) at 
40cm with Radner reading charts under a standard mesopic lighting condition, 
(Radner charts allow direct conversion i.e. 0.2 logMAR distance acuity is comparable 
to 0.2 logRAD reading acuity with high correlation at 40 cm to a logMAR equivalent for 
size of letters) and uncorrected intermediate visual acuity (UIVA) and corrected 
intermediate visual acuity (CIVA) at 70cm. Further examinations included keratometry, 
topography and auto refraction (OPD-Scan aberrometer (NIDEK Co. Ltd., Gamagori, 
Japan), subjective refraction, slit-lamp examination, Goldmann tonometry, dilated 
funduscopy and biometry (IOL Master, version 4.3, Carl Zeiss Meditec AG), and pupil 
diameter, angle kappa/p-dist with the Nidek OPD Scan II (NIDEK Co. Ltd. Gamagori, 
Japan).  
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The IOL Master was used to measure corneal curvature, anterior chamber depth, axial 
length and subsequent IOL calculation using the Hoffer Q formula for eyes with AL 
<22 mm and SKR/T formula for AL 22-25 mm and Haigis for AL >25 mm (A- constant 
of 118.2 for SRKT and a0 constant of 0.83, a1, a2 for Haigis). Emmetropia was the 
target in all cases. Postoperatively, patients were evaluated at 1 day, 1-month, 3 
months, 6-months, 1-year, and 18-months. In addition to the above-mentioned 
examinations, UIVA, UNVA, distance corrected intermediate visual acuity (DCIVA) 
and distance corrected near visual acuity (DCNVA) were assessed looking for 
evidence of differences in their mean or in their level of variation through assessment 
of outlier differences. Posterior capsule opacification (PCO) was graded by an 
ophthalmologist as follows: 1=none, 2=mild (early development of PCO), 3 = moderate 
(increased PCO with early visual acuity changes not requiring secondary capsulotomy) 
and 4 = severe (PCO affecting vision and requiring neodymium: YAG laser 
capsulotomy).  
 
 
3.3.6 Surgical technique 
 
One experienced surgeon (J.E.M.) performed all surgeries. The steep axis was 
marked in all patients preoperatively at the slit-lamp. Sub-tenons or topical 
anaesthesia was carried out on all patients. A standard sutureless on-steep axis 
corneal phaco surgery (2.75 mm incision) was performed through a 5.0 mm anterior 
capsulorhexis in all patients without complication. After irrigation/aspiration of cortex 
the multifocal IOL mentioned above were implanted in all cases with recommended 
injector cartridge. All residual viscoelastic was removed prior to intracameral antibiotic 
injection (cefuroxime). Where on-axis surgery was not possible, a 2.75 mm supero-
temporal corneal position was used to minimise induced astigmatism. Capsular 
tension ring (CTR) was used in all 180 eyes to benefit tilt and decentration. 
Postoperative topical therapy included 1 drop of ofloxacin 0.3% (Exocin) 4 times daily 
for two weeks, 1 drop of ketorolac trometamol 0.5% (Acular) 2 times daily for 1 month 
and 1 drop of dexamethasone 0.1% (Maxidex) 4 times daily for three weeks. 
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3.3.7 Pupil assessment 
 
All pupil assessments using the NIDEK OPD-Scan (NIDEK Co Ltd, Gamagori, Japan) 
were performed in a single test room that had a constant ambient illumination of 0.63 
lux. To standardise the postoperative pupil assessments, the ambient lighting was 
continuously monitored using a handheld Illuminometer light meter (Sekonic, Japan). 
Concurrently, before measuring the pupil size, the patient’s orbital region illumination 
was recorded and maintained at 0.63 lux to have minimum discrepancy among patient 
groups. The minimum luminance the photometer could record was 0.63 lux. 
 
 
3.3.8 Intraocular lens tilt and centration assessment 
 
As the designs of multifocal IOLs have improved and become more sophisticated the 
need to understand and improve lens misalignment on optical performance has 
increased. Scheimpflug image processing techniques can assess the pupillary axis, 
IOL centre and pupil centre from the three-dimensional anterior segment image 
capture system. Validation of this techniques by de Castro et al. on a physical eye 
demonstrates that IOL decentration and tilt can be approximated within an accuracy 
of 0.228 mm for decentration and 0.243 degree for tilt, in comparison to 0.094 mm and 
0.279 degree respectively using the Purkinje imaging apparatus (Rosales et al., 2010). 
The Scheimpflug imaging system (Pentacam; Oculus, Wetzlar, Germany) was used 
to assess IOL decentration and tilt. Postoperative IOL decentration and tilt were 
carefully measured according to methodology applied by de Castro et al., which is as 
follows: The pupil centre was calculated by locating as the midpoint between the two 
visible pupil segments and the IOL centre was determined as the midpoint intersection 
of the two diameter lines from the anterior and posterior edges of the IOL. The 
reference axis was calculated as the line passing through the centre of the pupil, 
known as the pupillary axis.  The IOL axis (L) is calculated as the line joining the 
centres of curvature of the anterior and posterior lens edges. These axes are referred 
to a vertical axis in each image. IOL decentration and tilt was calculated from the 
distance between the IOL centre and the pupillary axis. A scale of 0.02 mm in the 
lateral plane was used. Since there were no optical surfaces in the object, optical 
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distortion did not have any influence on the scale. The angles between these two axes 
are obtained to determine the IOL decentration. A CTR was used in all eyes. Eyes 
were examined at 6-months, 1-year and 18-months after IOL implantation to confirm 
both IOL clarity and tilt. 
 
 
3.3.9 Questionnaire 
 
For this study a validated QOV Questionnaire (McAlinden, Pesudovs and Moore, 2010) 
was used. The questionnaire was administered after six months, one year and 
eighteen months follow-up to assess for possible neural adaption. The patients were 
asked to rate their overall QOV separately for day and night from very poor (0), to 
excellent (10).  
 
 
3.3.10 Statistical analysis  
 
Data analysis was performed using SPSS for Windows (Statistical Package for the 
Social Sciences, Version 22, Chicago, Illinois, USA.). The relationship between the 
pupil size and QOV was modelled using a linear regression model and the differences 
in QOV between pupil size groups were evaluated by analysis of variance (ANOVA). 
Normality was checked by the Shapiro-Wilk test and Q-Q plot test. To assess the 
contribution of pupil size to the QOV, a correlation analysis was performed. 
Differences were considered statistically significant when the P value was less than 
0.05.  
 
 
3.4 Results  
 
All 90 patients had no intra-operative or postoperative complications at eighteen 
months follow-up.  
 
 
Quality of vision and pupil size  
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Statistically significant differences in postoperative QOV questionnaire score for six 
months, one year and eighteen months were found between the groups (P<0.001). A 
regression analysis was performed between the pupil diameter (photopic and mesopic) 
and the QOV (day and night) score to find out whether pupil size was a predictor for 
the QOV. At the six months postoperative assessment, QOV score correlated with the 
postoperative photopic pupil area with a r 2 =0.517; p<0.001 (Figure 3.2). The 
relationship between postoperative photopic pupil diameter with QOV score 
decreased slightly at one-year after operation assessment but was still significant at 
r2 = 0.480; p<0.001 (Figure 3.3) and the relation for QOV score at eighteen months 
was also significant at r2 = 0.472; p<0.001 (Figure 3.4). The regression analysis 
between mesopic pupil size and QOV night scores were: r 2 =.397; p<0.001 (six 
months postoperative) (Figure 3.5), r 2 =379; p<0.001 (1-year postoperative) (Figure 
3.6) and r 2 =.360; p>0.001 (eighteen months postoperative) (Figure 3.7). The mean 
preoperative photopic and mesopic pupil size was 4.3±0.3mm and 5.6±1.4mm 
respectively, eighteen months postoperative both the photopic and mesopic pupil 
diameter decreased by 0.5mm and 0.7mm respectively (Table 3.4).   There were 
statistically significant differences between the mean preoperative pupil size (photopic 
and mesopic) and eighteen months postoperative pupil size (photopic and mesopic) 
(P<0.001). The comparison between the mean QOV scores between groups showed 
a statistical difference at six months, one year and eighteen months postoperatively 
(Table 3.4). Group B, C and D with pupil size >2.99mm reported better mean QOV 
scores for day and night in comparison to group A.  
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Figure 3.2. A correlation analysis was performed between photopic pupil diameter 
and the QOV day score at six months after operation.  
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Figure 3.3. A correlation analysis was performed between photopic pupil diameter 
and the QOV day score at twelve months after operation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 32 
Figure 3.4. A correlation analysis was performed between photopic pupil diameter 
and the QOV day score at eighteen months after operation.  
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Figure 3.5.  A correlation analysis was performed between mesopic pupil diameter 
and the QOV night score at six months after operation.  
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Figure 3.6. A correlation analysis was performed between mesopic pupil diameter and 
the QOV night score at twelve months after operation.  
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Figure 3.7. A correlation analysis was performed between mesopic pupil diameter and 
the QOV night score at eighteen months after operation.  
 
 
 
Table 3.4. Comparison of pupil diameter 
 
Photopic Pupil Size (mm) 
Preoperative  
Postoperative 6 
months  
Postoperative 12 
months 
Postoperative 18 
months  
4.3 ± 0.3§||  4.2 ± 1.21||  4.1 ± 1.05†  3.8 ± 0.7 †‡§  
Mesopic Pupil Size (mm)  
Preoperative  
Postoperative 6 
months  
Postoperative 12 
months 
Postoperative 18 
months  
5.6 ± 1.4§|| 5.4 ± 1.63|| 4.9 ± 1.73 †‡ 4.9 ± 1.2 †‡ 
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mm: millimetre; n= 180 eyes                                                                      *Statistically 
significant across groups                                                                          † 
Statistically significant change compared with preoperative                                            
‡ Statistically significant change compared with 6-months postoperative                           
§ Statistically significant change compared with 12-months postoperative                                                                                                           
|| Statistically significant change compared with 18-months postoperative    
 
 
Visual Acuity and Refraction  
 
Table 3.5 shows the between-group comparison of postoperative data. The mean at 
six months, one year and eighteen months postoperative ocular parameters, visual 
and refractive outcomes had no statistically significant differences. The mean UNVA 
was better in patients with larger pupil group (group B, C and D) postoperative as 
compared to patients with smaller pupils (group A). Figure 3.8, 3.9 and 3.10 shows 
18-month postoperative cumulative monocular UDVA, UIVA, and UNVA visual 
outcomes comparison respectively. The safety plots in Figure 3.11 and Figure 3.12 
show the accuracy of the attempted spherical equivalent (SE).   
 
 
Table 3.5. Between-group comparison.  
 
Postoperative 6-month data. 
Parameter 
 Group A 
(2.50-
2.99mm) 
 Group B 
(3.00-
3.50mm) 
Group C 
(3.51-
4.00mm) 
Group D 
(4.01-
4.50mm) 
P 
Value
* 
Sphere (D)           
 Mean ± SD 0.16±0.36 0.09±0.47 0.18±0.21 0.1±0.44 0.081 
Cylinder (D)           
 Mean ± SD 0.37±0.40 0.4±0.34 0.29±0.35 0.39±0.33 0.174 
logMAR UDVA 
(monocular) 
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 Mean ± SD -0.04 ±0.21 
-0.03 ± 
0.10 
-0.03 ± 
0.07 
-0.03± 0.09 0.132 
logMAR UIVA 
(monocular) 
          
 Mean ± SD 0.26 ± 0.2 0.25 ± 0.09 0.25 ± 0.3 0.24 ± 0.15 0.077 
logMAR UNVA 
(monocular) 
          
 Mean ± SD 0.09 ± 0.15 0.09 ± 0.11 
0.08 ± 
0.11 
0.09 ± 0.10 0.952 
Angle Kappa 
(degree) 
          
 Mean ± SD 4.7 ± 0.8 4.3 ± 0.4 4.2 ± 0.9 4.2 ± 0.6 0.074 
QOV  (0-10)           
 Day 7.7±0.4‡§|| 8.5±0.3† 8.7±0.7† 8.6±0.5† 
0.029
* 
 Night 7.0±1.6‡§|| 7.5±1.7† 7.6±1.5† 7.6±0.8† 
0.015
* 
 Tilt (degree)           
 Mean ± SD 1.5° ± 0.50 1.5° ± 0.50 1.5°± 0.50 1.7°± 0.70 0.59 
Centration (mm)           
 Mean ± SD 0.20±0.05 0.25±0.05 0.25±0.05 0.15±0.05 0.24 
Postoperative 1-year data 
Sphere (D)           
 Mean ± SD 0.15±0.35 0.09±0.49 0.19±0.33 0.11±0.32 0.084 
Cylinder (D)           
 Mean ± SD 0.35+0.44 0.39±0.37 0.3±0.38 0.39±0.30 0.061 
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logMAR UDVA 
(monocular) 
          
 Mean ± SD -0.04±0.03 -0.03± 0.04 
-0.03 ± 
0.15 
-0.03± 0.03 0.752 
logMAR UIVA 
(monocular) 
          
 Mean ± SD 0.27±0.10 0.24 ± 0.15 
0.25 ± 
0.10 
0.24 ± 0.14 0.461 
logMAR UNVA 
(monocular) 
          
 Mean ± SD 0.09±0.12 0.08±0.15 0.08±0.25 0.08±0.12 0.952 
Angle Kappa           
 Mean ± SD 4.3±0.8 4.3±0.9 4.1±0.2 4.2±0.5 0.145 
QOV (0-10)           
 Day 7.5±0.7‡§|| 8.6±0.5† 8.7±0.5† 8.7±0.4† 
0.041
* 
 Night 7.2±0.3‡§|| 7.7±1.2† 7.7±0.5† 7.9±1.1† 
0.028
* 
 Tilt (degree)           
 Mean ± SD 1.5°±0.50 1.5°±0.70 1.5°±0.60 1.5°±0.60 0.675 
Centration (mm)           
 Mean ± SD 0.20±0.05 0.25±0.05 0.35±0.05 0.25±0.05 0.091 
Postoperative 18-months data 
Sphere (D)           
 Mean ± SD 0.16±0.38 0.1±0.48 0.18±0.35 0.1±0.32 0.065 
Cylinder (D)           
 Mean ± SD 0.34±0.43 0.37±0.40 0.29±0.31 0.38±0.40 0.057 
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logMAR UDVA 
(monocular) 
          
 Mean ± SD -0.04±0.12 -0.04± 0.10 
-0.03 ± 
0.09 
-0.03± 0.13 0.065 
logMAR UIVA 
(monocular) 
          
 Mean ± SD 0.27±0.13 0.25 ± 0.10 
0.26 ± 
0.12 
0.25 ± 0.15 0.072 
logMAR UNVA 
(monocular) 
          
 Mean ± SD 0.10 ± 0.12 0.09 ± 0.12 
0.08 ± 
0.15 
0.08 ± 0.10 0.729 
Angle Kappa           
 Mean ± SD 4.3 ± 0.9 4.4 ± 0.1 4.2 ± 0.3 4.3±0.7 0.29 
QOV (0-10)           
 Day 7.8 ± 0.5‡§|| 8.7 ±0.4† 8.8 ± 0.7† 8.7±0.6† 
0.034
* 
 Night 7.2±0.10‡§|| 7.7±0.9† 7.8±1.2† 7.9±0.9† 
0.023
* 
 Tilt (degree)           
 Mean ± SD 1°±0.50 1.5°±0.60 1.5°±0.50 1.5°±0.60 0.621 
Centration (mm)           
 Mean ± SD 0.20±0.05 0.25±0.05 0.25±0.05 0.24±0.07 0.248 
*Statistically significant across groups, P-value <0.05                                                                                                                                                                                                                  
† Statistically significant change compared with group A                                                                                                                                                                                
‡ Statistically significant change compared with group B                                                                                                                                                                                      
§ Statistically significant change compared with group C                                                                                                                                                                                 
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|| Statistically significant change compared with group D                                                                                                                                                                                            
UDVA: Unaided distance visual acuity; UIVA: Unaided intermediate visual 
acuity; UNVA: Unaided near visual acuity; SD: Standard deviation; mm: 
millimetre 
 
 
Figure 3.8. Cumulative monocular UDVA comparison between groups at 18-month 
postoperative assessment. 
 
 
UDVA: uncorrected distance visual acuity.  
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Figure 3.9. Cumulative monocular UIVA comparison between groups at 18-month 
postoperative assessment. 
 
 
UIVA: uncorrected intermediate visual acuity.  
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Figure 3.10. Cumulative monocular UNVA comparison between groups at 18- month 
postoperative assessment. 
 
 
UNVA: uncorrected near visual acuity.  
 
 
Figure 2.11. Monocular CDVA comparison between groups at 18-month 
postoperative assessment. 
 
CDVA: corrected distance visual acuity.  
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Figure 2.12. Accuracy to the intended SE refraction comparison between groups at 
18-month postoperative assessment. 
 
 
SE: Spherical equivalence; D: dioptre.  
 
 
Efficacy 
 
The mean preoperative UDVA was 0.67±0.09 logMAR and following eighteen months 
postoperatively it improved to -0.02±0.12 logMAR, -0.02±0.10 logMAR, -0.03±0.09 
logMAR and -0.03±0.13 logMAR between group A, B, C and D respectively. 
Preoperatively, UIVA was 0.25 ± 0.01 logMAR and postoperatively at eighteen months 
it was 0.18±0.11 logMAR, 0.17±0.09 logMAR, 0.17±0.12 logMAR, and 0.16±0.10 
logMAR respectively. The mean preoperative UNVA was 0.75 ± 0.25 logMAR and 
postoperatively it was 0.09±0.08 logMAR, 0.08±0.05 logMAR, 0.08±0.15 logMAR, and 
0.07±0.15 logMAR respectively.  
 
 
Tilt and Centration 
 
All IOLs retained complete clarity throughout the eighteen months follow-up as 
demonstrated after pupil dilation and direct slitlamp examination. Mean absolute lens 
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tilt between the groups was less than 2° ± 0.5 (SD), exceeding the standard for stability 
(≥90% of eyes with ≤5°). None of the lenses was repositioned during the study. There 
were also no statistical differences between the lens tilt (Table 3.5). Grossly decentred 
IOLs cases on dilated slit lamp biomicroscope examination and photographic analysis 
were excluded. 
 
 
Adverse Events and Posterior Capsule Assessments 
 
No serious complications (posterior capsule rupture, endophthalmitis, macular 
oedema or persistent raised intra-ocular pressure) occurred during the study. All 180 
eyes (90 patients) were retrospectively assessed and categorised into the respective 
pupil size groups. At six months, one-year and eighteen months, a single experienced 
ophthalmologist examined all 180 eyes and confirmed no or mild PCO was present. 
Cases with PCO were excluded from this retrospective analysis.      
 
 
Visual Disturbances and Photopic Phenomena 
 
Table 3.6 shows the individual symptom responses found in each group. ‘Glare’ and 
‘Halos’ were significantly different across the groups at 6-months postoperatively with 
group A experiencing the highest mean score for ‘Glare’ and ‘Halos’ in comparison to 
other groups. During one-year assessment only ‘Glare’ was found to be significantly 
different among the groups and group A once again had the highest mean ‘Glare’ 
score. At eighteen months assessment, none of the visual disturbances was 
significantly different across the groups, and the mean scores of all groups were all 
lower than the mean six months postoperative score. 
 
 
Table 3.6. Between-group comparison of subjective responses postoperatively 
 
Postoperative 6-month 
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QoV 
questions for 
visual 
symptoms 
 Group A 
(2.50-
2.99mm) 
 Group B 
(3.00-
3.50mm) 
Group C 
(3.51-
4.00mm) 
Group D 
(4.01-
4.50mm) 
P 
Value 
How much 
does glare 
bother you? 
0.64 ± 
0.73‡§ || 
0.36 ± 
0.49 †  
0.38 ± 
0.50 †  
0.28 ± 
0.46 †  
0.039* 
How much do 
the halos 
bother you? 
0.55 ± 
0.67‡§ || 
0.32 ± 
0.60†  
0.38 ± 
0.50 †  
0.36 ± 
0.49 †  
0.023* 
How much do 
the starbursts 
bother you? 
0.50 ± 0.60 
0.45 ± 
0.60 
0.33 ± 
0.48 
0.32 ± 
0.48 †   
0.835 
How much 
does hazy 
vision bother 
you? 
0.27 ± 0.55 
0.25 ± 
0.51 
0.33 ± 
0.58 
0.28 ± 
0.54 
0.286 
How much 
does blurred 
vision bother 
you? 
0.32 ± 0.57 
0.32 ± 
0.57 
0.29 ± 
0.56 
0.24 ± 
0.52 
0.557 
How much 
does 
distortion 
bother you? 
0.15 ± 0.22 
0.05 ± 
0.21 
0.14 ± 
0.36 
0.12 ± 
0.33 
0.253 
How much do 
double 
images 
bother you? 
0.18 ± 0.39 
0.18 ± 
0.39 
0.10 ± 
0.30 
0.08 ± 
0.28†  
0.211 
Postoperative 1-year 
How much 
does glare 
bother you? 
0.47± 
0.50||‡§ 
0.22 ± 
0.48†  
0.23 ± 
0.48†  
0.20 ± 
0.41†  
0.042* 
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How much do 
the halos 
bother you? 
0.36 ± 0.58 
0.30 ± 
0.50 
0.29 ± 
0.46 
0.20 
±0.41 
0.521 
How much do 
the starbursts 
bother you? 
0.45 ± 0.57 
0.32 ± 
0.48 
0.33 ± 
0.48 
0.28 ± 
0.46 
0.311 
How much 
does hazy 
vision bother 
you? 
0.23 ± 0.53 
0.23 ± 
0.53 
0.29 ± 
0.56 
0.24 ± 
0.52 
0.152 
How much 
does blurred 
vision bother 
you? 
0.27 ± 0.50 
0.25 ± 
0.55 
0.22 ± 
0.54 
0.24 ± 
0.52 
0.647 
How much 
does 
distortion 
bother you? 
0.18 ± 0.08 
0.00 ± 
0.20 
0.05 ± 
0.22 
0.00 ± 
0.00 
0.402 
How much do 
double 
images 
bother you? 
0.09 ± 0.29 
0.14 ± 
0.35 
0.10 ±0.30 
0.28 ± 
0.08 
0.233 
Postoperative 18-months 
How much 
does glare 
bother you? 
0.27± 0.46 
0.23 ± 
0.43 
0.24 ± 
0.44 
0.16 ± 
0.37 
0.138 
How much do 
the halos 
bother you? 
0.27± 0.55 0.24 ±0.39 
0.19 ± 
0.40 
0.16 ± 
0.37 
0.291 
How much do 
the starbursts 
bother you? 
0.35±0.47||  
0.32 ± 
0.48 
0.14 ± 
0.36 
0.16± 
0.37†  
0.623 
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How much 
does hazy 
vision bother 
you? 
0.26±0.55||  
0.22 ± 
0.43 
0.24 ± 
0.44 
0.12± 
0.33†  
0.541 
How much 
does blurred 
vision bother 
you? 
0.23 ±0.53 
0.18 ± 
0.39 
0.19 ± 
0.40 
0.24± 
0.52 
0.642 
How much 
does 
distortion 
bother you? 
0.00 ± 0.00 
0.00 ± 
0.00 
0.05 ± 
0.25 
0.04 
±0.20 
0.376 
How much do 
double 
images 
bother you? 
0.00 ± 0.00 
0.00 ± 
0.00 
0.10 ± 
0.30 
0.08 
±0.28 
0.753 
*Statistically significant across groups, P-value <0.05                                                                                                                                                                                                                                                                                                                                                                                                                                                 
† Statistically significant change compared with group A                                                                                                                                                                                                                                                                                                                                                                                                              
‡ Statistically significant change compared with group B                                                                                                                                                                                                                                                                                                                                                                                                   
§ Statistically significant change compared with group C                                                                                                                                                                                                                                                                                                                                                                                                   
|| Statistically significant change compared with group D                                                                                               
Grading scale: 0 = not at all; 1 =a little; 2 = quite; 3 = very                                                                                                                                                  
 
 
Patient Satisfaction 
 
Table 3.7 shows the key questions related to the visual performance from a computer-
based questionnaire 18-months postoperatively. The number of patients participating 
was 90. The results show high patient satisfaction with 0 (0%) being dissatisfied or 
very dissatisfied. Of the 90 patients, 81 (90%) reported they were very satisfied and 9 
(10%) satisfied with the outcome of the procedure. Ninety-six percent of patients 
stated that they would choose the procedure again and 98% said that they would 
recommend the procedure.  
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Table 3.7. Postoperative SBL-3 IOL patient survey at 18-months 
 
  Group A Group B Group C Group D Total Percentage 
How is your vision after the procedure? 
Very 
satisfied  
15 20 21 25 81 90 
Satisfied 7 2 0 0 9 10 
Dissatisfied 0 0 0 0 0 0 
Very 
Dissatisfied 
0 0 0 0 0 0 
Would you 
choose this 
procedure 
again? 
            
Yes  21 20 21 24 86 96 
Maybe  1 2 0 1 4 4 
No 0 0 0 0 0 0 
Would 
recommend 
the 
procedure  
            
Yes  21 22 21 24 88 98 
Maybe  1 0 0 1 2 2 
No 0 0   0 0 0 
n=90 patients 
 
 
3.5 Discussion 
 
The use of rotationally asymmetric multifocal IOLs to achieve pseudo-accommodation 
is a popular surgical option to improve postoperative visual performance and spectacle 
independence. Although several studies (Venter et al., 2014; de Wit et al., 2015; Pazo 
et al., 2016) have reported clinical outcomes following rotationally asymmetric 
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multifocal IOL implantation there is a paucity of literature comparing the subjective 
optical performance of these IOLs in daily routines, such as driving and shopping in 
brightly lit rooms.  
 
In addition to postoperative unaided VA, the aim of multifocal IOL implantation has 
been to improve quality of life, through better contrast sensitivity and night vision (de 
Wit et al., 2015).   The SBL-3 multifocal IOL is a relatively new asymmetric IOL and a 
case series of bilateral implantation on 53 eyes published by Venter et al. (2014) 
reported a good range of visual acuity retaining intermediate vision with minimal 
dysphotopsias.  
 
Lens tilt and decentration play an essential role in multifocal IOLs QOV postoperatively 
and has been found to significantly decrease retinal image quality when more than 5 
degrees (Gil-Cazorla et al., 2016).   In our study, tilt in all groups was found to be within 
2 degrees, and the difference among the groups was not significant (>0.05). This 
relatively low level of tilt and decentration can also be attributed to the better haptic 
design of the IOL and the use of CTR and in all study eyes. Therefore, we can safely 
state that the QOV among groups was not affected by postoperative IOL tilt and 
decentration. 
 
Assessment of pupil (photopic and mesopic) diameter and pupil shift (Porter et al., 
2006)  has become an integral part of preoperative patient suitability evaluation criteria 
for refractive surgery (Koch et al., 1996; Kamiya, 2014). The varying designs of 
multifocal IOL along with pupil size has proven to have a considerable effect on the 
objective and subjective vision of the patient (Hayashi et al., 2001; De Vries and Nuijts, 
2013). Ageing, in general, has been documented to have an impact on pupil size 
(Birren, Casperson and Botwinick, 1950; Hayashi et al., 2001).  The data from this 
study showed a decrease in the mean photopic and mesopic pupil size as time 
progressed. Although, the pupil size data were limited to Caucasian eyes there is no 
conclusive evidence regarding differences between races. However, Koch et al. (1996) 
did find that brown iris had larger pupil size in comparison to other iris colours. The 
mean preoperative photopic and mesopic pupil diameter in our study decreased at 
eighteen months by 0.5mm and 0.7mm respectively. Studies have suggested that the 
decrease in pupil size after cataract surgery could be due to the release of 
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neuropeptides (Miyake et al., 1978; Kamiya, 2014). However, in our study, we did not 
observe a significant early postoperative reduction in pupil size. The change in pupil 
size overtime is crucial in understanding postoperative visual outcome (Van Der 
Linden et al., 2013; McNeely et al., 2016; Pazo et al., 2016)  in a long-term prospective, 
as significant changes in pupil size after IOL implantation has a tendency to impact 
the subjective and objective QOV. 
 
In this study a curious but consistent finding was that among all the groups, group A 
(2.5 to 2.99mm) experienced reduced subjective QOV scores but overall had similar 
unaided distance VA after surgery as measured in clinic lighting conditions (Table 3). 
Conventional wisdom would suggest that patients with good visual acuity after surgery 
would also likely experience better subjective visual outcomes and report a higher 
level of visual satisfaction and QOV scores. However, in the findings from this study it 
was found that group A had a lower mean QOV when compared to other groups (Table 
3.5).  Even though all the groups provided equivocal and excellent distance, 
intermediate and near vision, however their subjective scores were significantly 
different. These findings are congruent with earlier reports that variations in normal 
pupil size have little to no effect upon the VA in patients with asymmetrical multifocal 
IOLs (Venter et al., 2014).  The overall objectively measured UDVA, UIVA and UNVA 
in this study demonstrated significant improvements between pre and postoperative 
periods and this improvement was found across the groups (Table 3). The reason for 
either groups performing similarly well during VA tests may possibly be that under 
controlled ‘office room’ lighting conditions (Watson and Yellott, 2012)  the design of 
the IOL allows both the principal refractive foci to lie on the central axis and not on 
diffractive concentric constructive interference for a clear image at a given focal length 
(Choi and Schwiegerling, 2008). However, the subjective QOV may have been 
affected by pupil miosis that prevents sufficient incident light to expose the central axis 
of the IOL, thereby only partial exposure of the distance or near section of these 
asymmetrical multifocal IOL. Therefore, the energy light distribution to distance focus 
and near focus seems to have an impact upon the QOV experienced by the patients. 
Additionally, we also found that the correlation (r2 value) between pupil size and QOV 
decreases over time, this may be due to possible neuroadaptation after IOL 
implantation. While comparing the r2 (correlation) value of photopic pupil and mesopic 
pupil, mesopic pupil size had a weaker relation with the QOV as compared to photopic 
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pupil size. This may be due to increased dysphotopsias at night increased by the effect 
of larger pupils (Table 3.6 and Table 3.7). 
 
A case report in press by Pazo et al. (2016) reported that by increasing the distance 
section of an asymmetric multifocal IOL within a photopic pupil resulted in improved 
subjective and objective visual outcome. This highlights the importance of SBL-3 IOL 
centration  and pupil area (Montés-Micó et al., 2004; Kawamorita and Uozato, 2005a; 
Alfonso et al., 2007; Sheppard et al., 2013)  in attaining good QOV. Pre-operative 
prediction of the centration of any multifocal IOL with respect to the physiological pupil 
centre can be difficult to determine exactly. As this is generally dictated by the position 
of capsular bag periphery (Alfonso et al., 2007)  and during surgery the only reference 
a surgeon has is the pharmacologically dilated pupil, whose centre can be quite 
different to the photopic pupil centre (Pazo et al., 2016).  
 
A recent literature search shows no published data on the impact of near or distance 
segment exposed within a photopic/small pupil in a rotationally asymmetric multifocal 
IOL. Studies on the near segment of Mplus (Lentis) asymmetric IOLs by de Wit et al. 
(2015) and Song et al. (2016) have only focused on the placement of the IOL and its 
resulting VA. The specific assessment of percentage or area of near and distance 
segment in a rotationally asymmetrical multifocal IOL especially within a small or 
photopic pupil has yet to be explored. Anecdotal evidence for patients experiencing 
mild to moderate blurred, glare and hazy vision while driving at night and in brightly lit 
rooms coincide with the fact that pupil constriction can occur while driving at night with 
incoming headlights or while shopping in brightly lit supermarkets. Although this study 
has not completely addressed the relationship between the pupil size and the surface 
area of near and distance segments exposed to incident light. However, our initial 
findings suggest: smaller photopic pupils (Group A; 2.50-2.99 mm) have a tendency 
to affect the postoperative QOV in asymmetric multifocal IOLs during miosis with no 
alterations in VA (Table 3.5). Our study will be extended to further assess the 
relationship between pupil and the area of asymmetrical multifocal IOL segment 
exposed by the incident light entering through the mesopic and photopic pupil.  
 
All groups reported a low incidence of visual symptoms. However, Group A was the 
most affected by each of the questioned symptoms, except for ‘double image’ at six 
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months postoperative assessment. However, these symptoms in all groups subsided 
at one year and eighteen months postoperative assessment, suggesting a 
neuroadaptive effect. However, group A had a greater mean score in comparison to 
other groups and especially with group D suggestion that pupil size has an impact 
upon visual symptoms in asymmetric multifocal IOL. 
 
It is well documented that decentration of multifocal IOL can lead to decreased VA and 
decreased QOV for the patient (Pazo et al., 2016).  The findings of IOL centration and 
tilt in our study show all eyes had well centred IOL, with <0.5 mm of mean decentration 
and the mean tilt was of less that 3 degrees, a CTR was also used in all eyes and no 
significant capsular contraction was found between one and eighteen months; nor was 
there any evidence of IOL rotation or movement indicating that small photopic pupil 
size is the most probable reason for the reduced postoperative QOV scores. 
Kawamorita & Uozato (2005) reported that in AMO Array multifocal refractive IOL, 
pupil size <4.5 mm was not able to achieve useful near VA. However, in asymmetric 
multifocal IOLs, VA with a small photopic pupil (Group A) was at par with large 
photopic pupil (Group B, C and D) but the subjective QOV was lower in group A. One 
benefit of this study is the follow-up of eighteen months which demonstrates a possible 
neuroadaptive effect with a general improvement in QOV overall groups with time. 
However, despite this, the deleterious impact of smaller pupil size is still retained even 
at eighteen months. Future investigations of the visual performance of multifocal IOL 
patients will include contrast sensitivity and optical aberrations to verify and validate 
the neuroadaptation phenomenon. However, one of the limitations to this study is that 
the groups were not gender matched. 
 
 
3.6 Conclusion  
 
Postoperative pupil diameter in rotationally asymmetric multifocal IOLs demonstrates 
significant subjective effects upon the QOV under miosis. Pupil size was shown to 
significantly decrease in size from its preoperative level at eighteen months after 
surgery. It is key to ensure that both the near and distance sections of asymmetric 
multifocal IOL are proportionally exposed under photopic pupil conditions. Since 
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asymmetric multifocal IOLs are not circular and nor is the capsular bag.  The most 
effective method of ensuring proportionate exposure of near and distance sections is 
to ensure that the postoperative photopic pupil size of >2.99 mm for SBL-3 asymmetric 
multifocal IOL implantation.  
 
 
3.7 Summary 
 
This chapter showed that in rotationally asymmetric multifocal IOL is subjectively 
affected by decreasing photopic pupil size. The asymmetrical design makes this 
multifocal IOL more suitable for postoperative patients with a photopic pupil diameter 
greater than 2.99 mm. Chapter 4 will investigate the effect of pupil centroid shift upon 
the QOV in asymmetric multifocal IOLs.  
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CHAPTER 4: THE IMPACT OF PUPIL CENTROID SHIFT UPON THE QUALITY OF 
VISION IN PATIENTS IMPLANTED ASYMMETRICAL MULTIFOCAL 
INTRAOCULAR LENS 
 
 
4.1 Introduction  
 
Locating the centre of the pupil is important for laser refractive treatment (Camellin, 
Gambino and Casaro, 2005) and multifocal IOL implantation (Pazo et al., 2016). 
However, pupil dilatation is not concentric and therefore its geometric centre alters 
under various lighting conditions (Camellin, Gambino and Casaro, 2005). Pupil 
assessment tools such as the Aladdin (Topcon, Tokyo, Japan) (Mandal et al., 2014) 
and OPD-Scan II (NIDEK Co Ltd, Gamagori, Japan) allows the dynamic assessment 
and graphical representation of pupil centroid shift. An off centred laser optical zone 
can lead to patient dissatisfaction due to induced aberrations and glare while a 
decentred  multifocal IOLs (Fay, Trokel and Myers, 1992; Pazo et al., 2016) can result 
in reduced QOV. Additionally,  it is important to accurately define the pupil diameter 
during preoperative assessment to enable the surgeon to predetermine the optical 
effects of a multifocal IOL (Sobaci et al. 2007; Pazo et al. 2017).  
 
 
4.2 Pupil centroid shift 
 
Several studies have examined the shift of centration of a pupil when subjected to 
varying lighting conditions. Walsh et al.  used photographic methodology to assess 
the change in pupil centration between light-adapted, dark-adapted, and 
pharmacologically dilated pupil conditions (Walsh, 1988). In this study 39 (78 eyes) 
participants were found to have an average change of 0.19 mm and the direction of 
the pupil centroid shift was superior nasal during pupil constriction.  Wilson et al. using 
video recording methodology with eight participants found a larger centroid shift of up 
to 0.59 mm and the direction of the shift varied in all participants (Wilson and Campbell 
1992). This contrast in the direction of pupil shift between studies may have been due 
to the fact that Wilson and Campbell (1992) used achromatic axis of the eye for 
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reference as compared to limbus centre reference by Walsh (1988). Therefore, an 
accurate comparison of direction of pupil shit cannot be ascertained by these two 
studies. Wyatt (1995) used a modified slit lamp biomicroscope to determine the 
change in pupil centration in natural dilated pupil in 23 participants and documented 
that the pupil had a tendency to move superior and nasally during constriction, these 
findings were similar to Walsh et al. with an average movement of approximately 0.1 
mm. However, these studies did not investigate factors such as refractive status or 
age.  
 
 
4.3 Evaluation of pupil centroid shift using OPD-Scan II 
 
The OPD Scan II (NIDEK Co Ltd, Gamagori, Japan) aberrometer/corneal topographer 
workstation which is has a touch screen user interface which provides 
autorefractometry, keratometry, angle kappa and pupillometry assessments. It plots 
sixteen different maps which displays information about the patient’s corneal shape, 
wavefront, internal aberrations and visual quality. The software in the workstation can 
also assist in the management of KC, cataract surgery and refractive laser surgery. 
The measurement range of the OPD Scan II (NIDEK Co Ltd, Gamagori, Japan) is -
20.00 to +22.00 dioptres, 0 to ± 22.00 cylinder and 0 to 180° axis, and a minimum 
measurable pupil size of 2.6 mm.  All of these assessments can be obtained in one 
particular session, therefore all of the data gathered can be referenced to each other. 
It uses the principle of dynamic skiascopy wavefront sensor. As a serial, double-pass 
aberrometer, an infrared light slit and photodetectors are located on a revolving wheel 
that rotates along a fixed axis across the pupil (MacRae and Fujieda, 2000). As the 
incident beam moves along a specific pupillary perimeter, it results in a reflected beam 
that travels in the same or reverse direction. When the wheel revolves, the instrument 
assesses the time delay for light to peak at each photodiode after passing a beam 
splitter (Jonathan D Solomon, 2010). The device then calculates the optical pathway 
difference and derives the wavefront error by comparing the results with the theoretical 
reference time and creates a refractive map, wavefront profile and angle kappa 
coordinates (Buscemi, 2002; Cervio et al., 2007). Pupil centroid shift refers to a shift 
in pupil centre between photopic and low mesopic pupil states. The OPD Scan II 
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(NIDEK Co Ltd, Gamagori, Japan) can measure pupil shift under low light mesopic 
(0.06 lux) and photopic (60 lux) illumination condition.  The pupil size and shift are 
automatically calculated with OPD Scan software.  The OPD Scan II has automated 
check of measurement quality, and alignment procedures that can be verified 
manually (Rozema, Van Dyck and Tassignon, 2005).  
 
 
4.4 Evaluation of intraocular lens centration and pupil shift using digital overlay 
technique 
 
Optimal visual outcome after multifocal IOL implantation requires precise IOL 
alignment and centration within the photopic pupil (Pazo et al., 2016). In addition to 
VA, refraction and keratometry, various studies generally assess IOL rotation and 
positioning subjectively (Viestenz, Seitz and Langenbucher, 2005) with the aid of 
slitlamp biomicroscope eyepiece graticule (Ruhswurm et al., 2000)  or eyepiece 
protractor (De Silva, Ramkissoon and Bloom, 2006). These methodologies of 
assessing the IOL with the capsular bag rely on the participant maintaining a steady 
head posture during the assessment and the assumption that in all intervals of 
assessment the participant has the same head posture as before. This technique has 
an estimation approximation of 1- 5 degrees. Digital image analysis can assess the 
location of the IOL. This methodology has been used by several studies along with 
generic (Nguyen and Miller, 2000; Goto et al., 2002; Becker, Auffarth and Volcker, 
2004) or custom image analysis software (Bender et al., 2004). A six month 
postoperative photographic analysis of rotational stability of toric IOL performed by 
Viestenz et al.(2005) revealed that there was an average of 2.5 degrees of rotation 
between visits; patients with greater rotation also had worse VA. The limitations to this 
study and methodology were head rotation, position of fixation light and error induced 
due to mounting of camera. These limitations can be alleviated by using an integrated 
slitlamp bio-microscope camera that allows visualisation of the iris, bulbar conjunctiva 
and retro-illumination with its external light source and slit beam. Since accurate 
overlay of two or more digital images is essential in assess the movement of the IOL 
and/or pupil;  Viestenz et al. (2005) recommended the land-marking the image with 
the use of conjunctival vessels, Axenfeld loops, or iris structure as references to 
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account for the intrinsic rotation of the IOL. While using this methodology Weinand et 
al. (2007) found that only 17 out of the 40 eyes could be analysed due to insufficient 
dilatation of the pupil that resulted in  poor visualisation of the IOL. Patel et al. (1999) 
used preoperative corneal ink-marking at 6 o’ clock position to compensate for head 
and eye rotation and found that the intra-observer variability was from 2.3 to 3.1 
degrees.  Shah et al. (2009) estimated the IOLs centration with a rectangle overlay on 
the visualised IOL and was documented to have a precision of 0.1 degrees. This study 
also used a single prominent episcleral vessel line joining the centre of the IOL to 
compensate for the possible movement of the eye and head of the participant. 
Intraocular lens positioning and centration has been assessed by image analysis in 
which the boundary for IOL is marked along with the limbus and the centres of the IOL 
optical disc and limbus centres are compared (Becker, Auffarth and Volcker, 2004; 
Bender et al., 2004; Tassignon, 2007) and the repeatability of the analysis of these 
objective retro-illuminated images at different postoperative periods of the IOL was 
found to be a sensitive assessment of IOL stability, rotation and centration (Wolffsohn 
and Buckhurst, 2010).  
 
 
4.5 Pupil centroid shift and multifocal intraocular lens 
 
The previous chapter demonstrated that pupil size influences the QOV in asymmetric 
multifocal IOLs (Pazo et al, 2017. in press). As the pupil dilates and constricts in an 
asymmetric manner the geometric centre of the pupil shifts (Moller, Buchholz and 
Huebscher, 2000; Wang et al., 2016). Although there have been significant 
improvements in multifocal design and material, pupillary influence is still an important 
preoperative factor to consider. Sobachi et al. examined 55 patients with unilateral 
pseudophakic (study group) age and gender matched patients with bilateral cataracts 
(control group) using the OPD Scan (Sobaci et al., 2007). The study reported that the 
differences in pupil shift between pseudophakic (0.11± 0.08 mm) and phakic (0.12 ± 
0.10 mm) eyes were not statistically significant in the study group. In the control group, 
differences in pupil size were not statistically significant. Sobaci et al. (2007) concluded 
that uncomplicated in-the-bag AcrySof MA30BA IOL (Alcon Laboratories Inc.) 
implantation has no influence on pupil size and shift as the pupil centroid shift was not 
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significantly large. Sobaci et al. (2007) also found a mean 0.11-mm pupil centroid shift 
in the infero-temporal direction. Asymmetric multifocal IOL implanted eyes can be 
more prone to centroid shift side-effects because changes in the pupil centre can lead 
to a relatively large change in the refractive state of the eye can occur (Pazo et al., 
2016) because the pupil can only expose a certain section, either for distance or near 
of the asymmetric multifocal IOL. Majority of studies assessing the performance 
multifocal IOLs assume the pupil is centred on the model axis whereas in the human 
eye the pupil is typically shifted approximately 0.3 mm nasal to the optical axis. This 
results in the decentration of the multifocal IOL which can induce photopic phenomena, 
thereby resulting in less optimal QOV. 
 
 
4.5.1 Study aim (Part-A) 
 
The aim of the study is to analyse the impact of pupil centroid shift upon QOV of 
patients implanted with asymmetrical multifocal IOL and a solution to compensate for 
larger pupil shift that could potentially impair / reduce light transmission through either 
the distance or near component of these IOLs without actual IOL decentration.  
 
 
4.5.2 Sample size  
 
The power calculation was conducted using G*Power 3.1 (Faul et al., 2007) (ANOVA 
repeated measures within factor) to show a medium effect size with 80% power and 
an alpha level of 0.05.  One hundred eyes of 50 patients (22 men, 28 women; mean 
age: 64.5 years ± 4.6) who had undergone phacoemulsification and bilateral 
implantation of an asymmetrical IOL (SBL-3, Lenstec Inc.) were assessed. Sample 
size was determined using power calculation (80% power at the 5% level of statistical 
significance, α=0.05) to detect a change of 1 unit change in QOV Score with 80% 
power (β=0.2) at the 5% level of statistical significance (α=0.05), 50 subjects were 
required based upon published data (standard deviation in patients =± 1.08) (McNeely 
et al., 2017).  
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4.5.3 Subjects  
 
This retrospective, case series is from a population of patients seeking IOL 
implantation surgery due to cataracts at Cathedral Eye Clinic, Belfast, Norther-Ireland, 
UK. Because this was a retrospective study, only informed consent and permission to 
use their data for analysis and publication was obtained from each patient as part of 
our routine preoperative protocol. The nature of the study was explained verbally and 
on paper to the participants by trained clinicians before obtaining a written informed 
consent (ref: Appendix D). A complete ocular examination was performed to screen 
for ocular abnormalities and determine patient candidacy for surgery. Exclusion 
criteria were previous ocular surgery, ocular disease such as corneal opacity, corneal 
irregularity, DE, and any degree of amblyopia, glaucoma or retinal disease, and 
complications during surgery. 
 
 
4.5.4 Experimental procedure 
 
The preoperative characteristics of patients are shown in Table 4.1.  This retrospective 
study included cataract patients that had undergone phacoemulsification followed by 
bilateral implantation of SBL-3 asymmetric multifocal IOL. The near section of the SBL-
3 IOL was placed in an inferonasal position within a dilated pupil. In all patients. Pupil 
diameters and pupil centroid shift were assessed using OPD Scan (NIDEK Co. Ltd. 
Gamagori, Japan) and Aladdin scan (Topcon medical systems, Inc.). To determine 
the effect of pupil centroid shit on the QOV, patients were divided into two groups 
based on pupil centroid shift: 0.00 to 0.30 mm (group A), 0.31 to 0.59 (group B). The 
categorization of these groups were based on previous studies on multifocal IOLs that 
suggest that 0.30 mm of pupil shift had nonsignificant impact upon the quality of vison 
(Sobaci et al., 2007).  Exclusion criteria were previous ocular surgery, ocular disease 
such as corneal opacity, corneal irregularity, DE, and any degree of amblyopia, 
glaucoma or retinal disease, and complications during surgery.  
 
 
Table 4.1 Patient demographics 
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Group A (0.00 to 
0.30mm) 
Group B (0.31 to 
0.59mm) 
P-value 
Age (years) 59.80±8.30 60.12±7.42 0.524 
Number of eyes  86 14 -- 
Follow-up time (months) 8.2±1.24 8.5±1.32 0.37 
Mean Astigmatism (D) 0.78±0.12 0.77±0.22 0.21 
Mean CDVA logMAR 0.14±0.15 0.1±0.20 0.083 
Pupil centroid shift (mm) 0.20±0.06 0.42±0.05 0.017* 
Mean QOV Score (0-10) 6.6±1.4 6.7±1.2 0.143 
*P-value <0.05, Statistically significant across groups                                                                                                                                                                                                                                                                                                                                                                                                             
D: Dioptres; CDVA: Corrected Distance Visual Acuity; mm: millimetres; QOV: 
Quality of Vision; *P<0.05 
 
 
4.5.5 Preoperative and postoperative examinations 
 
Preoperatively, all patients had a full ophthalmic examination including uncorrected 
distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) (4m 
logMAR, Early Treatment of Diabetic Retinopathy Study Chart 1 [ETDRS]), 
uncorrected near visual acuity (UNVA) and corrected near visual acuity (CNVA) at 
40cm with Radner reading charts under a standard mesopic lighting condition, 
(Radner charts allow direct conversion i.e. 0.2 logMAR distance acuity is comparable 
to 0.2 logRAD reading acuity with high correlation at 40 cm to a logMAR equivalent for 
size of letters) and uncorrected intermediate visual acuity (UIVA) and corrected 
intermediate visual acuity (CIVA) at 70cm. Further examinations included keratometry, 
topography and auto refraction OPD-Scan II aberrometer, subjective refraction, slit-
lamp examination, Goldmann tonometry, dilated funduscopy and biometry (IOL 
Master, version 4.3, Carl Zeiss Meditec AG), and pupil diameter with the OPD Scan II 
and Aladdin scan. The IOL Master was used to measure corneal curvature, anterior 
chamber depth, axial length and subsequent IOL calculation using the Hoffer Q 
formula for eyes with AL <22mm and SKR/T formula for AL 22-25mm and Haigis for 
AL >25mm (A- constant of 118.2 for SRKT and a0 constant of 0.83, a1, a2 for Haigis). 
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Emmetropia was the target in all cases. Postoperatively, patients were evaluated at 6-
months. In addition to the above-mentioned examinations, UIVA, UNVA, distance 
corrected intermediate visual acuity (DCIVA) and distance corrected near visual acuity 
(DCNVA) were assessed looking for evidence of differences in their mean or in their 
level of variation through assessment of outlier differences. Posterior capsule 
opacification (PCO) was graded by an ophthalmologist as follows: 1=none, 2=mild 
(early development of PCO), 3 = moderate (increased PCO with early visual acuity 
changes not requiring secondary capsulotomy) and 4 = severe (PCO affecting vision 
and requiring neodymium: YAG laser capsulotomy).  
 
 
4.5.6 Surgical technique 
 
One experienced surgeon (J.E.M.) performed all surgeries. The steep axis was 
marked in all patients preoperatively at the slit-lamp. Sub-tenons or topical 
anaesthesia was carried out on all patients. A standard sutureless on-steep axis 
corneal phaco surgery (2.75 mm incision) was performed through a 5.0 mm anterior 
capsulorhexis in all patients without complication. After irrigation/aspiration of cortex 
the multifocal IOL mentioned above were implanted in all cases with recommended 
injector cartridge. All residual viscoelastic was removed prior to intracameral antibiotic 
injection (cefuroxime). Where on-axis surgery was not possible, a 2.75mm supero-
temporal corneal position was used to minimise induced astigmatism. Capsular 
tension ring (CTR) was used in all 100 eyes to benefit tilt and decentration. 
Postoperative topical therapy included 1 drop of ofloxacin 0.3% (Exocin) 4 times daily 
for two weeks, 1 drop of ketorolac trometamol 0.5% (Acular) 2 times daily for 1 month 
and 1 drop of dexamethasone 0.1% (Maxidex) 4 times daily for three weeks.  
 
 
4.5.7 Pupil centroid shift assessment 
 
All pupil assessments using the Aladdin scan were performed in a single test room 
that had a constant ambient illumination of 0.63 lux. To standardize the postoperative 
pupil assessments, the ambient lighting was continuously monitored using a handheld 
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Illuminometer light meter (Sekonic, Japan). Concurrently, before measuring the pupil 
size, the patient’s orbital region illumination was recorded and maintained at 0.63 lux 
to have minimum discrepancy among patient groups. The minimum luminance the 
photometer could record was 0.63 lux. 
 
 
4.5.8 Intraocular lens centration within the photopic pupil and IOL tilt 
assessment 
 
The pupil centroid shift in respect to the IOL centration in all eyes was assessed by 
using  a validated methodology developed by Wolffsohn & Buckhurst (2010) was 
applied. All pupils of the eyes prior to dilated with tropicamide 1.0% were 
photographed to capture the normal pupil location under photopic condition. After 
dilatation the IOL was imaged with 5 times magnification in retroillumination using a 
SL 120 digital slit biomicroscope (Carl Zeiss Meditec). This was conducted  six months 
after IOL implantation. The centration of the IOL was determined by encircling the 
circular optical disc and intersecting this circle with two perpendicular lines (Figure 4.1). 
The location and centre of the photopic pupil centre was also determined circular 
photic pupil boundary and intersecting this circle with two perpendicular lines (Figure 
4.2).  This was normalized for rotation of the eye and head in front of the slitlamp 
between photographs and visits by comparing the axis of a line joining 3 consistent 
conjunctival vessels (Figure 4.3). All landmark features were visible on the images 
captured at every assessment. The photograph of the IOL centration and photopic 
pupil centration and three consistent conjunctival vessels were overlaid to determine 
the location of the IOL within the photopic pupil (Figure 4.3) using Adobe PS suite 
(Adobe Systems, Inc., San Jose, CA). Images from three random patients were 
analysed six times to assess the repeatability of the analysis. CTR was used in all 
eyes. At six months after IOL implantation IOL clarity was also assessed along with 
IOL tilt using the Pentacam-Scheimpflug camera.  
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Figure 4.1. Determining the centre of the IOL within a pharmacologically dilated pupil 
by encircling the circular boundary of the IOL and intersecting the circle with two 
perpendicular lines at a right angle. 
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Figure 4.2. Determining the centre of a photopic pupil by encircling the circular 
boundary of the photopic pupil and intersecting the circle with two perpendicular lines 
at a right angle. 
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Figure 4.3. Overlaying the centre of the IOL and the photopic pupil over 3 consistent 
conjunctival vessels landmarks.  
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Figure 4.4. Scheimpflug image of the horizontal cross-section of the anterior segment 
after SBL-3 IOL implantation. The central anterior chamber depth was measured from 
the central corneal posterior endothelium to the IOL anterior surface.   
 
 
 
Figure 4.5. Schematic drawing of the decentration and tilt measurement over the 
above depicted image (figure 4.4). Decentration was measured from the centre of the 
SBL-3 IOL anterior surface to the pupillary axis. Tilt was measured between the IOL 
axis and the pupillary axis.  
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4.5.9 Questionnaire 
 
For this study a validated QOV Questionnaire (McAlinden, Pesudovs and Moore, 2010) 
was used. The questionnaire was administered at six months follow-up to assess for 
possible neural adaption. The patients were asked to rate their overall QOV separately 
for day and night from very poor (0), to excellent (10).  
 
 
4.5.10 Statistical analysis  
 
Data analysis was performed using SPSS for Windows (Statistical Package for the 
Social Sciences, Version 22, Chicago, Illinois, USA.). The relationship between the 
pupil size and QOV was modelled using a linear regression model and the differences 
in QOV between pupil size groups were evaluated by analysis of variance (ANOVA). 
Normality was checked by the Shapiro-Wilk test and Q-Q plot test. To assess the 
impact of pupil size to the QOV, a linear regression analysis was performed. 
Differences were considered statistically significant when the P value was less than 
0.05. 
 
 
4.6 Results  
 
All 50 patients (100 eyes) had no intra-operative or postoperative complications at six 
months follow-up.  
 
 
Quality of Vision and Pupil Shift  
 
The mean postoperative pupil shift was 0.14±0.13mm for group A and 0.41±0.15mm 
for group B at six months (Table 4.2).  There were no significant differences between 
the mean preoperative and postoperative pupil shift in group A and group B at six 
months assessment. There were statistically significant differences in postoperative 
QOV questionnaire score at six months in both groups (P<0.05) (Table 4.3). A 
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regression analysis was performed between pupil centroid shift and the QOV (day and 
night) score to find out whether pupil shift had an impact upon the QOV. At six month 
postoperative assessment, QOV day score correlated with the postoperative pupil shift 
with a r 2 =0.506; p<0.05 (Figure 4.4) and QOV night score correlated with the 
postoperative pupil shift with a r 2 =0.418; p<0.05 (Figure 4.5). Postoperatively group 
A with pupil shift  £ 0.30 mm reported better mean QOV scores for day and night in 
comparison to group B. 
 
 
Table 4.2. Patient demographic.  
 
  
Group A (0.00 to 
0.30mm) 
Group B (0.31 to 
0.59mm) 
P-value 
Age (years) 59.80±8.30 60.12±7.42 0.414 
Number of eyes  86 14 -- 
Follow-up time (months) 8.2±1.24 8.5±1.32 0.37 
Mean Astigmatism (D) 0.78±0.12 0.77±0.22 0.21 
Mean CDVA logMAR 0.14±0.15 0.1±0.20 0.083 
Pupil centroid shift (mm) 0.14±0.13 0.41±0.15 0.017* 
Mean QOV Day Score (0-10) 6.6±1.4 6.7±1.2 0.143 
Mean QOV Night Score (0-
10) 
5.9±0.51 6.1±0.2 0.526 
*P-value <0.05, Statistically significant across groups                                                                                                                                                                                                                                                                                                                                                                                                             
D: Dioptres; CDVA: Corrected Distance Visual Acuity; mm: millimetres; QOV: 
Quality of Vision; *P<0.05 
 
 
Table 4.3. Pre and postoperative comparison.   
 
  Group A (0.00 to 0.30mm)   Group B (0.31 to 0.59mm)   
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Preoperativ
e  
Postoperativ
e  
P-
value 
Preoperativ
e  
Postoperativ
e  
P-
valu
e 
Pupil 
centroi
d shift 
(mm) 
0.20±0.06 0.21±0.04 0.411 0.42±0.05 0.42±0.09 0.42 
Mean 
QOV 
Day 
Score  
(0-10) 
6.6±1.4 8.66±0.69 0.05* 6.7±1.2 7.21±0.57 
0.03
* 
Mean 
QOV 
Night  
Score 
(0-10) 
5.9±1.5 8.15±0.52 
<0.05
* 
6.1±1.1 7.01±0.39 
0.02
* 
*P-value <0.05, Statistically significant across groups                                                                                                                                                                                                                                                                                                                                                                                                             
mm: millimetres; QOV: Quality of Vision.  
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Figure 4.4. A correlation analysis was performed between pupil centroid shift and the 
QOV day score at six months after operation. 
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Figure 4.5. A correlation analysis was performed between pupil centroid shift and the 
QOV night score at six months after operation.  
 
 
 
 
Visual Acuity and Refraction  
 
Table 4.4 shows the between-group comparison of postoperative data. The mean at 
six months postoperative ocular parameters, visual and refractive outcomes had no 
statistically significant differences. The mean VA was better in patients with smaller 
pupil shift group (group A) postoperative in comparison to patients with larger pupil 
shift (group B). 
 
 
Table 4.4. Postoperative 6-month data. 
 
Postoperative 6-month data. 
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Parameter Group A (0.00 to 
0.30mm) 
Group B (0.31 to 
0.59mm) 
P Value* 
Sphere (D)       
Mean ± SD 0.12±0.42 0.14±0.34 0.087 
Cylinder (D)       
Mean ± SD 0.38±0.27 0.37±0.30 0.129 
logMAR UDVA 
(monocular) 
      
Mean ± SD -0.03± 0.09 -0.04 ±0.15 0.274 
logMAR UIVA 
(monocular) 
      
Mean ± SD 0.17 ± 0.13 0.20 ± 0.10 0.084 
logMAR UNVA 
(monocular) 
      
Mean ± SD 0.19 ± 0.11 0.23 ± 0.20 0.490 
QOV (0-10)       
Day 8.66±0.69 7.21±0.57 0.014* 
Night 8.15±0.52 7.01±0.39 0.030* 
Pupil centroid shift 
(mm) 
      
Mean ± SD 0.21±0.04 0.42±0.09 0.029* 
Tilt (degree)       
 Mean ± SD 1.5°± 0.20 1.6° ± 0.10 0.73 
*P-value <0.05, Statistically significant across groups                                                                                                                                                                                                                                                                                                                                                                                                             
UDVA: Unaided distance visual acuity; UIVA: Unaided intermediate visual 
acuity; UNVA: Unaided near visual acuity; SD: Standard deviation; mm: 
millimetre 
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Efficacy 
 
Six months after operation, UDVA improved to -0.03 ± 0.09 logMAR and -0.04 ± 0.15 
logMAR, in group A, and B respectively. At six months postoperative UIVA for group 
A and group B was 0.17 ± 0.13 logMAR and 0.20 ± 0.10 logMAR, respectively. UNVA 
at six months postoperatively was 0.19 ± 0.11 logMAR and 0.23 ± 0.10 logMAR 
respectively.  
 
 
Adverse Events and Posterior Capsule Assessments 
 
No serious complications (posterior capsule rupture, endophthalmitis, macular 
oedema or persistent raised intra-ocular pressure) occurred during the study. All 100 
eyes (50 patients) were retrospectively assessed and categorised into the respective 
pupil size groups. At 6-months a single experienced ophthalmologist examined all 100 
eyes and confirmed no or mild PCO was present. Cases with PCO were excluded 
from this retrospective analysis. 
 
 
Visual disturbances and photopic phenomena 
 
Table 4.5 shows the individual symptom responses found in each group. Group B 
experienced significantly higher mean score for ‘Glare’, ‘Halos’ and ‘Hazy vision’ in 
comparison to group A. 
 
 
Table 4.5. Postoperative comparison at 6-month 
 
QOV questions for visual 
symptoms 
Group A (0.00 
to 0.30mm) 
Group B (0.31 
to 0.59mm) 
P 
Value 
How much does glare 
bother you? 
0.25 ± 0.10 2.05 ± 0.20 0.018* 
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How much do the halos 
bother you? 
0.28 ± 0.15 2.20 ± 0.18 *0.031 
How much do the starbursts 
bother you? 
0.23 ± 0.13 0.25 ± 0.09 0.081 
How much does hazy vision 
bother you? 
0.16 ± 0.10 0.49 ± 0.12 0.020* 
How much does blurred 
vision bother you? 
0.18 ± 0.09 0.57 ± 0.24 0.385 
How much does distortion 
bother you? 
0.14 ± 0.05 0.16 ± 0.11 0.527 
How much do double 
images bother you? 
0.10 ± 0.05 0.18 ± 0.10 0.092 
*P-value <0.05, Statistically significant across groups                                                                                                                                                                                                                                                                                                                                                                                                             
Grading scale: 0 = not at all; 1 =a little; 2 = quite; 3 = very                                                                                                                                                  
 
 
4.7 Study aim (Part-B) 
 
The aim of part B of this study was to optimise the QOV and reduce visual symptoms 
of glare and haloes by repositioning the IOL with a second surgical procedure on group 
B patients by rotating the IOL and centering it to the photopic pupil rather than the 
pharmacologically dilated pupil centre. The rational for rotating the IOL was based on 
the findings of the case study by Pazo et al. (2016), where rotating the previously 
implanted asymmetric multifocal IOL to compensate for the pupil shift resulted in 
improved QOV and significant reduction of photopic symptoms. 
 
 
4.7.1 Surgical technique 
 
One experienced surgeon (J.E.M.) performed all IOL rotation surgeries. On assessing 
the pupil of the affected eye under photopic conditions using a slit lamp biomicroscope, 
it was observed that the near-add surface had high exposure. Of the 100 eyes 
implanted with SBL-3 IOLs, fourteen of which had a pupil centroid shift of >0.3 mm 
nasally and experienced significant photopic phenomena such as glare, haloes and 
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hazy vision as shown in Table 4.6. These fourteen patients were explained about the 
risk and benefits of this second surgical intervention, the inferonasally placed (near-
add) asymmetric multifocal IOL was rotated clockwise according to the individuals’ 
pupil centroid shift and pupil size in order to enhance the exposure of both the distance 
and near component of the asymmetric multifocal IOL. 
 
 
4.7.2 Marking for intraocular lens rotation 
 
Preoperative marking when using asymmetric multifocal IOLs before pupil centroid 
shift correction is important because deviations of the IOL centre in the horizontal and 
vertical meridians within the photopic pupil may result in a relevant reduction in visual 
quality. Patients were asked to put their chin in the chinrest. The examiner first centred 
the slitlamp on the centre of the cornea and the slit of the slitlamp was turned on. The 
pupil was allowed to contract to a photopic state. The directional axis of pupil centroid 
shift was verified with the previous photographic overlay analysis performed. Next, the 
photopic centre of the pupil was marked on the cornea by initially indenting the 
epithelium with the sharp end of LASIK spatula. This was then turned into a 
microabrasion and subsequently stained with a sterile blue marker. The microabrasion 
provided the surgeon the reference to understand the centre of the photopic pupil 
when the pupil was pharmacologically dilated for IOL rotation. The degree of IOL 
rotation required to compensate for the photopic pupil centroid shift could not be 
precisely determined preoperatively as the IOL position is also dictated by the capsular 
periphery. Therefore, the degree of IOL rotation required for centration was done 
intraoperatively using the visual aid of the micro-abrasion as reference. 
 
 
Table 4.6. IOL rotation patients. 
 
Patient  Pupil centroid 
shift (mm) 
Eye Pupil shift axis Rotation  
1 0.37 Right eye Nasal 60° clockwise 
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2 0.38 Right eye Nasal 60° clockwise 
3 0.39 Left eye Nasal 60° clockwise 
4 0.39 Right eye Nasal 60° clockwise 
5 0.39 Left eye Nasal 60° clockwise 
6 0.41 Right eye Nasal 80° clockwise 
7 0.41 Right eye Nasal  80° clockwise 
8 0.43 Right eye Nasal 80° clockwise 
9 0.45 Left eye Nasal 90° clockwise 
10 0.46 Right eye Nasal 90° clockwise 
11 0.47 Left eye Nasal  120° clockwise 
12 0.47 Left eye Nasal 120° clockwise 
13 0.49 Right eye Nasal 120° clockwise 
14 0.5 Right eye Nasal 120° clockwise 
 
 
4.8 Results: After rotation of IOL (group B) 
 
All fourteen patients (fourteen eyes) had no intra-operative or postoperative 
complications at six months follow-up.  
 
 
Quality of Vision  
 
There were statistically significant differences between the mean pre-rotation and after 
rotation assessment at 6-months (Table 4.7).   
 
 
Visual Acuity and Refraction  
 
Table 4.6 shows the comparison of pre-rotation and after rotation data. The mean at 
after rotation six months visual and refractive outcomes was had no statistically 
significant differences but was better than pre-rotation.  
 
 77 
 
Efficacy 
 
The mean pre-rotation UDVA was -0.04 ± 0.15 logMAR and after rotation at six months 
it improved to -0.03 ± 0.10 logMAR. Pre-rotation, UIVA was 0.20 ± 0.10 logMAR and 
after rotation it was 0.20 ± 0.05. The mean pre-rotation UNVA was 0.23 ± 0.20 logMAR 
and after rotation it was 0.20 ± 0.12 logMAR.  
 
 
Table 4.7. Pre-and after rotation comparison at 6-month. 
 
Parameter Pre-rotation Group B 
0.31 to 0.59mm) 
After rotation Group B 
(0.31 to 0.59mm) 
P Value* 
Sphere (D)       
 Mean ± SD 0.14±0.34 0.15±0.47 0.40 
Cylinder (D)       
 Mean ± SD 0.37±0.30 0.36±0.40 0.347 
logMAR UDVA 
(monocular) 
      
 Mean ± SD -0.04 ±0.15 -0.03 ±0.10 0.390 
logMAR UIVA 
(monocular) 
      
 Mean ± SD 0.20 ± 0.10 0.18 ± 0.05 0.259 
logMAR UNVA 
(monocular) 
      
 Mean ± SD 0.23 ± 0.20 0.20 ± 0.12 0.273 
QOV (0-10)       
 Day 7.21±0.57 8.49±0.42 0.021* 
 Night 7.01±0.39 8.14±0.10 0.036* 
Pupil centroid 
shift (mm) 
      
 Mean ± SD 0.42±0.09 0.41±0.10 0.540 
 78 
 Tilt (degree)       
 Mean ± SD 1.6° ± 0.10 1.6° ± 0.21 0.419 
*Statistically significant across groups                                                                                                                                                                                                                                                                                                                                                                                                             
UDVA: Unaided distance visual acuity; UIVA: Unaided intermediate visual 
acuity; UNVA: Unaided near visual acuity; SD: Standard deviation; mm: 
millimetre 
 
 
Adverse events and posterior capsule assessments 
 
No serious complications (posterior capsule rupture, endophthalmitis, macular 
oedema or persistent raised intra-ocular pressure) occurred during the study. All 
fourteen eyes (fourteen patients) were retrospectively assessed and categorised into 
the respective pupil size groups. At six months a single experienced ophthalmologist 
examined all fourteen eyes and confirmed no or mild PCO was present.  
 
 
Visual disturbances and photopic phenomena 
 
Table 4.8 shows the individual symptom responses found in each group. ‘Glare’, 
‘Halos’ and ‘Hazy vision’ were significantly decreased at 6-months after rotation in 
group B.  
 
 
Table 4.8. Pre-and after rotation comparison at 6-month.  
 
QoV questions for 
visual symptoms 
Pre-rotation Group 
B 0.31 to 0.59mm) 
After rotation Group B 
(0.31 to 0.59mm) 
P Value* 
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How much does 
glare bother you? 
2.05 ± 0.20 1.09 ± 0.10 0.019* 
How much do the 
halos bother you? 
2.20 ± 0.18 1.12 ± 0.05 0.027* 
How much do the 
starbursts bother 
you? 
0.25 ± 0.09 0.23 ± 0.04 0.328 
How much does 
hazy vision bother 
you? 
0.49 ± 0.12 0.21 ± 0.04 0.030* 
How much does 
blurred vision 
bother you? 
0.57 ± 0.24 0.49 ± 0.21 0.475 
How much does 
distortion bother 
you? 
0.16 ± 0.11 0.16 ± 0.23 0.079 
How much do 
double images 
bother you? 
0.18 ± 0.10 0.19 ± 0.03 0.146 
*P-value <0.05, Statistically significant across groups                                                                                                                                                                                                                                                                                                                                                                                                             
Grading scale: 0 = not at all; 1 =a little; 2 = quite; 3 = very                                                                                                                                                  
 
 
4.8 Discussion 
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The aim of multifocal IOL use is to restore distance, intermediate, and near visual 
function following cataract surgery. Photic phenomena are commonly associated with 
multifocal IOLs but have also been known to occur with monofocal IOLs as well. 
(Schmitz et al., 2000). The new generation of refractive radially asymmetrical 
multifocal IOLs aim to alleviate the occurrence of optical side effects. The SBL-3 IOL 
is a bi-aspheric asymmetrical refractive multifocal IOL with a +3.00 D add in the inferior 
anterior optic. A transition zone separates the distance and the near-add sections of 
the lens and the near segment occupies 42% of the total lens optic. The case series 
of bilateral implantation on 53 eyes published by Venter et al. (2014) and McNeely et 
al. (2016)  reported a good range of distance, intermediate, and near VA in patients. 
The rotation of asymmetrical multifocal IOL on its axis was compared before by de Wit 
et al. (2015) who found that the placement of the near-add in the superior or inferior 
position in the Mplus IOL (Lentis Barbados, Inc.) had no significant overall difference 
in the mean subjective or objective outcomes. In AMO Array SA40N (Allergan) 
multifocal IOLs halos correlated with corneal irregularities and astigmatism greater 
than 1.00 D and glare correlated with monofocal IOL patients over the age of 70 years 
(Nijkamp et al., 2004). In our patients moderate or severe photopic phenomena was 
observed in patients with nasal pupil centroid shift of >0.3 mm, however they were still 
satisfied with good VA. This may be explained by their good postoperative UDVA and 
reduced dependence on reading spectacles. Nijkamp et al. (2004) found that distance 
vision without glasses correlated significantly with patient satisfaction after cataract 
surgery. Walkow et al. (2001) found that the most influential factor that predicted after 
cataract surgery satisfaction was UDVA. In our study it was found that although the 
group B patients experienced good distance and near vision but their overall QOV was 
severely compromised by photopic phenomena such as glare, haloes and hazy vision. 
However, after IOL rotation in group B, the IOL was better centred within the photopic 
pupil which resulted in statistically significant reduction in glare, haloes and hazy vision, 
including an overall improvement in the QOV for day and night without any significant 
loss of distance VA. Decentration of any multifocal IOL can lead to decreased VA and 
photopic phenomenon, which can deleteriously impact  the QOV (Pazo et al., 2016).  
The effect of decentration of a multifocal IOL on visual quality can be further 
compounded by a large angle kappa, resulting in central optical rays potentially 
passing through the periphery of the multifocal IOL rather than its centre (Prakash et 
al., 2011).  To ensure the centration of a multifocal IOL with respect to the physiological 
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pupil centre can be difficult, principally because this is dictated through the IOL haptics 
by the position of capsular bag periphery. The SBL-3 IOL is radially asymmetric and 
centration appears to play a crucial role for good QOV. As documented in this chapter 
that the nasal displacement of the pupil of > 0.3 mm from the centre resulted in poor 
QOV. Possible factors that can influence this decentration with respect to the 
physiological pupil include capsular contraction, haptic movement, IOL rotation, or 
pupil shift (Patel et al., 1999; Crnej et al., 2011; Van Der Linden et al., 2013).   However, 
haptic movement, and IOL rotation was not observed in this study.  Pupil shift refers 
to a slight change in reference to the pupil’s central location between mesopic, 
photopic, and pharmacologically dilated conditions (Yang Y, et al. 2002) and this 
tendency of the pupil to shift makes it more difficult to achieve a precise positioning of 
the asymmetric multifocal IOL. In this study we observed that pupil shift of less than 
0.30 mm (group A) did not have significant impact upon the objective and subjective 
vison. However, in group B which had pupil shift greater than 0.30 mm suffered from 
significant photopic phenomenon such as glare, haloes and hazy vision. Closer 
examination of the photopic pupil of group B patients eye revealed that a photopic 
pupil shift occurred toward the nasal region and thereby maximized the light exposure 
to the inferiorly placed near-add of the IOL, making distance vision during bright 
lighting conditions difficult for the patient. Postoperative rotation of an asymmetric 
multifocal IOL can be beneficial for some patients experiencing dysphotopsia and poor 
QOV. It is key to ensure that the dominant eye is optimized for distance viewing by 
maximizing the area of distance optic within the mesopic and photopic pupil. 
Determining where the physiological pupil centre lies during surgery in an attempt to 
centre the IOL within a pharmacologically dilated pupil is difficult. However, rotation of 
the IOL can result in different final positions for the centre of the IOL. This is due to 
the asymmetric nature of the capsular bag and the differences between the centre of 
the bag and the centre of the pupil. Asymmetric multifocal IOLs are not circular and 
neither is the capsular bag (Strenn, Menapace and Vass, 1997); therefore, one can 
actively alter the resultant centration of the IOL by rotating it into different positions. 
Taking these factors into consideration, the near-add positioning should be assessed 
individually for optimal positioning of a multifocal IOL and potentially different positions 
used for the dominant and non-dominant eyes. 
 82 
4.9 Conclusion  
 
Preoperative pupil shift assessment in rotationally asymmetric multifocal IOLs is 
essential. As it allows the surgeon to correctly position the IOL inside the capsular bag. 
Pupil shift of greater than 0.30 mm was shown to significantly decrease the QOV in 
asymmetric multifocal IOLs. It is key to ensure that both the near and distance sections 
of asymmetric multifocal IOL are proportionally exposed under various pupil conditions. 
Since asymmetric multifocal IOLs are not circular and nor is the capsular bag the most 
effective method of ensuring proportionate exposure of near and distance sections is 
by centering the IOL with respect to the photopic pupil centre, taking into consideration 
the pre-existing individual pupil centroid shit and its direction. 
 
The extension of this study will be to compare the microabrasion methodology of IOL 
centration with the new intraoperative imaging technology Verion / ORA system (Alcon, 
UK) to improve surgical centration of these asymmetric IOLs to the visual axis and 
also to take into account the pupil size and position. 
 
 
4.10 Summary 
 
This chapter showed that preoperative pupil centroid shift is an essential assessment 
for all patients opting for asymmetric multifocal IOL implantation. In general, the QOV 
in rotationally asymmetric multifocal IOL is not affected by pupil centroid less than 0.30 
mm. However, in pupil that have a centroid shift of greater than 0.30 mm, the 
implantation of asymmetric multifocal IOL must be personalised accordingly or a non-
pupil dependent IOL can be used as an alternative. 
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CHAPTER 5: EVALUATION OF DRY EYE AND TEAR FILM TEAR LIPID 
INTERFERENCE PATTERNS AFTER LASER REFRACTIVE SURGERY  
 
 
5.1 Introduction 
 
Corneal refractive surgery has the tendency to adversely affect the ocular surface, and 
a reduction of functional meibomian glands can lead to the disturbance and instability 
of the preocular TF (Lemp et al. 2007). The thickness of the preocular TF is 
approximately 3μm (King-Smith, Fink and Fogt, 2000) which provides nutrients to the 
corneal epithelium (Mishima, 1965; Bron et al., 2004). It also serves as a shield to the 
external environment (Govindarajan and Gipson, 2010). Since the precorneal TF is 
the first refractive interface for light rays entering the eye, it also pays a major role in 
ensuring optimal QOV (Tutt et al., 2000). The tear lipid layer is located at the outer 
most layer of the precorneal TF measuring from 20–180 nm (Eom et al., 2013).  The 
tear lipid layer has been said to contribute to the stability of the TF as it provides a 
protective envelope to the underlying aqueous layer from evaporation (Guillon and 
Guillon, 1989; Isreb et al., 2003). Since corneal refractive surgery has been reported 
to alter the distribution of TF layer and the relationship of the ocular surface to the 
inner lids (Ambrósio, Tervo and Wilson, 2008). These factors have been associated 
to contribute to the development or aggravation of DE.  Studies have reported that 
underlying DE in patients who undergo laser refractive surgery develop DE due to the 
combination of neurotrophic and inflammatory response (Toda et al., 2001a; Denoyer, 
Landman, Trinh, J. F. Faure, et al., 2015). LASIK associated DE is considered to be a 
major cause of patient dissatisfaction (Bailey et al., 2004). Symptoms of ocular 
dryness along with fluctuations in vision develop within the first weeks after surgery 
(Battat et al. 2001; Toda et al. 2001; Shen et al. 2016).  Flattening of the central cornea 
and steepening after myopic and hyperopic LASIK respectively has been associated 
to alter the ocular surface TF dynamics (Melki and Azar, 2001). Progressive decrease 
in tear fluorescein clearance has been observed in LASIK patients (Macri, Rolando 
and Pflugfelder, 2000). Since clearance of fluorescein dye on the preocular TF 
depends on aqueous tear volume production, tear spreading over the ocular surface 
after blinking and the pump mechanism which drains tears into the lacrimal drainage 
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system (Macri, Rolando and Pflugfelder, 2000). The possible factors leading to 
decreased tear clearance, include decreased blink rate caused by corneal denervation 
and resultant increased evaporation of TF. Identifying the factors that influence laser 
refractive surgery is critical in ensuring proper counselling and optimisation of the 
ocular surface in-order to achieve the best visual outcome. Understanding the 
implication of DE is laser refractive surgery is useful in preventing and addressing 
postoperative conditions.  
 
 
5.2 Analysis of tear film lipid layer 
 
The interaction of the ocular surface epithelium and the TF plays an important role in 
the maintenance of homeostasis of the ocular surface and the disruption of this 
homeostasis can lead to DE. Several diagnostic tools and techniques have been 
developed to examine the TF and DE, however majority of these traditional tests and 
techniques are invasive procedures and therefore they modify the parameter which 
they are designed to assess. Non-invasive and minimally invasive tests are the most 
appropriate test for TF assessment as they do not modify the parameter and hence 
produce a more accurate assessment of the TF condition.  
 
TF interferometry is a non-invasive screening and evaluating tool for assessing DE 
severity. TF interferometry in combination with other traditional DE assessment 
methods can also help determine the pathophysiology of tear lipid layer dysfunction. 
TF interferometry has been used to obtain to assess the thickness and state of 
meibomian gland function by observing the interference patterns created by the 
interferometer light reflecting from the lipid layer of the precorneal TF. The standard 
variations of the patterns provide useful objective information about the thickness and 
condition of the lipid layer. The pioneering studies on TF layer assessment was carried 
out by Mcdonald (1969) along with Hamano (1979), Norn (1979). and Guillon (1982) 
and the instrumentation for assessment was refined by Doane et al (Doane, 1989).  
Based on these foundations Yokoi et al. developed a commercial interferometer DR-
1w, Kowa Co. Ltd, Japan and a grading score from 1 to 5. DR-1 classification system 
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(on a scale of 1-5). A score of 3 or more is suggestive of DE, with higher score 
indicative of more severe DE (Yokoi, Takehisa and Kinoshita, 1996). 
 
 
5.2.1 Tearscope 
 
The Keeler Tearscope instrument (Keeler, Windsor, UK) can be mounted on a slit-
lamp biomicroscope that allows hands-free non-invasive assessment of the TF lipid 
layer interference patterns. The instrument consists of a tapered conical translucent 
tube that is illuminated by a cold cathode white light. The light produces a diffuse 
specular reflection against which the TF lipid layer. The interference pattern image is 
produced by reflection from the TF lipid layer located in front of the cornea. This device 
can be mounted on a photographic slit lamp biomicroscope to capture the 
interferometry patterns. When the eye is blinking normally the observed sees 
interference patterns and colours.  These images can be used to examine grade and 
scored on a five-point scale using a recognised DR-1 classification system (on a scale 
of 1-5) (Yokoi, Takehisa and Kinoshita, 1996). 
 
 
5.3 Tear film interferometry and dry eye 
 
It has been proposed that the formation of the tear lipid layer is the result of repeated 
expansion and compression of the upper and lower lid margins that expresses meibum 
from the meibomian glands (Holly, 1980; Bron and Tiffany, 1998). This lipid layer of 
the TF prevents aqueous layer evaporation and maintaining the stability of aqueous 
TF layer (Mishima and Maurice, 1961). Yokoi et al. using the DR-1w system and 2 mm 
diameter observation area developed the DR-1 interference pattern classification 
system (Yokoi, Takehisa and Kinoshita, 1996). Grade 1 shows a greyish colour of 
uniform distribution, grade 2 shows a greyish colour and a non-uniform distribution, 
grade 3 shows a few colours with a non-uniform distribution, grade 4 shows various 
colours and a non-uniform distribution, and grade 5 shows that the corneal surface is 
partially exposed, with no lipid layer interference pattern (Yokoi, Takehisa and 
Kinoshita, 1996). This study found that these categories of interference patterns 
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significantly correlated with the severity of DE. The normal control eyes in this study 
aligned to Grade 1 and 2, while DE patients were classified from 2 to 5 depending 
upon the severity of the DE. However, there was an overlap in Grade 2 between 
control and DE, suggesting that the grading scale is not sensitive enough to assess 
borderline patients. Therefore, the DR-1 grading cannot be used as a standalone 
system to assess DE but can be used as an adjuvant tool alone with other traditional 
methods of DE assessment. The merits of the DR-1 grading scale are that it is 
convenient to use and interpret the dynamic tear lipid layer. As the grade in the DR-1 
scale increases from 2 to 4, the colour of the tear lipid layer also increases, the 
possible explanation to this phenomenon Yokoi el al. was that the increased severity 
of DE leads to reduced aqueous tear volume which consequently leads to the forward 
displacement of the lid oil as the TF is compressed during the process of blinking. 
Therefore, leading to a greater accumulation and distribution of meibum on the 
precorneal TF (Yokoi, Takehisa and Kinoshita, 1996). Shimazaki et al. using the DR-
1 grading scale found that when the upper lid was squeezed by the examiner’s thumb 
to actively express some meibomian lipid. The DR-1 grades improved and a positive 
change in NIBUT was documented. This study showed greater TF stability was seen 
with thicker tear lipid layer (J, 1995).  Hosaka et al. using the DR-1 DE severity grading 
found that TF thickness showed good correlation with other DE examinations. After 
punctal occlusion, TF thickness increased from 1.7 ± 1.5μm to 4.9 ± 2.8μm (P = .001) 
with the improvement in tear meniscus height, fluorescein and rose bengal staining 
scores, TBUT, and Schirmer test. Interferometric TF thickness measurement found 
that impairment of precorneal TF formation in aqueous tear deficiency DE and was 
useful for showing the reconstruction of TF after punctal occlusion surgery. This study 
concluded that interferometry of precorneal TF is a useful tool that can evaluate DE in 
conjunction with other DE examinations (Hosaka et al., 2011) 
 
 
5.2.1 Study aim  
 
To compare the effects of SMILE and femtosecond laser-assisted in situ 
keratomileusis (fs-LASIK) on the ocular surface and precorneal lipid layer interference 
patterns.  
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5.2.2 Sample size 
 
The Power calculation was conducted using G*Power 3.1 (Faul et al., 2007) (ANOVA 
repeated measures within factor). A total of 100 patients (200 eyes) consisting of 50 
SMILE and 50 LASIK patients were assessed. Sample size was determined using 
power calculation (80% power at the 5% level of statistical significance, α=0.05) to 
detect a change of 1 unit change in interferometry DR-1 Score with 80% power (β=0.2) 
at the 5% level of statistical significance (α=0.05), 100 subjects were required based 
upon published data (standard deviation in normal patients =±0.7) (Hosaka et al., 
2011). 
 
 
5.2.3 Subjects 
 
This retrospective, case series is from a population of patients seeking refractive 
surgery at Cathedral Eye Clinic, Belfast, Norther-Ireland, UK. Because this was a 
retrospective audit study. Informed consent and permission to use their data for 
analysis and publication was obtained from each patient as part of our routine 
preoperative protocol. The nature of the study was explained verbally and on paper to 
the participants by trained clinicians before obtaining a written informed consent. A 
complete ocular examination was performed to screen for ocular abnormalities and 
determine patient candidacy for surgery. Exclusion criteria were previous ocular 
surgery, disease such as corneal opacity, corneal irregularity, meibomian gland 
dysfunction, glaucoma or retinal disease, and complications during surgery. 
 
 
5.2.4 Experimental procedure 
 
This retrospective, comparative, case series study was conducted in the Cathedral 
Eye Clinic, Belfast, Northern-Ireland, UK in accordance with the Declaration of Helsinki. 
All patients had provided informed consent for use of their anonymised pre and 
postoperative data for either audit, teaching or research purposes. Prior to the 
treatment, all patients were advised of the possible risks associated with the operation. 
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All SMILE and fs-LASIK was performed bilaterally by one experienced surgeon 
(J.E.M).  
 
 
5.2.5 Patients 
 
Fifty patients (100 eyes) had bilateral SMILE and fifty (100 eyes) spherical equivalent 
matched subjects with bilateral fs-LASIK were assessed. Myopic SMILE or fs-LASIK 
(spherical correction range, -1 to -7 dioptres; cylinder range, 0 to -1.5 dioptres), no 
contraindications to laser refractive surgery, and no previous history of DE were 
included in this retrospective analysis. Inclusion criteria were age 25 to 45 years, 
stable myopia for at least 1 year. Patients discontinued contact lenses 2-weeks before 
pre-operative baseline assessments were taken. Exclusion criteria were any active 
ocular pathology, previous ocular/eyelid medical or surgical treatment, systemic 
disorder, and pregnancy. Patients were assessed preoperatively and followed up at 
day-one, one-week, one-month, three-month and six-month postoperatively (Table 
5.1). 
 
A small (S) curved interface cone was used in all eyes. The femtosecond incisions 
were performed as follows:  
• posterior surface of the lenticule (spiral in pattern) 
• anterior surface of the lenticule (spiral out pattern) 
• followed by a side cut of cap 
The femtosecond laser parameters were as follows: 135μm cap thickness, 7.6 mm 
cap diameter, 6.5 mm lenticule diameter, 149 nJ power for lenticule making a 2.41 mm 
side cut for access to the lenticule, with angles of 90°.  
 
 
Table 5.1. Demographic data. 
 
  Mean ± standard deviation 
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  SMILE patients (n=100 eyes) 
fs-LASIK patients (n=100 
eyes) 
Age (years) 32.8 ± 6.7 31.5 ± 8.4 
Range 25, 42 24, 43 
Gender (F/M) 28/22 34/16 
Preoperative 
spherical 
equivalent 
–5.50±1.45 (range −1.00 to 
−7.00 D) 
–5.45±1.35  (range −1.00 
to −7.00 D) 
 Manifest cylinder 
(D) 
−0.51±0.65 D (range 0.00 to 
−2.25 D) 
−0.52±0.75 D (range 0.00 to -
2.25 D) 
Mean keratometric 
reading (D) 
43.3±1.33 D (range 40.5–47.0 
D) 
44.1±1.41 D (range 40.4–46.0 
D) 
  Endothelial cell 
density (cells/mm2)  
2804±267 (range 2265–3363 
cells/mm2) 
2810±252 (range 2195–3422 
cells/mm2) 
Central corneal 
thickness (μm) 
546.1±32.9 (range 471–614 
μm) 
551.2±41.7 (range 475–623 
μm) 
 
 
5.2.6 Clinical exam and questionnaire 
 
Slit-lamp examination of the ocular surface was conducted in a defined sequence 
including TBUT. QOV questionnaire, and OSDI questionnaires were also administered 
by a trained interviewer preoperatively and then at day-one, one week, one months 
and three months postoperatively. QOV visual symptoms questionnaire was also 
administered preoperatively and postoperatively at three-months. The QOV symptom 
questionnaire consists of seven questions related to common visual symptoms graded 
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on a scale from 0 to 3, depending upon the severity of the visual symptom (grading 
scale: 0 = not at all; 1 =a little; 2 = quite; 3 = very). Patient satisfaction questionnaire 
survey was administered to evaluate patient satisfaction survey after SMILE or fs-
LASIK treatment at one-month, three-month and six-month follow-up. It consisted of a 
single question “How were your expectations fulfilled?” and had four distinct scales as 
responses. This questionnaire was self-administered by the patient and the scale 
scores increased with satisfaction, ranging from 1 (not fulfilled at all) to 4 (more than 
fulfilled).  
 
Preoperatively and postoperatively at day-one, one-week, one-month and three-
month follow-up, all patients had a full ophthalmic examination on each eye, including 
manifest refraction (sphere, cylinder, and spherical equivalent), uncorrected distance 
visual acuity (UDVA) and corrected distance visual acuity (CDVA), uncorrected near 
visual acuity (UNVA) and corrected near visual acuity (CNVA) at 40cm with Radner 
reading charts under a standard mesopic lighting condition, (Radner charts allow 
direct conversion i.e. 0.2 logMAR distance acuity is comparable to 0.2 logRAD reading 
acuity with high correlation at 40 cm to a logMAR equivalent for size of letters) and 
uncorrected intermediate visual acuity (UIVA) and corrected intermediate visual acuity 
(CIVA) at 70cm. Further examinations included keratometry, corneal topography 
(Pentacam; Oculus, Germany), and OPD-scan auto refraction (NIDEK Co. Ltd., 
Japan), subjective refraction, slit-lamp examination, Goldmann tonometry, dilated 
funduscopy, pupil diameter, and angle kappa/p-dist with the Nidek OPD Scan II 
(NIDEK Co. Ltd., Japan).  
 
 
5.2.7 Tear osmolarity and lipid layer distribution quality 
 
Tear osmolarity was measured using the TearLab osmolarity system (TearLab Corp, 
San Diego, CA). An overall classification of the severity of DE was determined 
according to the modified scheme of the DEW Report (Lemp et al., 2007). The tear 
samples for osmolarity measurements were collected by placing the TearLab probe 
(TearLab Corp., San Diego, CA) (Albert, 2010) gently at the inferior lateral tear 
meniscus, taking care not to induce reflex tearing by touch the corneal surface. The 
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tear lipid layer quality was evaluated by using the Tearscope (Keeler, UK) along with 
DR-1 grading system (Yokoi, Takehisa and Kinoshita, 1996), based on a 2mm 
diameter observation area, by observing interference patterns of the lipid layer 
distribution layer on the corneal surface. Observed patterns were classified into five 
grades: grade 1, somewhat grey colour, uniform distribution; grade 2, somewhat grey 
colour, non-uniform distribution; grade 3, a few colours, non-uniform distribution; grade 
4, many colours, non-uniform distribution; and grade 5, corneal surface partially 
exposed (Yokoi, Takehisa and Kinoshita, 1996).  Assessments were conducted 
preoperatively, at day-1, 1-week, 1-month and 3-months postoperatively.  
 
 
5.2.8 Corneal esthesiometry 
 
Corneal sensitivity was measured using the contact nylon thread Luneau 12/100mm 
Cochet-Bonnet esthesiometer (Luneau, France). Starting from 6.0 cm, the filament 
length was progressively reduced in 5-mm steps until the first response occurred. The 
mean of 3 measurements taken at the centre of the cornea was measured 
preoperatively, at day-one, one-week, one-month, three-month and six-months 
postoperatively.  
 
 
5.2.9 Statistical analysis 
 
Descriptive statistics were created using SPSS (Statistical Package for the Social 
Sciences, Version 22, Chicago, Illinois, USA) and Excel (Microsoft; Redmond, 
Washington, USA). The Kolmogorov-Smirnov test was used to assess normality. The 
Student t test for paired parametric data was applied to assess the significance of 
differences between preoperative and postoperative data. The Wilcoxon rank-sum test 
was used when non-parametric data prevailed. Windows (Statistical Package for the 
Social Sciences, Version 22, Chicago, Illinois, USA.). The correlation between the DE 
tests and visual symptoms was performed using correlation coefficients.  Differences 
were considered statistically significant when the P-value was less than 0.05.  
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5.3 Results 
 
No adverse effects occurred in any of the 200 procedures. Figure 5.1 A and 5.1.B 
shows the visual outcomes of the 2 groups postoperatively. 
 
 
Figure 5.1 A. Uncorrected distance visual acuity and corrected distance visual acuity 
postoperative of SMILE patients. 
  
 
UDVA: uncorrected distance visual acuity; CDVA: corrected distance visual acuity.  
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Figure 5.1.B. Uncorrected distance visual acuity and corrected distance visual acuity 
postoperative of fs-LASIK patients. 
 
 
UDVA: uncorrected distance visual acuity; CDVA: corrected distance visual acuity. 
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Figure 5.2. Changes in corrected distance visual acuity (Snellen/ logMAR lines) at 6 
months postoperative.  
 
 
 
 
At day-one and one-week postoperatively there was a high rate of signs and 
symptoms (OSDI questionnaire) of dryness experienced by all patients in both groups 
(Table 5.2) with no significant differences between the two groups. However, at one-
month and six-months after surgery the SMILE patients experienced significantly 
lower symptoms of dryness as shown in Table 5.2. Tear osmolarity was higher in the 
fs-LASIK group at one-week, one-month, three-month and six-month postoperatively. 
At one, and three months after surgery corneal sensitivity, TBUT and tear lipid layer 
quality were significantly impaired in the fs-LASIK group compared to the SMILE group. 
When QOV questionnaire scores were analysed, a gradual improvement was found 
in the SMILE and fs-LASIK patients’ subjective appreciation of vision.  However, there 
was no statistically significant difference between SMILE and fs-LASIK groups. The 
percentage of patients using artificial tears six-months postoperatively in the SIMLE 
group was 10% and 30% in the fs-LASIK group (Table 5.2).  
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Table 5.2. Comparison of parameters  
 
  
Pre 
treatment 
SMILE  
Pre 
treatment 
F-LASIK 
 p-
value 
Tear 
osmolarity 
(mOsm/L) 
295.6±11.7 292.6±15.2 0.032 
Esthesiometry 
scale 60.1±3.7 62.8±5.8 0.4 
DR-1 grading 
(1-5) 2.1±1.2 2.3± 1.3 0.08 
TBUT (s) 6.9±1.4 7.3 ± 1.7 0.063 
OSDI score 
(0-100) 6.3±3.7 7.1±2.5 0.042 
QOV score (1-
10) 8.5±2.1 8.2±1.5 0.61 
Artificial tear 
use - - - 
  
After 
treatment 
SMILE 1-
day 
After 
treatment 
fs-LASIK 
1-day 
 p-
value 
Tear 
osmolarity 
(mOsm/L) 
318.7±9.7 320.1±12.7 0.059 
Esthesiometry 
scale 37.2±3.4 26.2±4.8 0.06 
DR-1 grading 
(1-5) 3.5±1.5 3.5±1.5 0.51 
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TBUT (s) 4.7±1.1 3.9±1.5 0.064 
OSDI score 
(0-100) 22.7±10.7 23.9±12.3 0.073 
QOV score (1-
10) 7.1±1.5 6.2±2.8 0.06 
Artificial tear 
use - - - 
  
After 
treatment 
SMILE 1-
week 
After  
treatment 
fs-LASIK 
1-week  
 p-
value 
Tear 
osmolarity 
(mOsm/L) 
309.4±5.2 322.3±15.4 0.017* 
Esthesiometry 
scale 42.6±2.9 30.5±2.4 0.032* 
DR-1 grading 
(1-5) 2.7 ± 1.0 3.5±1.5 0.011* 
TBUT (s) 6.2±2.7 4.3±2.3 0.024* 
OSDI score 
(0-100) 20.4 ± 9.7 22.3±11.2 0.020* 
QOV score (1-
10) 9.3±0.5 8.1±1.1 0.065* 
Artificial tear 
use - - - 
  
After 
treatment 
SMILE 1-
month  
After 
treatment 
fs- LASIK 
1-month  
 p-
value 
Tear 
osmolarity 
(mOsm/L) 
302.9±10.8 319.2±9.4 0.027* 
Esthesiometry 
scale 55.9±8.1 31.7±3.9 0.041* 
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DR-1 grading 
(1-5) 2.3±1.1 3.5±1.5 0.023* 
TBUT (s) 6.5±1.8 5.1±1.5 0.029* 
OSDI score 
(0-100) 15.1±9.4 20.3±8.2 0.015* 
QOV score (1-
10) 9.5±0.4 8.7±1.2 0.32 
Artificial tear 
use 
26% (13 
patients) 
44%(22 
patients)  - 
  
After 
treatment 
SMILE 3-
month 
After 
treatment 
fs-LASIK 
3-month 
 p-
value 
Tear 
osmolarity 
(mOsm/L) 
297.1±11.2  317.8±9.7 0.031* 
Esthesiometry 
scale 56.3±9.1 32.9±9.7 0.026* 
DR-1 grading 
(1-5) 2.3±1.2 3.0±1.5 0.015* 
TBUT (s) 6.7±1.5 5.01±1.3 0.034* 
OSDI score 
(0-100) 9.7±5.7 19.3±6.5 0.009* 
QOV score (1-
10) 9.3±1.1 9.0±0.7 0.31 
Artificial tear 
use 
12% (6 
patients) 
32% (16 
patients) - 
  
After 
treatment 
SMILE 6-
month 
After 
treatment 
fs-LASIK 
6-month 
 p-
value 
Tear 
osmolarity 
(mOsm/L) 
297.1±11.2  317.8±9.7 0.035* 
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Esthesiometry 
scale 56.3±9.1 32.9±9.7 0.010* 
DR-1 grading 
(1-5) 2.3±1.2 3.0±1.5 0.041* 
TBUT (s) 6.7±1.1 5.5±1.2 0.027* 
OSDI score 
(0-100) 9.6±3.1 15.6±5.2 0.011* 
QOV score (1-
10) 9.2±1.0 9.1±1.2 0.4 
Artificial tear 
use 
10% (5 
patients) 
30% (15 
patients) - 
 
Comparison between preoperative and postoperative (three-month) QOV visual 
symptoms (scale of 0-3) revealed that SMILE group had significant increase in ‘glare’ 
from 0.10±0.04 to 0.19±0.05. While in fs-LASIK group, ‘glare’ and ‘fluctuation in vision’ 
increased significantly from 0.12±0.05 to 0.25±0.15 and 0.05±0.04 to 0.17±0.10 
respectively (Table 5.3).  
 
 
Table 5.3. Comparison of visual symptom 
 
QOV questions for 
visual symptoms 
Pre-treatment 
SMILE  
After treatment 
SMILE 3-month P-value  
How much does glare 
bother you? 0.10±0.04 0.19±0.05 0.04* 
How much do the halos 
bother you? 0.15±0.05 0.17±0.06 0.41 
How much do the 
starbursts bother you? 0.12±0.10 0.13±0.05 0.7 
How much does hazy 
vision bother you? 0.09±0.06 0.05±0.09 0.92 
How much does 
blurred vision bother 
you? 
0.18±0.05 0.15±0.10 0.3 
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How much does 
fluctuating vision 
bother you? 
0.04±0.05 0.06±0.09 0.43 
How much do double 
images bother you? 0 0 - 
  Pre-treatment fs-LASIK 
After treatment fs-
LASIK 3-month P-value  
How much does glare 
bother you? 0.12±0.05 0.25±0.15 0.02* 
How much do the halos 
bother you? 0.10±0.02 0.13±0.05 0.08 
How much do the 
starbursts bother you? 0.10±0.05 0.11±0.05 0.52 
How much does hazy 
vision bother you? 0.05±0.05 0.03±0.10 0.73 
How much does 
blurred vision bother 
you? 
0.12±0.08 0.09±0.05 0.28 
How much does 
fluctuating vision 
bother you? 
0.05±0.04 0.17±0.10 0.02* 
How much do double 
images bother you? 0 0 - 
*Statistically significant.      
Grading scale: 0 = not at all; 1 =a little; 2 = quite; 3 = very       
 
Correlation between these increased visual symptoms (glare and fluctuating vision) 
with DE test revealed that tear lipid layer (DR-1 score) and TBUT had a strong 
correlation with these visual symptoms (Table 5.4).    
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Table 5.4. Correlations between dry eye test and visual symptoms 
  
Post treatment 
SMILE 3-month 
Post treatment fs-LASIK 3-month 
How much does 
glare bother you? 
How much does 
glare bother you? 
How much does 
fluctuating vision 
bother you? 
  R2 
P-
value  
R2  
P-
value  
R2 
P-
value  
Tear osmolarity 
(mOsm/L) 
0.21 0.010* 0.18 0.025* 0.17 0.4 
Esthesiometry 
scale 
0.13 0.45 0.2 0.32 0.29 0.037* 
DR-1 grading (1-5) 0.51 0.029* 0.57 0.013* 0.46 0.028* 
TBUT (s) -0.43 0.027* 0.59 0.030* -0.54 0.033* 
*Statistically significant 
 
 
Postoperatively, at one-month 96% and 86% and at three months 98% and 90% of 
patients undergoing SMILE and fs-LASIK treatments respectively were ‘fulfilled’ and 
‘more than fulfilled’ with their treatment (Table 5.5). 
 
 
Table 5.5. Patient satisfaction   
  SMILE: 1 month postop fs-LASIK: 1 month postop 
How were your 
expectations fulfilled? 
No. of 
patients  
Percentage 
No. of 
patients  
Percentage 
Not fulfilled at all 0 0% 0 0% 
Sufficiently fulfilled  2 4% 7 14% 
Fulfilled  36 72% 30 60% 
More than fulfilled  12 24% 13 26% 
  SMILE: 6-month postop 
fs-LASIK: 6-month 
postop 
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5.4 Discussion 
 
Since most of the standard DE assessment tools and methods such as Schirmer test, 
corneal staining and tear osmolarity test are invasive or minimally invasive (Sweeney, 
Millar and Raju, 2013). These tests therefore involve clinicians or researchers 
disturbing the natural TF of the patient. Tearscope, on the other hand, allows non-
invasive assessment of the TF layer. Along with a digital slitlamp, Tearscope enables 
the assessor to capture images and videos of interference patterns and non-invasive 
TBUT of patients non-invasively.  
 
Tearscope is a self-contained unit with a very small footprint. It only requires a USB 
electric power source.  Once plugged into the power source, it can be held in hand or 
mounted on a slit lamp biomicroscope to make observations of the TF (Elliott et al., 
1998).  Despite these advantages, there are other considerations before such 
instruments are likely to be adopted in general clinics. Currently, there is a lack of DE 
tear interferometry literature on tests, retest and diurnal variations of tear assessment 
by Tearscope and other similar instruments. Tearscope is a subjective instrument. 
Therefore, it is important to assess examiner variability, as this can influence the 
accuracy of results obtained by the Tearscope. In our study to overcome subjective 
bias; all patients first had their TF photographed and stored digitally. Later these 
photographs were anonymised, randomised and then scored.  The scores were based 
on the validated DR-1 tear lipid layer grading system by a single experienced DE 
researcher.  
 
How were your 
expectations fulfilled? 
No. of 
patients  
Percentage 
No. of 
patients  
Percentage 
Not fulfilled at all 0 0% 0 0% 
     
Sufficiently fulfilled  1 2% 5 10% 
Fulfilled  28 56% 31 62% 
More than fulfilled  21 42% 14 28% 
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Pathological changes in the TF physiology such as DE can frequently lead to 
decreased visual performance in patients during work and leisure activities. It has 
been well documented that a stable TF is essential in maintaining ocular health, visual 
quality and QOL (Jabbur et al. 2004; Lemp et al. 2007; De Paiva et al. 2006). Patients 
who have a myopic refraction are also frequently contact lens wearers and can be 
more prone to DE. Therefore, these patients frequently opt for laser refractive surgery 
(Solomon et al., 2009). fs-LASIK for the past two decades has predominantly been the 
most popular corneal refractive surgery used to correct myopia (Solomon et al., 2009).  
Studies have shown that although the refractive outcomes of fs-LASIK are excellent, 
ocular surface complaints such as DE are highly prevalent in postoperative patients 
(Toda, 2007; Solomon et al., 2009).  Post fs-LASIK DE symptoms can be sufficiently 
alleviated with artificial tear use, however artificial tears lack the complex mixture found 
in the healthy TF and only provide temporary relief. The current understanding of 
ocular surface physiology suggests that the disruption of corneal nerves during flap 
creation and excimer photoablation are the probable cause of DE post fs-LASIK (Toda 
et al. 2001; Albietz & Lenton 2004; Ang et al. 2001).  As a result, there can be a 
decrease in TF quality, quantity and impairment in the epithelial wound healing 
process (Battat et al., 2001).  Although femtosecond laser in fs-LASIK improves 
patients’ VA it is relatively common to suffer some degree of post-operative DE (Albietz 
and Lenton, 2004).  SMILE is a procedure that involves femtosecond laser to create 
an intrastromal lenticule, which is then removed through a small corneal incision. In 
comparison to fs-LASIK, SMILE does not require excimer laser photoablation or 
complete flap creation. It is a minimally invasive approach as it requires only a key 
hole/ small incision which can potentially reduce the impact of corneal refractive 
surgery upon the corneal nerves and the general ocular surface, thereby protecting 
patients against DE  (Reinstein, Archer and Gobbe, 2014).  The Dry Eye Workshop 
defines DE to be multifactorial in origin at the ocular surface, which includes TF 
changes with or without corneal damage, ocular symptoms, visual degradation, and 
increased tear osmolarity  resulting in a degradation of QOL (Lemp et al. 2007). 
Therefore, an objective and subjective assessment were included in this study. DE 
has been recorded to be the most frequent complication following laser refractive 
surgery (Ang et al. 2001; Solomon et al. 2009; Denoyer et al. 2015). Although DE is 
usually benign and transient, it has the potential to impair visual performance and QOV. 
The injury to corneal nerves results in a decrease in corneal sensitivity which leads to 
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altered tear production both in quality and quantity (Battat et al., 2001; Benitez-del-
Castillo et al., 2001; Barequet, Hirsh and Levinger, 2008). Inflammation can also 
decrease tear lipid layer quality and toxicity from medication can further compound DE 
problems (Peng et al., 2014). In our study an alteration to TF physiology and corneal 
sensitivity was observed immediately after surgery in both the SMILE and fs-LASIK 
groups and was more prominent and prolonged in the fs-LASIK group. The findings at 
day-one post laser refractive surgery in both groups may not be conclusive, as they 
might have been influenced by post-operative medication and drops. However, at one-
week, one-month, three-months and six-months significant differences in post-
operative findings were observed. We know that laser refractive surgery has an 
influence upon TF physiology and thereby also affects the tear lipid layer quality. Tear 
lipid layer quality and quantity has been documented to play an important role in DE 
(Versura, Profazio and Campos, 2010; Peng et al., 2014). Meibum from meibomian 
glands contribute to the outermost lipid layer of the TF and a stable lipid layer is 
important for a healthy corneal surface (Peng et al., 2014). Since the meibum secretion 
is modulated by the blink rate (Korb and Greiner, 1994) and it has been observed that 
meibomian gland dysfunction can be exacerbated by fs-LASIK as it disrupts the blink 
rate (Pflugfelder et al., 1998; Benitez-del-Castillo et al., 2001; Chao, Golebiowski and 
Stapleton, 2014). In creation of the LASIK flap, the femtosecond laser energy level is 
higher and the position and extent of treatment impacts to greater degree than SMILE 
upon the corneal nerves. The resultant nerve injury and inflammatory response may 
lead to disruption of the neuroanatomic reflex controlling blink rate, aqueous tear 
production and in turn affect lipid expression from meibomian glands. In our study the 
increase in visual symptoms of ‘glare’ and ‘fluctuating vision’ correlated significantly 
with the tear lipid layer and TBUT suggesting the importance percorneal in QOV and 
the disruption in the tear lipid layer leads to increased DE symptoms following laser 
refractive surgery. This in turn, had an influence in the visual performance in patients 
(Table 5.4).  Corneal sensitivity, tear lipid layer, and osmolarity along with VA improved 
in both groups at six-months but corneal sensitivity, tear lipid layer, osmolarity and 
OSDI scores were significantly better in the SMILE group.  It is there for plausible to 
state that reduced surgical impact upon the corneal and principally the corneal nerves 
is the reason for reduced post-refractive DE present in the SMILE cohort (Li et al., 
2013)(Table 5.2). 
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The corneal sensitivity findings in our study are consistent with other studies that have 
documented a delay in the normalisation of corneal sensitivity in fs-LASIK patients 
compared to SMILE patients at six-months post-surgery (Versura, Profazio and 
Campos, 2010; Sekundo, Kunert and Blum, 2011; Vestergaard et al., 2013). However, 
these published studies have indicated that it took up to twelve-months for corneal 
sensitivity to reach preoperative levels. This study to date has been assessed only up 
to six months postoperatively, it is yet to be seen if and at what postoperative period 
both corneal sensitivity along with TF osmolarity, tear breakup time and tear lipid 
quality will fully normalise. The difference in QOV scores between the two groups was 
not significant postoperatively, suggesting that the optical performance of both the 
procedures were at par with each other. This study also observed that the mean QOV 
gradually improved in both the groups. This gradual improvement was also observed 
with other objective parameters such as corneal sensitivity, TBUT and tear lipid layer. 
This gradual change therefore can be attributed to the healing process of the ocular 
surface post operation. 
 
The boundary between the TF and the outer environment accounts for the largest 
refractive index differential and therefore is crucial for good vision. DE due to unstable 
TF and tear lipid layer can therefore lead to glare and fluctuations in vision and affect 
the overall QOV in patients. The gradual improvement in the QOV questionnaire 
scores up the three months period may be partly explained by the demonstrable 
improvement in TF and general ocular surface function also demonstrated by a 
gradual reduction in OSDI scores. 
 
This study indicates a possible advantage of the SMILE procedure over LASIK, with 
regards to postoperative recovery time of the ocular surface health. This could indicate 
a value in stratifying patients preoperatively into either SMILE or fs-LASIK, depending 
upon the risk of postoperative DE problems. A limitation in our study however, was 
that patients the two groups were not matched by gender. 
  
  
5.5 Conclusion  
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SMILE procedure demonstrated improved TF characteristics and subjective DE 
symptoms over fs-LASIK up to six months post laser refractive surgery for myopic 
patients. Reduction in lipid layer was demonstrated to be greater in the fs-LASIK group 
and correlated with the subjective symptoms of glare and fluctuation of vision 
postoperatively. Non-invasive interferometry assessment of precorneal TF may be 
helpful for evaluating DE along with other DE examinations.  It can be a usefully tool 
assess and monitor recovery from laser procedures.  
 
 
5.6 Summary  
 
This chapter showed that the severity and TF dysfunction can vary between different 
refractive surgeries; these differences should be considered in patient management. 
TF lipid layer contributes to the overall QOV and can be used for pre and postoperative 
assessment of DE along with other DE examinations.  
  
 106 
Chapter 6: THE IMPACT OF CROSSLINKING AND TRANSEPITHLIAL 
PHOTOTHERAPEUTIC KERATECTOMY UPON THE QUALITY OF VISION AND 
QUALITY OF LIFE IN KERATOCONIC EYES  
 
 
6.1 Introduction  
 
The concept of corneal collagen cross-linking (CXL) was described over a decade ago 
and now it is considered as one of the most important findings in modern 
ophthalmology. In biological science, the term ‘cross-linking’ refers to the formation of 
chemical links following a chemical reaction between proteins or other molecules. 
Cross-links are usually formed by chemical reactions facilitated by heat, pressure, or 
radiation. Enzymatic and non-enzymatic cross-linking can be observed in the ageing 
process of the human body where various tissues such as the skin and arteries 
undergo stiffening and hardening. An important observation that led to the therapeutic 
use of CXL for kerataconic eyes was the finding that diabetic patients often did not 
express the progression of corneal ectatic disorders as nonenzymatic cross-linking 
was occurring on the cornea due to the pathophysiology of diabetes (Seiler et al., 
2000).    Prior to CXL, there were no available treatments to address the underlying 
pathology. Management simply consisted of, observation and using hard contact 
lenses to optimise the VA. If the use of contact lens resulted in scarring or corneal 
ectasia due to the loss of corneal weakness, corneal transplantation was preformed 
to regain vision. CXL is able to arrest the progression of corneal ectasia by 
strengthening the biomechanical structure of the corneal and increasing the resistance 
of the treated collagen to collagenases (Spoerl, Wollensak and Seiler, 2004). Long 
term safety and efficacy of CXL has now been established and documented in several 
studies. CXL has not only shown to stop the progression of disease but also 
significantly improve VA, spherical equivalent, astigmatism and keratometric 
parameters of the diseased cornea. These positive findings of CXL treatment have 
prompted researchers to investigate outcomes from combining CXL with other 
refractive procedures (termed CXL plus) in-order to optimise visual and topographic 
outcomes. Overall, CXL and CXL plus has demonstrated significant promise and 
represents a clear example of recent advances in ocular therapy.  
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6.2 Scheimpflug imaging for keratoconus and ectatic disease 
 
Scheiumpflug cross sectioning anterior segment imaging systems have several 
advantages in comparison to the traditional placido curvature analysis and ultrasound 
pachymetry. A three-dimensional reconstruction of the anterior segment is achieved 
by measuring the anterior and posterior corneal surface along with the anterior and 
posterior surface of the lens. Since changes on both posterior cornea and corneal 
thickness are early indicators of ectatic change, Scheimpflug imaging improves 
identification of these pathological changes. Additionally, a larger surface of the 
cornea is assessed in comparison to placido devices. This added coverage allows for 
the diagnosis of peripheral diseases such as pellucid marginal degeneration (PMD).   
   
The advent of corneal refractive surgery and CXL has revealed that better and more 
accurate imaging systems are required for the diagnosis and treatment of KC and 
therefore cannot be solely based on central corneal thickness and anterior curvature 
analysis of the cornea (Ciolino, Khachikian and Belin, 2008; Li et al., 2008; Greenstein, 
Fry and Hersh, 2011). The removal of the corneal tissue in refractive surgery places a 
physical demand on the cornea.  Therefore it is imperative to identify and locate 
potential corneal ectatic changes (Holland and Reinstein et al. 2000). Additionally, in 
CXL, in-order to stabilise early progression and prevent visual loss the ectatic changes 
must be identified prior to significant changes to the corneal structure. Ultrasonic 
central pachymetry has been proven to be a useful corneal assessment tool in very 
early KC where epithelial compensation can be masked by the presence of an 
underlying cone as seen on front surface topography (Reinstein, Archer and Gobbe, 
2009).  
 
There have been numerous advancements in imaging techniques such as optical 
cross-sectioning, and OCT that enables the assessor to measure the anterior and 
posterior cornea, corneal thickness maps and greater corneal assessment coverage 
using videokeratoscopes (Belin and Khachikian, 2007; Kim et al., 2009; Yazici et al., 
2010). The advantages of using Scheimpflug photography system is its ability to 
construct a full corneal thickness map that can be used to locate and identify the 
location and magnitude of the thinnest part on the cornea (Belin and Ambrósio, 2013). 
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The Pentacam (OCULUS GmbH, Wetzlar, Germany) currently provides a 
comprehensive refractive screening display (Belin/Ambrosio Enhanced Ectasia 
Display III– (BAD III)) that combines nine different tomographic parameters as a 
screening tool. The parameters are also displayed as a regression analysis plot to 
enable the assessor to identify potential risk for ectatic change (Belin and Ambrósio, 
2013): 
• Anterior elevation at the thinnest point 
• Posterior elevation at the thinnest point 
• Anterior elevation change 
• Posterior elevation change 
• Corneal thickness at thinnest point 
• Thinnest point on cornea (x/y postion) 
• Pachymetric progression 
• Ambrósio relational thickness 
• Kmax 
 
 
6.3 Corneal cross-linking in keratoconus  
 
CXL has been documented to be a minimally invasive surgical treatment for managing 
ectatic corneal disorders, such as KC, PMD and post-LASIK corneal ectasia 
(Wollensak, Spoerl and Seiler, 2003; Wollensak, 2006; Hafezi et al., 2007; Spadea, 
2010).  It has been documented in previous studies that in KC there is a significant 
reduction in diagonal linking collagen fibrils (Sherwin and Brookes, 2004). Since these 
fibrils contribute to the mechanical stability of the cornea. The reduction of these fibrils 
contributes to the weakening of the corneal structure and thinning of the central and 
para-central areas. Consequently, leading to irregular astigmatism, myopia and 
reduction in VA. CXL therapy leads to the formation of cross-links which are chemical 
bonds among stromal collagen fibrils which results in strengthening and stabilisation 
of the weak cornea. CXL uses riboflavin (vitamin B2) in conjunction with UV-A 
irradiation upon the cornea that allows the formation of crosslinks between collagen 
fibrils in the corneal stroma. This results in stiffening and arrests the progression of 
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corneal ectasia (Wollensak, Spoerl and Seiler, 2003; Wollensak, 2006). Prior to 
therapeutic CXL the treatment options for ectatic corneal disorders were spectacle 
correction, contact lenses, intrastromal and corneal ring segment (Siganos et al., 
2003). In advanced cases of KC, lamellar or penetrating keratoplasty (Frost et al., 
2006). These interventions only provided symptomatic solution and did not address 
the pathology of ectatic disorder. In comparison, CXL has been documented to halt 
the progress by intervening at the pathophysiology level rather than purely symptom 
alleviation.  
 
Dresden protocol is the original surgical CXL technique which was first described by 
Wollemsak et al. (Wollensak, Spoerl and Seiler, 2003). The Dresden treatment 
protocol constitutes the benchmark for all other CXL procedures to be evaluated 
against for safety and efficacy. The CXL procedure is conducted under a sterile 
operating room after the application of topical anaesthesia. The central 8 to 9 mm of 
the epithelium is removed with the aid of mechanical removers such as a blade or 
rotating brush. It can also be removed with the use of alcohol or laser.  Riboflavin (B2) 
solution (0.1%) is applied at an interval of 2 to 5 mins for approximately 30 minutes to 
promote the complete penetration of the riboflavin into the corneal stroma. A yellow 
flare in the anterior chamber signifies complete stroma penetration of riboflavin. The 
riboflavin in CXL treatments functions as a photo sensitizer for the induction of cross-
links and selectively filters, which protects the underlying tissues from the harmful 
influence of UV-A. Wollensak et al demonstrated the cytotoxic irradiance levels is at 
0.5 mW/cm2  for keratocytes after UV-A irradiation combined with the photosensitizer 
riboflavin, which is 10-times lower than the cytotoxic irradiance of 5 mW/cm2  after 
UV-A-irradiation alone (Wollensak et al. 2003). Wollensak et al. also demonstrated 
that the minimum preoperative corneal thickness required to safely prevent posterior 
corneal tissue injury during CXL was 400 um (Wollensak, 2006). These findings were 
also verified by Spoerl et al. who reported that the safety threshold of 400 um  was 
necessary to limit UV-A irradiance to less than 1 J/cm2  at the level of the corneal 
endothelium, anterior chamber, lens and retina (Spoerl et al., 2007). The riboflavin 
saturated cornea is exposed to UV-A energy for a total of 30 minutes.  During the CXL 
treatment, riboflavin is applied every 2 to 5 minutes to ensure adequate absorption. 
After the completion of the procedure, a bandage contact lens is applied until the 
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epithelium is completely healed along with the application of topical corticosteroids, 
non-steroidal anti-inflammatory agents and antibiotic. 
 
The factors related to successful CXL treatment in-terms of postoperative VA, 
improved keratometry and absence of adverse events have been investigated  and 
have concluded that preoperative  VA, eccentricity of the cone, pretreatment maximum 
keratometry (Kmax), age above 35 years, and sex are all predictors of CXL efficacy 
and safety (Koller et al. 2009; Koller et al. 2011). In addition, the negative association 
between smoking and KC has also been reported (Spoerl, 2008). While Hafezi (2009) 
suggests that smoking could possibly alter the biomechanical structure of the cornea 
and precorneal TF lipid layer (Altinors et al., 2006).  
 
 
6.4 Corneal cross-linking plus 
 
The term ‘CXL Plus’ was first introduced by Kymionis in 2011, which generally refers 
to the addition of laser refractive procedures to optimise the outcome of CXL therapy 
(Kymionis, 2011). It has documented that CXL therapy on its own cannot significantly 
improve vision. Therefore, the addition of other complimentary procedures such as 
laser refractive surgery, intracorneal ring segments, phakic intraocular lens 
implantation along with CXL has shown to significantly improve VA. Currently, 
controlled clinical studies on CXL plus procedures are: 
 
• Transepithlial phototherapeutic keratectomy (trans-PTK). 
• Topography -guided and other forms of photorefractive keratectomy (PRK). 
• Corneal implants, also known as intracorneal ring segments. 
 
Kymionis et al. (2012) found that modifying Cretan protocol by removal of epithelium 
using trans-PTK resulted in better visual and refractive outcome in comparison to 
mechanical epithelial debridement.  Labiris et al. (2012) investigated the effect of CXL 
and CXL combined with trans-PTK upon the QOL by means of the 25-item National 
Eye Institute Visual Function Questionnaire (NEI-VFQ 25). The study concluded that 
CXL, and especially CXL combined with trans-PRK, had a greater positive impact on 
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self-reported QOL (Labiris et al., 2012). While Kanellopoulos & Binder (2011) were 
successful with topography-guided PRK–CXL in post-LASIK ectasias, using the 
Athens protocol, results from Coskunseven et al. and Awady et al. have shown the 
benefits of combining intracorneal ring segments along with CXL in keratoconic eyes 
(Coskunseven et al., 2009; El Awady, Shawky and Ghanem, 2012). Historically, trans-
PTK using an excimer laser has been used to effectively smooth the anterior, irregular 
cornea as well as to remove the epithelium (Ambrósio & Wilson 2003; Holzer et al. 
2005; Greenstein et al. 2011). In all the published studies it is apparent that there is 
significant variation in the postoperative responses to either the CXL treatment or the 
combined CXL plus treatments. It is likely that here are many factors which may be 
involved in the effectiveness and consequences of trans-PTK CXL treatment. In this 
chapter a comprehensive set of pre and postoperative factors are analysed in an 
attempt to determine the influence of preoperative factors that might impact 
subsequent postoperative VA outcomes in kertoconic eyes undergoing trans-PTK 
treatment. The aim of this study is to determine preoperative factors that can predictive 
positive outcomes from CXL plus trans-PTK treatment. Table 6.1 summarises various 
CXL studies performed in eyes with progressive KC. 
 
 
Table 6.1. Outcomes with CXL and combined trans-PTK and CXL procedures 
 
Author 
Number of 
Eyes 
Follow-
up 
(months) 
Procedure  Outcomes 
G 
Wollensak 
et al. 
(2003) 
23 3 to 48 CXL 
↓2.01 D Ksteep*; ↑1.26 lines in 
65 per cent 
Raiskup-
Wolf et al. 
(2008) 
480 6 to 72 CXL 
↓Ksteep 2.68D at 1year; ↓4.84D 
at 3-years*; ≥1 line in 53 per cent 
at 1-year and 58 per cent at 3-
years* 
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Coskunsev
en, Jankov 
& Hafezi 
(2009) 
38 5 to 12 CXL 
↓Kmax 1.57 D*; ↑UCV 0.06 
logMAR; ↑ VA 0.1* 
Caporossi 
et al. 
(2010) 
44 48 to 60 CXL ↓Kave 2.26 at 4-years;  ↑UCV 2.85 
Snellen lines. 
Koller et al. 
(2011) 
151 12 CXL 
↓Kmax >1.00 D in 37.7 per cent, 
↓ Kmax >2.00 D in 13 per cent, 
60.3 per cent stable 
Wittig-
Silva et al. 
(2008)** 
66 12 CXL 
↓Ksteep 1.45, 50 per cent > 1.00 
D 
Hassan 
Hashemi 
(2013) 
40 60 CXL ↓Kmax 0.16 D 
Kymionis 
et al. 
(2012) 
38 12 
trans-
PTK+CXL 
(group 1) 
and  
↑ VA*, ↓Ksteep* in group 1 
CXL 
(group 2) 
Kapasi et 
al. (2012) 
34 1 
trans-
PTK+CXL 
(group 1) 
and  
↓SE* in group 1 
CXL 
(group 2) 
*Statistically significant result. **Randomised controlled trial. UCVA: uncorrected 
vision, VA: best visual acuity, Ksteep: maximum keratometry value on the steepest 
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axis, Kmax: maximum keratometry, Kave: average keratometry reading, PTK: 
photorefractive keratectomy, CXL: corneal collagen cross-linking 
 
 
6.4.1 Study aim  
 
This was an interventional case series of 41 patients (48 eyes). The primary purpose 
of this study was to evaluate the outcomes of a series of patients who were treated 
with either simultaneous trans-PTK or mechanical epithelial removal prior to CXL for 
progressive KC and to determine the possible preoperative factors that promote 
improved VA after trans-PTK treatment.  
 
 
6.4.2 Sample size  
 
Kapasi et al. (2012) had compared visual outcomes of patients with KC treated with 
either trans-PTK or mechanical epithelial removal prior to CXL based on this data, a 
sample size calculation using G*Power 3.1 (Faul et al., 2007) using two-way paired t-
test to achieve 80% power at an alpha level of 0.05, indicating a total of 48 eyes).  
 
 
6.4.3 Subjects 
 
This retrospective, case series is from a population of patients seeking treatment for 
KC at Cathedral Eye Clinic, Belfast, Norther-Ireland, UK. Because this was a 
retrospective study, only informed consent and permission to use their data for 
analysis and publication was obtained from each patient as part of our routine 
preoperative protocol. The nature of the study was explained verbally and on paper to 
the participants by trained clinicians before obtaining a written informed consent. A 
complete ocular examination was performed to screen for ocular abnormalities and 
determine patient candidacy for surgery. Exclusion criteria were previous ocular 
surgery, ocular disease such as corneal opacity, corneal irregularity, DE, and any 
degree of amblyopia, glaucoma or retinal disease, and complications during surgery. 
In this retrospective nonrandomized comparative case series study, 41 patients (44 
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eyes; in a consecutive series), 29 men and 12 women, with progressive KC were 
included. The clinical diagnosis of KC was based on corneal topography data 
(Pentacam; Oculus, Germany). Inclusion criteria were progressive KC (KC was 
described as progressive when there was an increase in the cone apex keratometry 
of 0.75 diopters (D) or an alteration of 0.75 D in the spherical equivalent refraction in 
the last six months) (Gore, Shortt and Allan, 2013). Once the diagnosis of KC was 
confirmed, the patients were informed of their options, including CXL and CXL with 
trans-PTK. All the patients were advised of the possible risks associated with the 
operation. Surgery was performed in the following manner: same-day simultaneous 
trans-PTK and CXL in group-1 eyes and CXL on group-2 eyes. Expected corneal 
thickness at the apex of the cone after phototherapeutic keratectomy (trans-PTK) was 
more than 400μm, and no other corneal pathologic sign was observed. 
 
 
6.4.4 Experimental procedure  
 
Clinical Assessment 
 
The preoperative and postoperative (at one, three, six, and nine months) evaluations 
consisted of general and ocular health history assessment; corneal topography 
(Oculus Pentacam), assessment of uncorrected distance visual acuity (UDVA), 
corrected distance visual acuity (CDVA), and manifest refraction, Aladdin pupillometry 
(Topcon), and slit-lamp examination of the anterior and posterior segments were 
performed on all eyes. Patient reported outcome measures for the QOV and DE were 
captured using the QOV, QOV-L (McAlinden, Pesudovs and Moore, 2010) and OSDI 
questionnaires respectively at (preoperative and postoperative at one, three, six, and 
nine months). The QOV questionnaire is a validated questionnaire that assesses 
visual satisfaction of a patient on a linear 0 to 10 scale, to define each patient's 
comprehensive subjective view of total QOV. The QOV-L questionnaire is a six-
question instrument for the evaluation of the impact of vision impairment upon the QOL 
of the patient. It is a vision-specific instrument that assesses 3 vision-depended 
domains that include patient specific distance activities, intermediate activities and 
near activities rated on a scale of 1 to 5, depending according to level of visual 
 115 
impairment (1=clear; 2=slight impairment; 3=moderate impairment; 4=severe 
impairment; 5=intolerable). 
 
Table 6.2 describes abnormal and pathological values for the topography indices (from 
topography device user’s manual).  
 
Index of Surface Variance (ISV) was assessed in all treatment eyes. ISV is a measure 
of the standard deviation of individual corneal sagittal radii from the mean curvature of 
the same eye. It expresses the corneal surface irregularity. It is elevated when the 
corneal surface is irregular. An index of surface variance equal to or greater than 37μm 
is considered abnormal and larger than 41μm is considered pathological 
(Kanellopoulos and Asimellis, 2013). 
 
Index of vertical asymmetry (IVA) which is expressed in mm was assessed in all 
treatment eyes. IVA is the mean difference between the superior and inferior corneal 
curvature. Therefore, IVA denotes the value of curvature symmetry with respect to the 
horizontal meridian as the axis of reflection. An IVA value of larger than 0.28 is 
abnormal and larger than 0.32 is considered pathological (Kanellopoulos and Asimellis, 
2013). 
 
Keratoconus Index (KI) was also assessed.  KI is the ratio between mean radius 
values in the upper and lower segment (r sagittal superior to r sagittal inferior). A value 
equal to or larger than 1.07μm is considered abnormal/pathological (Kanellopoulos 
and Asimellis, 2013).  
 
Central keratoconus index (CKI) is the ratio between the mean radius values in a 
periphery ring divided by the central. CKI is found to be elevated in central pachymetric 
and increases with central KC severity. A value of greater than 1.03 is considered as 
abnormal and pathological (Kanellopoulos and Asimellis, 2013). 
 
Index of height asymmetry (IHA) is the mean difference between the height values 
superior minus the height values inferior with the horizontal meridian as minor axis 
and is expressed in um. It denotes the degree of symmetry of the height 
measurements with respect to the horizontal meridian as the axis of reflection. IHA 
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and IVA are similar, however since IHA is based on corneal elevation, it is considered 
to be more sensitive. An IHA value of greater than 19 is considered abnormal while 
greater than 21 is considered pathological (Kanellopoulos and Asimellis, 2013).  
  
Index of height decentration (IHD) is the value of decentration of elevation data in the 
vertical direction and is expressed in um. It is calculated on a ring of radius of 3mm 
and provides the degree of decentration in the vertical direction. An IHD value of 
greater than 0.014 is abnormal while a value of larger than 0.016 is considered 
pathological (Kanellopoulos and Asimellis, 2013).   
 
Additionally, minimum radius of Curvature (Rmin) of all treated eyes was measured. 
This is a measurement of the smallest/minimum radius of sagittal corneal curvature 
(i.e. the maximum steepness of the cone). Values less than 6.71mm are considered 
abnormal and/or pathological (Kanellopoulos and Asimellis, 2013).  
 
Table 6.2. Description of topography indices 
 
Index  Abnormal  Pathological 
ISV ≥37 ≥41 
IVA  ≥0.28 ≥0.32 
KI  ≥1.07 ≥1.07 
CKI ≥1.03 ≥1.03 
Rmin <6.71 <6.71 
IHA ≥19 >21 
IHD >0.014 ≥0.016 
ISV: index of surface variance; IVA: index of vertical 
asymmetry; KI: keratoconus index; CKI: central keratoconus 
index; Rmin: minimum radius of curvature; IHA: index of height 
asymmetry; IHD: index of height decentration.  
 
 
6.4.5 Surgical Technique (Dresden protocol and modified Dresden protocol) 
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All procedures were performed at Cathedral Eye Clinic, Northern-Ireland, Belfast by 
the same surgeon (J.E.M.) under sterile conditions. All patients received CXL, 
according to the Dresden protocol (Wollensak, 2006). Additionally, group 1 patients 
underwent a modification of the Dresden protocol with trans-PTK ablation using a 
5.5mm optical zone and a depth of 55μm with Amaris excimer laser (Schwind, GmbH) 
prior to their CXL treatment. The epithelial defect was then manually enlarged using 
an epithelial scraper.  
 
 
6.4.6 Numerical Evaluation 
 
Corneal flattening at 6-months post-CXL was defined by a decrease in the maximum 
K reading compared with the preoperative value. Thus, the main variable was:  
ΔKmax = Kmax (preop) – Kmax (9 month) 
where ΔKmax is the change in the maximum K value, Kmax (preop) is the maximum 
preoperative K value, and Kmax (9month), is the maximum K value at 9 months 
postoperatively.  
The magnitude of change of outcomes in parameters such as ΔKmin, ΔUDVA, ΔCDVA, 
Δindex of surface variance, Δkeratoconus index, ΔRmin, ΔQOV score, ΔQOV-L score 
ΔOSDI questionnaire, and Δendothelial cell count was also calculated. 
 
 
6.4.7 Statistical Analysis 
 
Statistical analysis was performed using SPSS for Windows software (version 22, 
SPSS, Inc.) and Excel software (Microsoft Corp.). The Kolmogorov-Smirnov test was 
used to assess normality. For assessing continuous normal data, 1-way analysis of 
variance (ANOVA) with Tukey post hoc comparison was used. For assessing 
nonparametric data, the Kruskal-Wallis and Mann-Whitney U tests were applied. 
Linear regression analysis was performed to seek possible correlations. For all 
statistical analysis, the level of significance was a P value less than 0.05. 
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6.5 Results 
 
Follow-up time was 9 months for all patients included in the study. Table 6.3 shows 
the demographic data. Figures 6.1 and 6.2 show preoperative and postoperative 
topographies of sample patients’ A and B who had undergone simultaneous trans-
PTK prior to CXL (group 1) and manual debridement CXL (group 2), respectively. 
 
 
Table 6.3. Patient demographics 
 
Patients     
     Trans-PTK (group 1) 20 
     Manual debridement (group 2) 21 
     Total  41 
Eyes    
     Trans-PTK (group 1) 24 
     Manual debridement (group 2) 24 
     Total  48 
Age (years)   
     Trans-PTK (group 1) 28±3.5 
     Manual debridement (group 2) 27±4.7 
    
Sex   
     Trans-PTK (group 1) 14 males 6 females 
     Manual debridement (group 2) 15 males  6 females  
  
Parameters  Preop 
SE (D)   
     Trans-PTK (group 1) -4.2±3.5 
     Manual debridement (group 2) -3.7±3.1 
     P-value  0.12 
  
Corneal Pachymetery (μm)   
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     Trans-PTK (group 1) 442±45 
     Manual debridement (group 2) 467±42 
     P-value  0.09 
D: Dioptre; SE: Spherical equivalent; trans-PTK: transepithelial phototherapeutic 
keratectomy; μm: micrometre.  
 
 
Figure 6.1. Topographies obtained from patient A. Remodelling process following 
CXL: topographical changes. Scheimpflug analysis of the anterior corneal surface at 
nine-months after CXL with trans-PTK.  
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Figure 6.2. Topographies obtained from patient B. Remodelling process following 
CXL: topographical changes. Scheimpflug analysis of the anterior corneal surface at 
nine-months after CXL. 
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Visual Acuity 
 
Table 6.4 shows UDVA and CDVA over nine-months follow-up. The inter-group 
statistical analysis between group 1 and 2 at baseline found no significant differences 
between them. The mean UDVA in group 1 at baseline was 0.84±0.43 logMAR and 
improved to 0.55±0.24 logMAR at nine-months (P<0.05). In group 2, mean baseline 
UDVA was 0.81±0.24 logMAR and at nine-months postoperative assessment it 
improved to 0.62±0.23 logMAR (P<0.05). The mean UDVA of group 1 was better than 
group 2 at three, six and nine months (P<0.05). The mean CDVA in group 1 at baseline 
was 0.31±0.23 and improved to 0.19±0.10 logMAR at 9-months (P<0.05). In group 2, 
mean baseline was 0.27±0.20 and at 9-months postoperative it improved to 0.22±0.16 
logMAR (P<0.05). The improvement in mean CDVA in group 1 and group 2 reached 
significance difference at nine months (P<0.05).  
 
 
Tomography  
 
Table 6.4 shows the inter-group statistical analysis between group 1 and 2 Kmax at 
baseline found no significant differences between them (P=0.062). Group 1 and group 
2, showed significant improvements in Kmax at nine-months after treatment to 
47.39±4.20 (P<0.05) and 46.45±4.61 (P<0.05) respectively. However, group 1 had a 
greater magnitude of change (ΔKmax) compared to group 2 at nine-months 
postoperative assessment. Kmax in group 1 was significantly better than group 2 at 
three, six and nine months (P<0.05). Kmin preoperatively for group 1 and 2 was 
46.40±4.30 and 45.20±5.10 (P=0.093) respectively. At six-months mean Kmin in 
group 1 (42.57±4.60) had a significantly better improvement in comparison to group 2 
(43.10±3.39) (P<0.05). ΔKmin for group 1 was 3.83 and 2.1 for group 2.  
 
 
Table 6.4 summarises the QOV and OSDI data. Mean baseline QOV for group 1 and 
group 2 was 7.3 ± 2.5 and 7.0±1.9 respectively. At nine-month post treatment, mean 
QOV improved in both groups to 8.5±1.25 (P<0.05) and 8.05±2.13 (P<0.05) 
respectively. 
QOV Lifestyle score for distance and near improved significantly in both groups at 
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nine-months postoperative assessment. The mean Δ QOV-L score for distance, 
intermediate and near was larger in group 1 in comparison to group 2. The baseline 
OSDI score for group 1 and 2 was 37.51±7.15 and 35.34 ±6.35 respectively, and at 
nine-months it was relatively the same at 36.76±4.92 (P=0.173) and 35.14±3.14 
(P=0.089) respectively. As shown in Table 6.4, the mean OSDI scores for the 
keratoconic group 1 and 2 are higher than the average of healthy patients, signifying 
the severity of these symptoms in keratoconic eyes.  
 
 
Endothelial cell count 
 
Mean baseline endothelial cell count (ECC) for group 1 and 2 was 2429±213.5 
cell/mm2 and 2361±206.70 cell/mm2 respectively. Nine months after the procedure, it 
was 2420±239.1 cell/mm2 and 2363±204.0 cell/mm2 respectively (Table 6.4).  
 
Table 6.4. Preoperative and postoperative comparison. 
 
  Preoperat
ive  
Postoperative   
Parameter Baseline 1 
Month  
 3 
Months  
 6 
Months  
 9 
Months  
P-
value 
(within 
group) 
UDVA (LogMAR) 
Trans-PTK 
(group 1) 
0.84±0.4
3 
0.75±0
.35 
0.57±0.
21 
0.56±0.
20 
0.55±0.
24 
0.01* 
Manual 
debrideme
nt (group 
2) 
0.81±0.2
4 
0.78±0
.21 
0.62±0.
20 
0.63±0.
19 
0.62±0.
23 
0.03* 
P-value 
(inter 
group) 
0.07 0.13 0.02* 0.02* 0.04*   
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Δ UDVA 
(group 1) 
0.29   
Δ UDVA 
(group 2) 
0.19   
  
CDVA (LogMAR) 
Trans-PTK 
(group 1) 
0.31±0.2
3 
0.27±0
.19 
0.22±0.
21 
0.20±0.
16 
0.19±0.
10 
0.04* 
Manual 
debrideme
nt (group 
2) 
0.27±0.2
0 
0.38 ± 
0.19 
0.23±0.
20 
0.22±0.
18 
0.22±0.
16 
0.03* 
P-value 0.15 0.06 0.07 0.01 0.02*   
Δ CDVA 
(group 1) 
0.12   
Δ CDVA 
(group 2) 
0.05   
    
Kmax (D) 
Trans-PTK 
(group 1) 
49.72±5.
00 
49.51±
4.20 
48.43±4
.30 
47.37±4
.50 
47.39±4
.20 
<0.05* 
Manual 
debrideme
nt (group 
2) 
47.36±4.
60 
48.12±
5.00 
47.23±4
.90 
46.49±4
.70 
46.45±4
.61 
<0.05* 
P-value 0.062 0.059 0.04* 0.02* 0.03*   
Δ Kmax 
(group 1) 
2.33   
Δ Kmax 
(group 2) 
0.91   
    
Kmin (D) 
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Trans-PTK 
(group 1) 
46.40±4.
30 
45.32±
3.70 
44.27±4
.10 
43.25±3
.70 
42.57±4
.60 
0.04* 
Manual 
debrideme
nt (group 
2) 
45.20±5.
10 
46.41±
4.20 
44.12 ± 
4.30 
44.13±3
.80 
43.10±3
.39 
0.018 
P-value 0.09 0.02* 0.07 0.03* 0.03*   
Δ Kmin 
(group 1) 
3.83   
Δ Kmin 
(group 2) 
2.1   
    
QOV Day score 
Trans-PTK 
(group 1) 
7.3±2.50 8.1±1.
20 
8.5±1.5
0 
8.7±1.1
0 
8.8±1.2
5 
0.01* 
Manual 
debrideme
nt (group 
2) 
7.0 ±1.90 7.9±2.
30 
8.3±2.2
0 
8.0±2.5
0 
8.0±2.1
3 
0.04* 
P-value 0.08 0.03* 0.06 0.02* 0.02*   
Δ QOV 
(group 1) 
1.2   
Δ QOV 
(group 2) 
1.05   
    
QOV Night score 
Trans-PTK 
(group 1) 
6.5±2.70 7.10±1
.40 
7.60±1.
40 
7.95±1.
20 
8.05±1.
15 
0.03* 
Manual 
debrideme
nt (group 
2) 
6.7 ±2.50 7.05±1
.20 
7.15±1.
05 
7.10±1.
10 
7.22±1.
11 
0.04* 
P-value 0.120 0.080 0.240 0.04* 0.04*   
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Δ QOV 
(group 1) 
1.55   
Δ QOV 
(group 2) 
0.52   
    
QOV Lifestyle score (1-5) 
QOV-Distance vision score   
Trans-PTK 
(group 1) 
3.50±0.2 2.97±0
.4 
3.00±0.
75 
2.98±0.
59 
2.45±0.
45 
0.02* 
Manual 
debrideme
nt (group 
2) 
3.20±0.4 3.10±0
.1 
3.10±0.
20 
3.03±0.
22 
3.00±0.
13 
0.04* 
P-value 0.120 0.03* 0.04* 0.04* 0.04*   
Δ QOV-D 
(group 1) 
1.05   
Δ QOV-D 
(group 2) 
0.20   
    
QOV-Intermediate vision score   
Trans-PTK 
(group 1) 
3.30±0.5 3.16±0
.5 
3.12±0.
75 
2.98±0.
59 
2.45±0.
45 
0.03* 
Manual 
debrideme
nt (group 
2) 
3.22±0.3 3.13±0
.4 
3.15±0.
5 
3.14±0.
4 
3.12±0.
5 
0.07 
P-value 0.08 0.02* 0.16 0.04* 0.04*   
Δ QOV-I 
(group 1) 
0.85   
Δ QOV-I 
(group 2) 
0.10   
    
QOV-Near vision score   
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Trans-PTK 
(group 1) 
4.20±0.5
0 
3.50±1
.10 
3.50±0.
70 
3.00±1.
10 
3.00±0.
75 
0.04* 
Manual 
debrideme
nt (group 
2) 
4.10±0.4
0 
3.80±1
.28 
3.70±1.
20 
3.50±1.
50 
3.46±1.
00 
0.03* 
P-value 0.12 0.21 0.07 0.03* 0.02*   
Δ QOV-N 
(group 1) 
1.20   
Δ QOV-N 
(group 2) 
0.64   
    
OSDI Score 
Trans-PTK 
(group 1) 
37.51±7.
15 
40.16±
6.65 
35.32±5
.28 
36.52±5
.42 
36.76±4
.92 
0.17 
Manual 
debrideme
nt (group 
2) 
35.34±6.
35 
39.47±
7.26 
36.67±6
.74 
35.28±4
.39 
35.14±3
.14 
0.08 
P-value 0.83 0.21 0.29 0.3 0.62   
Δ OSDI 
(group 1) 
0.75   
Δ OSDI 
(group 2) 
0.2   
    
ECC (cells/mm2) 
Trans-PTK 
(group 1) 
2429±21
3.5 
2313±
240.3 
2417±2
20.6 
2418±2
31.4 
2420±3
29.1 
0.24 
Manual 
debrideme
nt (group 
2) 
2361±20
6.7 
2309±
190.9 
 
2357±2
31.5 
 
2363±2
24.0 
 
2363±2
04.0 
0.19 
P-value 0.92 0.31 0.06 0.075 0.093   
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Δ ECC 
(group 1) 
9   
Δ ECC 
(group 2) 
2   
* Statistically significant                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Kmax: Maximum keratometry                                                                                                                                               
Kmin: Minimum keratometry                                                                                                                                                      
CDVA: Corrected distance visual acuity                                                                                                                                       
UDVA: Uncorrected distance visual acuity QOV: Quality of vision 
questionnaire                                                                                                                         
OSDI: Ocular surface disease index questionnaire                                                                                                              
ECC: Endothelial cell count                                                                                                                                                                                                                                                                                        
ΔKmax = Kmax pre-op - Kmax 9-months                                                                                                                                                                                                                                                    
ΔKmin = Kmin pre-op - Kmin 9-months                                                                                                                                                                                                                                                     
ΔUDVA = UDVA pre-op - UDVA 9-months                                                                                                                                                                                                                                                  
ΔCDVA = CDVA pre-op - CDVA 9-months                                                                                                                                                                                                                                                      
ΔQOV = QOV pre-op - QOV 9-months                                                                                                                                                                                                                                                              
ΔOSDI Score = OSDI pre-op - OSDI 9-months                                                                                                                                                                                                                                               
ΔECC = ECC pre-op - ECC 9-months                                                                                                                                                             
QOV Lifestyle score: 1=Clear; 2=Slight; 3=Moderate; 4= Severe; 
5=Intolerable.   
 
 
Index of Surface Variance 
 
The baseline measurements in group 1 (100.80±56.6) and group 2 (99.50±18.20). In 
group 1, at nine-months the ISV decreased from baseline (mean change 10.06μm; 
P<0.05). In group 2, there was an overall mean decrease of 4.26μm at nine-months 
assessment (Table 6.5).  
 
 
Index of vertical asymmetry  
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In group 1, at nine-months, the IVA decreased from baseline (mean change 0.08; 
P>0.05). In group 2, at nine months the IVA also decreased but this improvement was 
not significant (mean change 0.04; P>0.05) (Table 6.5). 
 
 
Keratoconus Index 
 
In group 1, at nine months, the KI decreased from baseline (mean change 0.12; 
P<0.05). In group 2, at nine months the KI also decreased but this improvement was 
not significant (mean change 0.05; P=0.179) (Table 6.5). 
 
 
Central keratoconus index 
 
In group 1 and 2, at nine months, the CKI decreased from baseline. The mean change 
was 0.03 and 0.01 respectively.  The decreased IN CKI was not significant (Table 6.5). 
 
 
Minimum radius of curvature 
 
Baseline measurements between group 1 (5.54±0.48) and 2 (5.77±0.19).  In group 1, 
at 9-months, the Rmin increased significantly (the cornea was flattened) from baseline 
(mean change 0.48; P<0.05). In group 2, there was a significant improvement in the 
Rmin between baseline and 9 months (mean change 0.19; P<0.05) (Table 6.5).  Rmin 
at nine months was better in group 1 (6.02±0.41mm) than group 2 (5.96±0.30mm).  
 
 
Index of height asymmetry  
 
In group 1, at nine months, the IHA decreased from baseline (mean change 6.32; 
P<0.05). In group 2, at nine months the IHA also decreased (mean change 4.25; 
P<0.05) (Table 6.5).   
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Index of height decentration  
 
The baseline measurements in group 1 and 2 was 0.091±0.057 and 0.089±0.068 
respectively. In group 1, at nine months the IHD decreased from baseline (mean 
change 0.049; P<0.05). In group 2, there was an overall mean decrease of 0.029 at 
nine months assessment (Table 6.5).   
 
Table 6.5. Comparison of corneal topography indices 
 
 
Preoperative Postoperative Postoperative P-value (within group) 
Parameter Baseline 6 Months 9 Months 
 
ISV (μm) 
Trans-PTK 
(group 1) 
100.80±56.6 93.60±43.40 90.74±44.52 0.02* 
Manual 
debridement 
(group 2) 
99.50±18.20 96.00±13.70 95.24±15.63 0.25 
Δ ISV (group 1) 10.06 
 
Δ ISV (group 2) 4.26 
 
 
IVA (mm) 
Trans-PTK 
(group 1) 
1.10±0.52 1.02±0.55 1.02±0.54 0.46 
Manual 
debridement 
(group 2) 
1.08±0.40 1.05±0.43 1.04±0.49 0.72 
Δ IVA (group 1) 0.08 
 
Δ IVA (group 2) 0.04 
 
 
KI (μm) 
Trans-PTK 
(group 1) 
1.33±0.24 1.22±0.26 1.21±0.30 0.04* 
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Manual 
debridement 
(group 2) 
1.30±0.21 1.27±0.11 1.25±0.28 0.27 
Δ KI (group 1) 0.12 
 
Δ KI (group 2) 0.05 
 
 
CKI 
Trans-PTK 
(group 1) 
1.10±0.10 1.08±0.06 1.07±0.09 0.25 
Manual 
debridement 
(group 2) 
1.07±0.03 1.06±0.05 1.06±0.03 0.49 
Δ CKI (group 1) 0.03 
 
Δ CKI (group 2) 0.01 
 
 
Rmin (mm) 
Trans-PTK 
(group 1) 
5.54±0.48 5.89±0.38 6.02±0.41 0.04* 
Manual 
debridement 
(group 2) 
5.77±0.19 5.90±0.21 5.96±0.30 0.04* 
Δ Rmin (group 1) 0.48 
 
Δ Rmin (group 2) 0.19 
 
IHA 
Trans-PTK 
(group 1) 
27.13±15.24 21.20±14.10 20.81±12.48 0.03* 
Manual 
debridement 
(group 2) 
26.51±16.01 23.30±17.25 22.26±18.63 0.04* 
Δ IHA (group 1) 6.32 
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Δ IHA (group 2) 4.25 
 
 
IHD 
Trans-PTK 
(group 1) 
0.091±0.057 0.049±0.055 0.042±0.050 0.02* 
Manual 
debridement 
(group 2) 
0.089±0.068 0.062±0.040 0.060±0.047 0.03* 
Δ IHD (group 1) 0.049 
 
Δ IHD (group 2) 0.029 
 
ΔISV= ISV preop - ISV 9 months                                                                                                                                                                        
ΔIVA=IVA preop - IVA 9 months                                                                                                                                                                                
ΔKI= KI preop - KI 9-months;                                                                                                                                                                                     
ΔCKI= CKI preop - CKI 9-months                                                                                                                                                                             
ΔRmin= Rmin preop - Rmin 9-months                                                                                                                                                                       
ΔIHA= IHA preop - IHA 9 months                                                                                                                                                                                                                     
ΔIHD= IHD preop - IHD 9 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
* Statistically significant 
 
 
Table 6.6 compares the outcomes between the subgroups in group 1, i.e group 1A 
(higher ∆CDVA change) and 1B (lower ∆CDVA change). This comparison was 
performed to statistically compare and differentiate the Group 1A and Group 1B with 
regards to factors that may be related to the higher or lower change in CDVA. The 
only statistically significant differences between the two groups were in the 
postoperative maximum K value, ISV and IHA indices. To investigate whether these 
significant postoperative differences in the maximum K value, ISV and IHA indices 
were also present preoperative, preoperative statistically comparison of maximum K 
value, ISV and IHA indices between Group 1A and Group 1B was also performed. The 
only statistically significant differences between the two groups were in the 
preoperative maximum K value. To verify the impression that preoperative maximum 
K might have upon the postoperative improvement of CDVA, Odds Ratio (OR) and 
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Confidence Interval (CI) algorithm must be used, however due to the small sample 
size, this simplified statistical comparison was carried out providing a pilot for further 
investigation.  
 
 
Table 6.6. Comparison within Group 1.  
  
  Group 1A Group 1B   
  ∆CDVA ≥0.30 (n=9 eyes) ∆CDVA ≤0.10 (n=6 eyes) p-value  
        
Kmaxb (D) 45.24±3.12 46.51±4.17 0.03* 
        
Kminb (D) 40.79±4.18 41.32±3.29 0.49 
        
ISVb  88.45±31.25 91.17±25.10 0.02* 
        
IVAb  0.99±0.35 1.05±0.26 0.102 
        
KIb  1.15±0.04 1.23±0.08 0.72 
        
CKIb 1.04±0.11 1.10±0.15 0.29 
        
Rminb 6.27±0.52 5.13±0.32 0.5 
        
IHAb 19.35±7.15 21.24±5.23 0.02* 
        
IHDb  0.040±0.020 0.054±0.010 0.23 
  
Comparison of pre-operative parameters between groups  
  ∆CDVA ≥0.30 (n=10 eyes) ∆CDVA ≤0.10 (n=7 eyes) p-value  
        
Kmaxa (D) 51.10±3.20 45.05±2.60 <0.05* 
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ISVa 102.40±25.10 105±19±20 0.08 
        
Rmina 5.67±0.70 5.80±0.50 0.4 
Kmax: Maximum keratometry                                                                                                                                               
Kmin: Minimum keratometry                                                                                                                                                      
CDVA: Corrected distance visual acuity                                                                           
ISV: index of surface variance                                                                                       
IVA: index of vertical asymmetry                                                                                               
KI: keratoconus index                                                                                                             
CKI: central keratoconus index                                                                                           
Rmin: minimum radius of curvature                                                                                             
IHA: index of height asymmetry                                                                                              
IHD: index of height decentration                                                                                       
a: preoperative                                                                                                                         
b: postoperative 9 months                
 
 
6.6 Discussion 
 
Table 1 summarises various CXL studies performed in eyes with progressive KC. 
There is a variability in the definition of ‘progression’ between studies and preoperative 
groups. This poses significant difficulty when trying to compare between studies 
particularly to define the effect of different CXL treatment protocols upon progression 
of the disease. Nevertheless, clinical studies provide evidence that suggests CXL and 
modified CXL treatments halt progression of KC with a failure rate of only 
approximately 3% and a complication rate of 1% or less (Coskunseven, Ii and Hafezi, 
2008; Caporossi et al., 2010). However, here is a paucity of clinical study literature 
identifying which preoperative parameters are likely to be associated with enhanced 
corneal flattening post CXL.  In this study, group 1 and group 2 had comparable 
preoperative findings in topography and VA and endothelial cell counts to previous 
studies.  
 
Koller et al. (2011) investigated various factors such as age, CDVA, minimum corneal 
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thickness, ISV, KI, and asphericity of the anterior corneal shape, to determine their 
influence upon corneal flattening post-CXL. In their cohort of 151 eyes (151 patients), 
preoperative maximum curvature (Kmax) was the only factor that showed a 
statistically significant correlation with the flattening of corneal post-CXL. Curvature 
between the range of 54D and 58D of Kmax had a flattening rate greater than 50% 
and a failure rate of less than 1%.  Kmax of ≤54D had subsequent less flattening but 
stabilisation of KC was achieved outside the 54D to 58D (>99% success rate) range 
as well. Additionally, Koller et al. (2011) stated that a Kmax value greater than 58 D 
predicts more flattening but increased rates of failures. In our study, the mean 
preoperative Kmax for group 1 and group 2 was 49.72±5.00 D and 47.36±4.60 D 
respectively and a greater magnitude of improvement was observed in group 1 (Δ 2.33) 
in comparison to group 2 (Δ 0.91). These changes could possibly be due to the higher 
curvature as suggested by Koller et al. (2011). Furthermore, greater improvements in 
group 1 can be attributed due to the combination of larger preop Kmax values. 
 
As progression or improvement of KC is generally recorded by maximum and 
minimum keratometric value. Raiskup et al. (2015)  found that mean Kmax values 
decreased by 2.57 D at six years and at six months was close to 1 D, these findings 
are similar to group 2 (CXL group; mean Kmax: 47.36±4.60 D) of our study. However, 
studies such as Coskunseven et al. (2009) reported greater than 1 D of improvement 
within six to nine months post-CXL treatment, again the groups had relatively high 
mean preoperative Kmax of 54.02±4.15 D and 53.02±8.42 D respectively. These 
studies that indicate improvements of greater than 2D in the mean Kmax could 
possibly have been due to their higher pre-operative Kmax in comparison to our study, 
thereby resulting in a greater flattening change.  Kymionis et al. (2012) reported that 
Ksteep value decreased by 1.11D in the group that was treated with PTK and CXL at 
SIX months postop. In our study, patients in group 1 (CXL with PTK) at 9 months 
postoperatively had a mean Kmax improvement of 2.33 D. The magnitude of change 
in topography are similar, however in comparison, our study had a lower preoperative 
mean Kmax in comparison to Kymionis et al (2012).  In our study, the mean 
improvement in CDVA and UDVA at nine months in group 1 was 0.12 and 0.05 
respectively. At nine months postop our study found that 38.5% of eyes gained ≥1 
lines, 57.3% of eyes neither gained nor lost any line and 4.2% lost 1 line of CDVA. 
While Kymionis et al. (2012) in their twelve month comparative, prospective report 
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found that CDVA improved by 0.08 at six months post-op in the CXL with PTK group; 
it further improved by 0.11 at twelve months postop.  At twelve months 42.1% of eyes 
gained ≥1 lines of CDVA, 52.6% of eyes neither gained nor lost any line and only 5.3% 
lost 1 line of CDVA. 
 
On the other hand, CXL group in Kymionis et al. (2012)  at twelve months follow-up 
reported 33.3% of eyes gained ≥1 lines of CDVA, 55.6% of eyes neither gained nor 
lost any line and 11.1% lost 1 line of CDVA.  At nine-month follow-up of our CXL group, 
26.7% of eyes gained ≥1 lines and 65.2% of eyes neither gained nor lost any line of 
CDVA, while 8.1% lost 1 line of CDVA. The percentage lines gained of CDVA either 
groups were greater in Kymionis et al. (2012). This could be attributed to the longer 
post-CXL recovery in the Kymionis paper, as visual and topography improvements are 
known to gradual improve over twelve months postop. Therefore, it is possible that our 
CDVA will also improve over twelve months. However, lost lines of CDVA were similar 
to our study. 
 
Regarding UDVA, Kymionis et al. (2012) at twelve month reported 53% of trans-PTK-
CXL treated eyes presented 0.6 LogMAR or better and 28% of CXL eyes presented 
0.6 LogMAR or better. While in our study at nine months, group 2 improved by 0.19. 
In group 1, 51% had 0.6 LogMAR or better at nine months and 36% of group 2 eyes 
presented 0.6 LogMAR or better. 
 
The mean ECCs remained stable in both groups during the entire follow-up, as 
reported in most series. In our group 1, trans-PTK was used to help flatten the apex 
of the cone before CXL. To prevent the progression of the KC, corneal damage and 
endothelial cell toxicity from UV-A irradiation, trans-PTK ablation was performed to an 
intended depth of only 55μm which avoided removing significant amounts of corneal 
stromal tissue which could further compromise the biomechanical integrity of the 
keratoconic cornea. In most cases the 55μm PTK treatment although obviously 
smoothing the steep parts of the cornea had not fully removed all the epithelium within 
the 5.5mm region. This would provide the potential to treat further PTK amounts to 
utilize the full effects of epithelial masking. This was deliberately not not done to reduce 
the thinning effect upon steeper ectatic stromal regions. 
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The mean OSDI score 35 or greater was observed in both groups. However, OSDI 
scores were already elevated and at similar levels prior to treatment and may have 
had some negative impact upon the QOV and QOV-L scores pre and postoperatively. 
Postoperatively, both treatment groups had a significant improvement in their QOV 
and QOV-L scores.  The negative impact of KC on the QOL has been indicated by 
various former studies  and our findings indicate that CXL with and without trans-PTK 
improved the QOL significantly (Tatematsu-Ogawa et al., 2008; Cingu et al., 2015). 
This might be attributed to the improvement in subtle visual disturbances because of 
irregular astigmatism, coma, and light scatter postoperatively. Significant differences 
in the QOV-L scores detected, suggests that keratoconic patients experience 
significant visual impairment that affects the majority of their distance vision and near 
vision activities. 
 
The degree of stromal ablation in these cases is directly related to the degree of 
thinning of the epithelium overlying the area of conic protrusion. At one-week after 
procedure full re-epithelialisation was observed in all patients. Similar to Carracedo et 
al. (2014) our study also found that the OSDI scores were high in both keratoconic 
groups at baseline and postoperatively (Dienes et al., 2015). 
 
Our findings suggest that group 1 had a significantly greater improvement in various 
parameters of both corneal shape and visual outcomes (Table 6.4 and 6.5). The trans-
PTK prior to CXL procedure, makes use of epithelial masking to guide the laser 
stromal treatment to produce a subsequent smoother corneal surface with very limited 
stromal treatment confined to only those regions where there has been compensatory 
epithelial thinning over irregular areas of stromal protrusion. This enables a relative 
treatment of the irregular astigmatism present to allow quicker visual recovery post 
CXL. Reinstein et al. (2009) found that an epithelial doughnut pattern with epithelial 
thinning over the cone surrounded by a region of thickened epithelial. This pattern was 
consistent with an underlying stromal cone. Due to this phenomenon, removal of 
epithelial at a constant depth removes some stromal and epithelial tissue at the top 
cone, resulting in a smoothening effect. 
 
Enhancement in postoperative visual acuity was observed in both groups along with 
improved contour of the cornea. Since group 1 had a greater magnitude of anterior 
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corneal changes (denoted by Δ). Significantly greater improvement in visual acuity 
was observed in group 1 at nine months postoperative assessment in comparison to 
group 2. Group 1 also demonstrated incremental improvement in topography indices 
postoperatively. While in group 2, these improvements were documented mostly at 
nine months post treatment. This improvement with group 1 is expected to result from 
improved topography regularity by the PTK smoothening (flattening) procedure. 
Therefore, this study documents significant improvement in topography and VA 
changes in trans-PTK combined with CXL treatment group (Group 1) for KC, as early 
as 1-month post treatment. At 9-months significant inter-group improvements were 
observed in Rmin, IHA and IHD indices for both groups suggesting that the cone had 
decreased in curvature and flattened thereby becoming more optically regular and 
symmetric. However, long-term follow-up is needed to determine the differences in 
outcome of the two groups.  Additionally, postoperative astigmatism smoothing of the 
5.5mm corneal visual axis zone in group 1 (Figure 6.1) appears to have resulted in 
improved visual outcomes in comparison with group 2 (Figure 6.2). Visual 
rehabilitation between these groups are evident by their respective ΔCDVA (Table 6.4).  
These initial results require larger sample sizes and longer follow-up to determine 
long-term effectiveness of this combination treatment methodology. 
 
Currently the information about factors affecting the visual outcome trans-PTK are 
limited. Toprak et al. (2014) reported in patients with progressive KC: age, baseline 
VA and baseline thinnest pachymetry had a determining impact upon the visual 
outcome. In comparison, our study did not have a large enough sample size to assess 
this.  De Angelis et al. (2015) reported that low preoperative best-corrected distance 
visual acuity (BCVA), high refractive astigmatism, and advanced KC as factors 
predictive of BCVA improvement. Kirgiz et al. (2016) found correlation between 
preoperative and postoperative visual acuity. In this study, we sought to determine 
what factors in the PTK-CXL group were associated with a higher improvement of 
CDVA between pre and postoperatively.  
 
To assess this, we first determined the magnitude of improvement in corrected VA: 
∆CDVA. Then arranged the cases into those with greatest improvement (higher 
∆CDVA change: Group 1A) and those with the least improvement (lower ∆CDVA 
change) (Group 1B). An analysis of postoperative factors was then carried out to 
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statistically compare and differentiate what factors differed between the two groups: 
Group 1A and Group 1B with the higher or lower change in CDVA postoperatively. 
The only statistically significant differences between the two groups were in the 
postoperative maximum K value, ISV and IHA indices. Preoperative statistically 
comparison of maximum K value, ISV and IHA indices between Group 1A and Group 
1B was then also performed to determine whether these factors were different 
preoperatively between the Group 1A who demonstrated the postoperative enhanced 
change CDVA compared to the less significantly improving Group 1B. The only 
preoperative statistically significant differences between the two groups were in the 
maximum K value. None of the other indices were significantly different preoperatively 
among group 1A and 1B.  
 
These findings might suggest that the impact of trans-PTK CXL upon the postoperative 
visual performance is not clearly predictable by changes in corneal indices. The 
limitations of these findings are that a larger sample size, longer follow-up and possibly 
other pre and postoperative testing measures are required to attempt to determine 
predictive factors indicative of better or worse visual outcomes post PTK CXL 
treatments. Additionally, the flattening effect of this PTK treatment could potentially 
have been enhanced through deeper ablations which used the full epithelial masking 
effect. Longer follow-up and other studies demonstrating the safety of this type of 
procedure in ectatic corneas will potentially enable surgeons to be more aggressive in 
attempting to utilise either PTK or topography guided laser treatments to improve 
corneal shape and hence VA in addition to stabilising the ectatic condition.  
 
 
6.7 Conclusion 
 
This study appears to indicate that the combination of trans-PTK with CXL is a safe 
treatment which can potentially provide earlier functional improvement in vision and 
QOL, while still producing stabilization of the ectatic disorder. Further follow-up and 
additional cases will be required to draw final conclusions about the benefit of this 
combined technique in keratoconic patients. 
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6.8 Summary 
  
This chapter showed that combine trans-PTK with CXL may enhance visual quality 
along with improved corneal topography.  This preliminary study serves to lay the 
foundation for a more robust, prospective study but also highlighted the potential 
factors that benefit visual acuity post trans-PTK CXL treatment.   
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CHAPTER 7: COMPARISON OF TWO VISION-RELATED QUALITY OF LIFE 
QUESTIONNAIRES 
 
 
7.1 Introduction  
 
VA tests on patients in a routine postoperative assessment have been used to 
determine a successful outcome in visual rehabilitation; these measures include 
distance acuity, intermediate acuity, near acuity, and contrast sensitivity. ‘Success’ in 
visual rehabilitation is often defined based on the improvement in these 
measurements. After 1980s, clinicians and researchers started to explore visual 
function from a patients’ perspective using questionnaires because VA test alone was 
not able to capture all aspects of the patient’s QOV and its impact upon their QOL; 
henceforth emphasis upon visual function and vision related quality of life (VR-QOL) 
was established (Massof and Rubin, 2001; Stelmack, 2001). The multidimensional 
structure of QOL includes physical, functional, social and psychological dimensions 
(Aaronson, 1988). Generic VR-QOL questionnaires generally contain all these four 
domains, while disease specific QOL instruments are more specific and may not have 
all these domains included in them.   
 
The improved understanding of the concept of VR-QOL has led to the development of 
instruments that aim to capture and measure this concept. Majority of VR-QOL 
assessment instruments are sets of questionnaires. Although the growing trend to 
patient-based questionnaires is commendable; however currently there is an 
overabundance of overlapping questionnaires with regards to functionality. This 
plethora of questionnaires can sometimes pose problems for a clinician or researcher.  
As it can be unclear which of these questionnaires are of sufficient psychometric 
quality. However, a systematic review of existing questionnaires could serve as a 
guide for selecting the appropriate instrument. 
 
There have also been developments in the methodology of re-evaluating 
questionnaires with the use of Rasch analysis (Velozo, Lai and Mallinson, 2000; 
Massof and Fletcher, 2001; Pesudovs et al., 2003).  Various VR-QOL questionnaires 
have been validated for refractive surgery patients; these include Activities of Daily 
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Vision Scale (ADVS) (Mangione et al., 1992), the Visual Disability Assessment (VDA) 
(Pesudovs, Wright and Gothwal, 2010), Visual Functioning 25 (VF-25) (Nordmann et 
al., 2004) and the Visual Functioning 14 (VF-14) (Steinberg et al., 1994). These 
questionnaires have been shown to be sensitive to clinically meaningful change after 
surgery (Mangione et al., 1992; Schein et al., 1995). However, further validation using 
item response theory, Rasch analysis, and variability of responses has shown 
limitations in questionnaire development and validation that were previously not 
highlighted (Pesudovs et al., 2003; Mallinson, Stelmack and Velozo, 2004). Table 7.1 
highlights collect all the subjective questionnaires previously designed to address QOL; 
such as activities of daily living, social and emotional factors. However, all of these 
questionnaires have pre-determined items based on Rasch or Classic test theory 
analysis, excluding VR-QoL questionnaire; in which the items are user defined.  
 
 
Table 7.1 List of subjective questionnaires designed for assessing quality of life. 
  
Questionnaire 
Authors 
Condition Items  Grading Scales 
Ross and 
colleagues 
(1984) 
Glaucoma Pre-
determined  
Ordinal 1–5 
Mills and 
Drance (1986) 
Glaucoma Pre-
determined  
Yes, uncertain, 
no 
Nilsson and 
Nilsson (1986) 
ARMD Pre-
determined  
Yes, no 
Lowe and 
Drasdo (1992) 
Retinitis 
pigmentosa 
Pre-
determined  
Yes, no; 2 to 4 
categories; open 
ended 
Mangione and 
colleagues 
(1992) 
Cataract (ADVS) Pre-
determined  
Five categories 
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Leat and 
colleagues 
(1994) 
Low vision Pre-
determined  
Yes, no; 3 to 5 
categories; open 
ended 
Rubin and 
colleagues 
(1994) 
Old age visual 
impairment 
Pre-
determined  
Three categories 
Steinberg and 
colleagues 
(1994a,b) 
Cataract (VF-14) Pre-
determined  
Yes (4 
categories), 
no/not applicable 
Ellwein and 
colleagues 
(1995) 
Blindness Pre-
determined  
Four 
categories/does 
someone help 
you 
Parrish (1996) Glaucoma Pre-
determined  
Three to 5 
categories; 
ordinal 0–10 
Abrahamsson 
and colleagues 
(1996) 
Cataracts Pre-
determined  
Yes, no 
Wu and 
colleagues 
(1996) 
Cytomegalovirus Pre-
determined  
Yes, no 
Cleary and 
colleagues 
(1997) 
Optic neuritis Pre-
determined  
Five 
categories/not 
applicable 
Javitt and 
colleagues 
(1997) 
Cataract Pre-
determined  
Ordinal 0–4 or 0–
10; 5 categories; 
open ended 
Lundstrom 
andcolleaguess 
(1997) 
Cataract 
(Catquest) 
Pre-
determined  
Yes, no; yes (3 
categories), no; 2 
to 5 
categories/cannot 
say 
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Carta and 
colleagues 
(1998) 
ARMD, branch 
retinal vein 
occlusion, 
cataract, primary 
open-angle 
glaucoma 
Pre-
determined  
Ordinal 1–3 with 
descriptors 
Moore and 
colleagues 
(Current study)  
Cataract and 
laser refractive 
surgery (QoL)  
User defined  Yes, 3 categories 
ARMD = age-related macular degeneration. ADVS = Activities of Daily 
Vision Scale. 
 
 
7.2. Dimensions of QOL  
 
To specify and categorise the items of the questionnaires, these items are assigned 
to one of the four dimensions of QOL: physical dimensions, functional dimensions, 
social dimensions and psychological dimensions (Aaronson, 1988).  
 
 
7.3. Response categories 
 
Response categories of the questionnaire reflect the number of ordered responses 
that an item in the questionnaire contains. Not applicable (NA) response is not counted 
as a response category. In any given questionnaire, the number of response 
categories to an item may vary (Frost et al., 2001).  
 
 
7.4. Psychometric aspects 
 
The psychometric aspects impart information about the psychometric quality of the 
questionnaires. This information helps researcher and clinician in their choice between 
potentially applicable instruments. Generally psychometric properties of VR-QOL are 
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based on classic test theory (CTT) or on Rasch rating scale analysis (Sébille et al., 
2010) .  
 
 
7.5. Mode of administration and languages 
 
Modes of administration of questionnaires can be: self-administered, interviewer 
administered, telephone administered, electronically administered (website or App 
based) and possibly proxy versions. The psychometric properties of an instrument 
have been found to differ with modes of administration, languages or cultures (Frost 
et al., 2001).  
 
 
7.6. VF-14 questionnaire  
 
The Visual Function-14 (VF-14) questionnaire (Ref: Appendix B), contains 14 fixed 
(pre-defined) vision-dependent activities questions, which was first developed for use 
in patients with cataract.  Since then, it has been used with several other chronic eye 
diseases. Each question is scored on a scale of 0 (unable to perform an activity at all) 
to four (able to engage in activity fully). The average score is multiplied by 25 to give 
an overall score ranging from 0 to 100. For VF-14 the scores are given in points. Zero 
implies inability to do any of the activities, whereas a score of 100 denotes ability to 
perform all activities without any difficulty (Steinberg et al., 1994).  
In-order for VR-QOL questionnaires to be useful for research and clinical applications, 
a VR-QOL questionnaires needs to be reliable and valid. Reliability refers to the extent 
to which the measure yields the same number or score each time it is administered, 
all other things being equal (i.e., no true change in the attribute being measured has 
occurred). Validity is the degree to which the measure reflects what it is supposed to 
measure rather than something else. The distinction between reliability and validity is 
important because a measure may be reliable (i.e., always yield the same score for 
the same patient), but it may be consistently measuring the wrong thing (i.e., not what 
it is supposed to measure). 
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Due to the 14 pre-defined nature of questions in the VF-14 questionnaire, frequently 
clinicians encounter missing information (as these fixed questions at times are not 
applicable or relevant to every individual patient).  There is a strong possibility that a 
compilation of these missing data error can lead to bias in measurement as it causes 
the score to be consistently too high or too low relative to the true score. 
 
The well accepted traditional questionnaires such as VF-14 assess the ability of the 
patient with pre-defined items, such as the visual ability to perform tasks like ‘cooking’ 
and ‘filling checks or forms’ before and after vision rehabilitation on the assumption 
that these questions are meaningful and relevant to the individual’s VR-QOL. Although, 
these pre-defined items have the benefit of expediency, at times these items may not 
represent the visual function needs of the patient. The alternative to this methodology 
would be to have a detailed questionnaire that encompasses all the possible items 
that might be relevant to an individual; however, such a questionnaire would be time 
consuming and expensive to administer. The next best approach would be to 
administer a short questionnaire that is individually tailored to the patients’ visual 
function needs.  
This chapter hypothesises that by asking the patient two specific items that are 
relevant and meaningful to their VR-QoL questionnaire for distance, intermediate and 
near vision (total 6 items) will generate a more accurate status and representation of 
their visual function in comparison to generic items on a questionnaire.  
 
 
7.6.1 Study aim  
 
To compare VF-14 and VR-QoL questionnaire for measuring preoperative cataract 
patient reported outcomes. 
 
 
7.6.2 Sample size  
 
The power calculation was conducted using G*Power 3.1 (Faul et al., 2007)  (ANOVA 
repeated measures within factor). Sample size was determined using power 
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calculation (80% power at the 5% level of statistical significance, α=0.05) to detect a 
change of ±1.99 unit change in VF-14 score based on the Gothwal et al. (2010).  
 
 
7.6.3 Subjects  
 
This retrospective, case series is from a population of patients seeking IOL 
implantation surgery due to cataracts at Cathedral Eye Clinic, Belfast, Norther-Ireland, 
UK. Because this was a retrospective study, only informed consent and permission to 
use their data for analysis and publication was obtained from each patient as part of 
our routine preoperative protocol. The nature of the study was explained verbally and 
on paper to the participants by trained clinicians before obtaining a written informed 
consent. A complete ocular examination was performed to screen for ocular 
abnormalities and determine patient candidacy for surgery.  
 
This study retrospectively assessed 51 patients who were administered VF-14, VR-
QoL and QOV questionnaires consecutively on the same day prior to cataract surgery.   
The mean age was 74, and the age range was 50 to 85 (Table 7.2). In this study, along 
with the VF-14 questionnaire and VR-QOL questionnaire and previously developed 
QOV questionnaire (McAlinden et al., 2010) was completed.  
 
 
Table 7.2 Patient demographics  
 
Number of patients 51 
Age (years) 74 ± 17 
Gender (% males) 37 
Visions status Cataract  
 
 
7.6.4 Experimental procedure 
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Fifty-one pre-operative patients were asked to complete three questionnaires, namely:  
VF-14, VR-QoL and QOV questionnaires. The results were used to evaluate their VR-
QOL status.  
 
The VF-14 questionnaire (Ref: Appendix B), contains 14 vision-dependent activities 
questions. Each question is scored on a scale of 0 (unable to perform an activity at all) 
to 4 (able to engage in activity fully). The average score is multiplied by 25 to give an 
overall score ranging from 0 to 100. The VF-14 the scores are given in points. Zero 
implies inability to do any of the activities, whereas a score of 100 denotes ability to 
perform all activities without any difficulty (Steinberg et al., 1994).  
 
The VR-QoL questionnaire (Ref: Appendix C) comprises of six questions which are 
categorised into 3 subgroups, namely; distance vision related activity, intermediated 
vision related activity and near vision related activity. The subject is asked to mention 
two relevant activities regarding distance vision, intermediate vision and near vision to 
the assessor and rate them on a scale of 1 to 5 (1=clear; 2=slight difficulty; 3=moderate 
difficulty; 4=severe difficulty; 5=intolerable). The total score and mean score are not 
derived as each item is treated individually based on the rational that averaging the 
score will misrepresent the individual’s appreciation of vision. However, due to the 
comparative nature of this study between VF-14 and VR-QoL questionnaire scores 
mean range was derived for both. 
 
Since this study was the comparison of VR-QoL questionnaires, only two components 
of the QOV questionnaire was used for this study, namely: Overall QOV for day and 
overall QOV for night. This was measured on a Likert scale of 0-10, zero represented 
worst visual appreciation while ten represented best visual appreciation. 
 
First, the original scores obtained from the 2 questionnaires were categorised into 
three groups: distance vision, intermediate vision and near vision related activities. In 
VF-14, higher scores represent better visual functioning (less difficulty) and, therefore, 
greater ability in performing the activity while in VR-QoL questionnaire, higher scores 
represent poor visual functioning (more difficulty). Since the two questionnaires had 
two different methods of measuring visual function (although both used ordinal/Likert 
5-point scale where numerical values in an increasing order are assigned to categories 
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of increasing or decreasing difficulty) variable transformation was performed before 
comparative analysis, namely the conversion of VF-14 scores into VR-QoL equivalent 
and the rescaling of the 0-10 QOV score into a score in the range 1-5. This 
transformation was necessary in-order to carry out a meaningful comparison between 
the scores from the two questionnaires (VF-14 and VR-QoL questionnaire) and the 
QOV score. 
 
The VF-14 scores were converted into VR-QoL equivalent by subtracting each VF-14 
item score from 5. This variable transformation resulted in a both VF-14 and QoL score 
becoming equivalent. The overall QOV score for day and night (0-10) was also 
rescaled to 1 to 5 by subtracting the half of the QOV 0-10 score from 5. 
 
The purpose of the rescaling VF-14 and QOV scores was to standardise the 5-point 
Likert scale where numerical values in an increasing order represented increasing 
difficulty of visual function for a meaningful comparison.  
 
Paired samples t-test was conducted to compare the mean of the ranges of scores. 
Rasch analysis of the median scores for both questionnaires, where the items were: 
distance vision, intermediate vision, near vision, QOV Day and QOV Night was also 
performed.  Rasch analysis was also used to determine how visual function tasks were 
affected the QOV during day and night.  
 
 
7.6.5 Statistical analysis 
 
Statistical analysis was performed using SPSS for Windows (Statistical Package for 
the Social Sciences, Version 22, Chicago, Illinois, USA) and Excel (Microsoft; 
Redmond, Washington, USA). The Kolmogorov-Smirnov test was used to assess 
normality. One-way ANOVA with Tukey post hoc comparison procedures were used 
when assessing continuous normal data. For ordinal and non-normally distributed data, 
the non-parametric Mann-Whitney U test was applied.  For all statistical analysis, the 
level of significance was P<0.05.  
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7.7 Results  
 
Figure 1 shows the relative distribution of the VF-14 and VR-QoL scores 
preoperatively and in the overall group. As hypothesized, all paired t-test conducted 
to compare the mean of the ranges of scores for: 
- VF-14 questionnaire and VR- QoL for distance vision (Pair A) (Figure 7.1) 
- VF-14 questionnaire and VR- QoL for intermediate vision (Pair B) (Figure 7.2) 
- VF-14 questionnaire and VR-QoL for near vision (Pair C) (Figure 7.3) 
 
The above-mentioned analysis revealed significantly less variability in VR-QoL 
questionnaire in discriminating visual function of preoperative patients (Table 7.3). 
There was a statistically significant difference (P<0.05) in the mean range score 
obtained with the VF-14 questionnaire compared to mean range score obtained with 
VR-QoL questionnaire for pair A, B and C (Table 7.3).  
 
In Pair A: There was a statistically significant difference, at level 0.05 (p=6.85e-15) in 
the mean range score obtained with the VF-14 questionnaire compared to mean range 
score obtained with VR-QoL questionnaire. In Pair B: There was a statistically 
significant difference, at level 0.05 (p=1.40e-15) in the mean range score obtained with 
the VF-14 questionnaire compared to mean range score obtained with VR-QoL 
questionnaire. In Pair C: There was a statistically significant difference, at level 0.05 
(p=2.979e-9), in the mean range score obtained with the VF-14 questionnaire 
compared to mean range score obtained with VR-QoL questionnaire. 
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Figure 7.1. Comparision of score range of VF-14 and VR-QoL questionnaires for 
distance vision related visual function. 
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Figure 7.2. Comparision of score range of VF-14 and VR-QoL questionnaires for 
Intermediate vision related visual function.   
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Figure 7.3. Comparision of score range of VF-14 and VR-QoL questionnaires for 
Intermediate vision related visual function.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7.3 Paired t-test for the mean ranges of the scores 
 
Paired Samples t-test Statistics  
 
 
 
p-value 
Confidence 
Interval (CI) at 
95% 
Value of t-test 
statistic (t) 
Degree of 
freedom (df) 
Std. Deviation 
of the pair 
difference 
 
 
Pair A 
 
 
 
6.85e-15 
 
 
[1.345; 1.949] 
 
 
10.954 
 
 
50 
 
 
1.074 
 
 
Pair B 
 
 
1.40e-15 
 
 
[1.067; 1.521] 
 
 
11.448 
 
 
50 
 
 
0.807 
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Pair C 
 
 
 
2.979e-
9 
 
 
[0.593; 1.053] 
 
 
7.194 
 
 
50 
 
 
0.817 
 
 
Similar in all Rasch analysis revealed that VF-14 questionnaire underestimates the 
item difficulty parameter, and this can be attributed to the variability caused by 
irrelevant questions from the item categories (distance, intermediate vision and near 
vision) in the VF-14 questionnaire (Table 7.4). Table 7.5 displays the number of 
patients that found the items on the VF-14 questionnaire was not relevant to their daily 
visual function.  
 
 
Table 7.4 Rasch analysis of the median scores for both questionnaires, where items 
related to near, intermediate and distance vision, QOV for day and QOV for night. 
 
VR-QoL 
Items 
Items 
difficulty 
Standard 
Error 
Outfit 
MNSQ 
Infit 
MNSQ 
Near vision   -5.41 0.35 1.84 0.96 
Distance vision  -1.9 0.33 0.73 0.76 
Intermediate vision  -1.63 0.33 1.04 1.14 
QOV-Night 3.07 0.37 1 0.97 
QOV-Day 5.88 0.39 1.02 1.03 
     
VF-14 
Items 
Items 
difficulty 
Standard 
Error 
Outfit 
MNSQ* 
Infit 
MNSQ* 
Near vision   -3.97 0.34 0.84 0.87 
Distance vision  -1.6 0.31 1.29 1.19 
Intermediate vision  -1.11 0.31 1.2 1.14 
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QOV-Night 2.04 0.35 0.98 0.91 
QOV-Day 4.63 0.39 0.81 0.9 
*MNSQ = Mean Squared 
 
 
Table 7.5 Patients perspective on VF-14 questionnaire   
 
Items on VF-14 
Not relevant to 
patients  
Not relevant to 
patients (%) 
playing sports 30 58 
watching television 5 9 
difficulty driving during the day -- -- 
difficulty driving at night 10 19 
reading signs 5 9 
recognizing people -- -- 
seeing steps or curbs or stairs -- -- 
writing checks or filling out 
forms 
12 23 
playing board games 20 39 
cooking 15 29 
reading small print 14 27 
reading a newspaper or book -- -- 
reading a large print publication -- -- 
doing handwork 25 49 
n=51 patients  
 
 
7.8 Discussion 
 
Although several questionnaires are available to measure VR-QOL.  A brief, valid, 
relevant and easily comprehensible questionnaire that allows for a precise monitoring 
of severity is essential. The VF-14 questionnaire is a validated questionnaire 
developed by Steinberg et al. It has gained increasing acceptance in clinical and 
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research settings. In contrast, the VR-QoL questionnaire is short and personalised 
questionnaire that measures distance, intermediate and near visual function relevant 
to the patient.  These unique characteristics of the VR-QoL questionnaire has 
demonstrated to be more precise with less variability in assessing patient’s VR-QOL 
(Table 7.3).  
 
The results from the Rasch analysis demonstrates that this cohort of patients are more 
affected by near vision task.  Since the items for “Near vision” had the lowest item 
difficulty for both questionnaires, suggesting that both questionnaires were in 
agreement with near vision tasks being difficult. However, the item difficulty score for 
VR-QoL questionnaire was greater than VF-14. This finding implies that pre-defined 
items/questions on the VF-14 questionnaire did not clearly define and capture near 
vision related tasks of the patient. The item difficulty in VR-QoL questionnaire is 
greater than VF-14 questionnaire for distance and intermediate vision. This highlights 
the fact that pre-determined visual function questions on a questionnaire cannot 
correctly assess the true visual function of an individual (Table 7.4). Additionally, the 
item difficulty for QOV questionnaire at night was lower than the item difficulty 
parameter for the QOV questionnaire at day.  This indicates that the patients are more 
affected by near vision tasks particularly during the night. 
 
Gothwal et al. (2010) also demonstrated that out of the fourteen items in VF-14 
questionnaire, two items measured a construct different than the remaining twelve 
items (not visual functioning). Principal component analysis conducted by  Gothwal et 
al. (2010) further confirmed the lack of unidimensionality by revealing the presence of 
a secondary dimension. Conversely, VR-QoL questionnaire items are defined by the 
patient and highly relevant to the patients QOL. The VR-QoL questionnaire 
demonstrated to be better at capturing with less variations.  Although the sample size 
was small, significant differences was found. The analysis of VF-14 questionnaire 
responses revealed that 58% of the patients did not find the item ‘playing sports’ 
relevant. This low level of relevance of this item can explained by the patient 
demographics (mean age: 74 ± 17; morbidity: cataract). ‘Playing board games’ 
‘cooking’ and ‘doing handy work’ also had high percentage of not being relevant to the 
patients (39%, 29% and 49% respectively). These findings of high irrelevancy of items 
in the VF-14 questionnaire to patients suffering from age related cataract suggest the 
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weakness of the questionnaire to capture the QOL status of the individual. Finally, with 
only 6 relevant items on the VR-QoL questionnaire, the respondent burden and 
administration time are minimal. 
 
The proposed VR-QoL questionnaire and this study is not without limitations. This 
current study is pilot study for the validation of VR-QoL questionnaire. For this purpose, 
a larger sample size visual function score would have to correlate with VA. This will 
be tested using the VA data and Pearson correlation coefficients.  
 
 
7.9 Conclusion  
 
In conclusion, our results show that VR-QoL questionnaire performs better than VF-
14 questionnaire in-terms of less variability in the mean range scores. The tailored 
items of VR-QoL questionnaire was better able to assess the patients VR-QOL. Given 
these benefits, it is passable to conclude that the concept of personalised and adaptive 
QOL questionnaires are better in comparison to traditional pre-determined items on a 
questionnaire.   
 
 
7.10 Summary   
 
Questionnaires in ophthalmology are increasingly being required for assessing visual 
function in patients. Traditional psychometric VR-QOL questionnaires items lack 
brevity and do not take into consideration the individuality of the patient’s visual 
function needs therefore VR-QoL questionnaire has the potential to accurately assess 
patients by means of direct active interaction with each patient.    
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CHAPTER 8: DISCUSSION AND CONCLUSION   
 
This body of work has sought to assess the impact of anatomical variations in visual 
axis, pupil size and ocular surface pathologies upon the QOV achieved during both 
multifocal IOL surgery along with other forms of refractive laser surgery. It has also 
sought to explore both: 
-how these issues can impact VR- QOL, and  
-assess if the traditional VR-QOL questionnaires can be improved.  
 
A comprehensive set of pre-assessment equipment was used to investigate the pupil 
size, centroid shift, preoperative aberrations, and a photographic methodology 
developed to assist in the visualization of IOL centration. Improved IOL centration with 
regards to the centre of the photopic was demonstrated to improve a patient’s overall 
QOV.  A novel methodology of placement of the near add was developed.  This 
enabled patients to increase the likelihood of high level of postoperative QOV and 
improved VR-QOL. This new methodology has now been advocated by the IOL 
manufacturer (Lenstec, UK) for common usage of these IOLs throughout the world. 
The results obtained with regards to the optimal pupil size can guide surgeon to 
preoperatively stratify patients and determine whether asymmetric multifocal IOLs 
should be used.   
 
The human eye is not symmetrical and therefore in some patients a large deviation in 
the form of angle kappa. If this angle kappa coincides with a large centroid pupil shift, 
this combination can result in a significant encroachment of the pupil upon the near or 
distance section of an asymmetric multifocal IOL.  This results in a significant reduction 
of QOV for either distance or near vision. A similar problem can also occur for different 
reasons: 
 
Asymmetric fibrosis of a capsular bag can significantly decentre an IOL. For this 
reason, the authors have advocated the routine use of CTR in all routine IOL 
implantation surgery.   
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Another common cause of IOL decentration encountered was due to the periphery of 
the capsular bag not being centred upon the centre of the photopic pupil. This was 
found to be relatively consistent with 70% of the centre of the IOLs decentred 
superotemporal from the centre of the photopic pupil. With this knowledge, placing the 
near section of the asymmetric multifocal IOL in a superoptemporal position to 
enhances distance vision in the dominant eye. In the non-dominant eye placing the 
near section in the inferionasal position enhances near vision. 
 
The preoperative assessments of angle kappa, pupil size and pupil centroid shift 
should be done in all eyes when using asymmetric multifocal IOLs.  These 
assessments allow preoperative patient stratification for optimal visual outcome and 
postoperative patient satisfaction. The importance of multifocal IOL centration stated 
on this thesis is in line with findings of Werblin et al. (2001). Therefore, the findings of 
chapter 2, 3 and 4 of this thesis all reinstate the value of preoperative planning and 
accurate placement of asymmetric multifocal IOL. Additionally, chapter 3 of this thesis 
demonstrated the difficulty of centering the asymmetric multifocal IOL within a 
pharmacologically dilated intraoperative pupil. As there are no reference to where the 
photopic pupil centre would be postoperatively. The accurate depiction of the position 
of photopic pupil centre intraoperatively could allow bespoke positioning of asymmetric 
IOLs which took into account any unexpected malposition due to capsular bag 
positional anomalies.   
 
The causation of photopic phenomena is multifactorial and our study suggests that 
angle kappa may possibly be one of the factors influencing it. However, it was also 
demonstrated that if the photopic pupil was greater than 3.2 mm postoperatively that 
angle kappa had less of an impact upon the overall QOV. 
 
Less optimal QOV in asymmetric multifocal IOLs can arise from inadequate pupil size 
as a smaller pupil (< 3.00 mm) does not allow adequate exposure of both the optical 
sections of the asymmetric multifocal IOL. In other words, small pupils do not allow 
enough light to enter and fall on asymmetric multifocal IOL leading to poor QOV. 
Therefore, this poor exposure of the asymmetric multifocal IOL within a pupil can be 
alleviated by preoperatively selecting patients who have pupil diameter of a minimum 
of 3.00mm. 
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The role of pupil size and pupil centroid shift in multifocal lens is further verified by the 
fact that in a study conducted on monofocal IOLs concluded that pupil size and IOL 
decentration did not correlated with the postoperative visual outcome, contrary to the 
belief that decentration in all IOLs can lead to degradation of visual image and 
refractive error Werblin (2001). The plausible explanation to this finding may be due 
to the fact that monofocal IOLs have single optical design, unlike in multifocal IOLs 
where under exposure of light to a specific optical region of the IOL can occur. The 
role and importance of adequate exposure of the asymmetric multifocal IOLs within 
the pupil was further supported by the IOL rotation study where postoperative patients 
with poor QOV with pupil centroid shift had their IOLs rotated to compensate the pupil 
shift for a better centration of the IOL. This resulted in significant improvement of QOV. 
We have therefore incorporated these findings to our daily clinical practice and 
recommend preoperative pupil assessment in all patients opting for asymmetric 
multifocal IOLs.  
 
The importance of tear lipid layer and its role in vision is underlined by the definition of 
DE (Lemp, Baudouin and Baum, 2007a). Observation and analysis of interferometry 
patterns of the tear lipid layer has been used by various studies to measure and 
quantify the severity of DE with relatively good agreement among different researchers 
where the thickness  was measured to be 102 ± 3 nm using an interference microscopy 
(Norn, 1979), 68 nm by interference microscopy (Lemp and Marquardt, 1992), 13–70 
nm by specular reflectometry(Guillon, 1982), 70–80 nm by specular reflectometry 
(Olsen, 1985) and 32–46 nm by photometric reflectometry (Yokoi, Takehisa and 
Kinoshita, 1996). The value to using these techniques to assess tear lipid layer lies is 
their simplicity of use and non-invasiveness nature. TF instability due to poor or lack 
of meibomian gland function can precipitate optical disturbances resulting in reduced 
QOV which is generally reported by DE and post laser surgery patients (Goto et al., 
2002; Savini, Barboni and Zanini, 2006). This direct relationship between interference 
patterns and the amount of lipid layer on the TF make it an attractive technique. It also 
offers researcher the opportunities to relate tear lipid layer with other tests and DE 
symptomology. The short coming of TF interferometry assessment for now is that it 
does not yield direct quantitative data and relies on a grading scale. The tear lipid layer 
chapter showed a strong correlation with the postoperative glare in SMILE and glare 
and fluctuations in vision in fs-LASIK patients. It also demonstrated that the immediate 
 161 
effects of laser refractive surgery had the tendency to disrupt the TF. However, 
additional work is required to understand the dynamics and recovery of lipid layer 
disruption after laser refractive surgery. The understanding from this chapter highlights 
the importance of tear lipid layer in post laser refractive surgery visual recovery. Along 
with other DE tests tear lipid layer interferometry allows for holistic and comprehensive 
ocular surface assessment approach to preoperative stratification and selection of 
patients considering refractive laser surgery treatment.  
 
In CXL the removal of the corneal epithelium is an essential step that allows the 
penetration, homogenous absorption and distribution of riboflavin solution into the 
stroma of the cornea. The inadequate removal of the epithelium has been documented 
by Kymionis et al. (2012) to result in reduced biomechanical stiffening effect of the 
treatment. Additionally, corneal imaging using anterior segment OCT and corneal 
confocal microscopy have revealed clear distinction between CXL performed with and 
without epithelial debridement. These findings support the comparative study between 
CXL with manual epithelial debridement and CXL combined with trans-PTK excimer 
mode in chapter 6.  The findings of chapter 6 demonstrate that combining trans-PTK 
with CXL led to an earlier functional improvement of vision and stabilises the ectatic 
disorder. Trans-PTK smoothens the anterior corneal stroma by masking effect of the 
epithelium to partially eradicate some of the underlying irregular stroma astigmatism. 
This leads to an overall improvement in the corneal topography of the keratoconic eye 
(Kymionis et al., 2014). Although the clinical utility and success of CXL alone has been 
well documented there are multiple different forms of additive treatments called ‘CXL 
plus’ and ‘CXL extra’. These methodologies are designed to stabilise the ectatic 
disorder and improve VA. However, since every individual patient has different level 
of disease severity. It is important to evaluate these methodologies to gain a better 
understanding on how varying levels of KC severity responds to these added 
treatments. The findings in chapter 6 suggests that larger levels of preoperative 
maximum K could be a positive preoperative factor in determining a beneficial 
improvement in postoperative visual outcomes. The extension of this research would 
be to examine the implication of preoperative maximum K values on a larger cohort 
for a longer period time. This will help us validate our initial findings.  
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Chapter 7 of this thesis initiated the investigation to test the validity and assumptions 
of VR-QOL questionnaires. Unfortunately, it has not been possible to attain a sufficient 
sample size to validate the proposed hypothesis that “asking the patient to choose two 
specific items that are relevant and meaningful to their VR-QOL for distance, 
intermediate and near vision (total 6 items) will generate a more accurate status and 
representation of their visual function in comparison to generic prechosen items on a 
questionnaire”. Using Rasch analysis, initial findings of this chapter appears to 
demonstrate the weakness of generic pre-determined items on a questionnaire. Due 
to heterogeneity and variations in any given population regarding visual function, the 
static nature of pre-defined items on a questionnaire fails to be relevant to all or some 
participant (depending upon the sample population). This failure of relevancy in 
previously Rasch validated questionnaires was also been documented by Gothwal et 
al. (2010). Gothwal and colleauges administered the VF-14 questionnaire (validated 
and accepted) to a cohort of 210 cataract patients. Out of the 14 items, they found that 
only 8 items were considered ideally suited for measuring cataract surgery outcomes. 
Therefore, using Rasch analysis Gothwal et al. (2010) removed these irrelevant items 
and derived a shorter VF-8 questionnaire which had high precision in ‘their’ sample of 
cohort. In-order to mitigate such irrelevancy of items on a questionnaire, chapter 7 of 
the thesis devised a novel approach by allowing the participants to personally define 
VR-QOL items most relevant to them ‘within’ the domain of distance, intermediate and 
near vision. The findings of Gothwal et al. (2010) further supports the narrative that 
Rasch methodology of validation of psychometric questionnaires is based on the 
assumption that a given population is homogenous and does not take into account the 
possible heterogeneity. The follow-up to the findings of chapter 7 will be to test the 
hypothesis on a larger sample size and validate it against pre and postoperative VA 
readings.  
 
 
Limitations  
 
When comparing the effect of pupil size or angle kappa upon the QOV, one needs to 
recognise that QOV is a binocular impression which may be impacted more from one 
eye than another. There is usually little variation in angle kappa or pupil size between 
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eyes, to take into account any variation we initially averaged the pupil size and angle 
kappa between the left and right eyes. 
 
One of the limitations to the interferometry and DE study was the lack of sex matching 
between the two groups, this might have influenced the results of the findings. In this 
study the tear lipid layer was interferometry patterns were captured 2 seconds after a 
complete blink as suggested by King-Smith et al. (2000), while other studies such as 
Monte´s-Mico´ et al. (2005) suggest measuring 5 seconds after a complete blink. As 
we know that TF in DE becomes unstable sooner than in normal eyes.  Therefore by 
assessing the tear lipid layer after 2 seconds, the interferometry pattern was able to 
captured the patterns before the TF was destabilised.  However, in the future, the TF 
assessment utilising various timings will be explored. This study also did not explore 
the assessment of tear lipid layer interferometry of different areas of the cornea and 
only focused on the central corneal region around the pupil. Since TF and tear lipid 
layer thickness is suggested to vary on the corneal surface (King-Smith et al., 2000).  
 
The primary limitation to CXL and trans-PTK study is that it is a retrospective in nature.  
And for valid comparison, patients in both mechanical group were matched to patients 
in the trans-PTK group on the parameters of keratometry and pachymetry prior to 
being included in the study sample.  Therefore, this study suffers from selection bias.  
 
 
Conclusion  
 
Since the expectations of patients continues to grow. This demand can be met by 
improving technology and techniques to enhance examinations and treatments. 
Continued research is occurring throughout the world using different methodologies to 
improve the available treatments for presbyopia. The target of these technological 
enhancement is to better mimic true accommodation rather than iteratively improve 
upon the existing multifocal IOLs or other forms of monovision treatment. As the TF is 
the primary refracting surface of the eye, it is essential to ensure the ocular surface is 
consistently optimised to improve the quality of the TF.  In our clinic, we aim to further 
explore the best processes to both improve the TF and monitor both the change in TF 
quality through interferometry and other methodologies. The goal to accurately 
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measure and monitor QOV and VR-QOL in laser refractive and cataract patients using 
the proposed hypothesis in chapter 7 will therefore continue to be pursued.   
 
This body of work has currently attempted to understand various objective and 
subjective aspects of vision and their implications in vision rehabilitation. The future 
studies will be to validate the findings and examine long term changes.   
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